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RESUMO 
 
 
Antecedentes: A pré-eclâmpsia e eclampsia são o transtorno hipertensivo mais 
comum da gravidez, afeta cerca de 5% de todas as primíparas, sendo uma das 
três principais causas de mortalidade materna em todo o mundo. É a causa de 
10-15% das mortes maternas, e a maioria ocorre nos países em 
desenvolvimento. Objetivo: Desenhar uma rede virtual de cuidados de 
enfermagem para gestantes visando a prevenção da pré-eclâmpsia e eclâmpsia. 
Método: Os estudos realizados incluíram uma revisão sistemática sem meta-
análise, revisões integrativas e uma proposta teórica de uma rede virtual de 
cuidados de enfermagem para gestantes. Resultados: Os resultados são 
integrados por informações para delinear e justificar a proposta de rede virtual. 
Os resultados obtidos são apresentados em quatro manuscritos, em observância 
as Instruções Normativas do Programa de Pós-Graduação em Enfermagem da 
Universidade Federal de Santa Catarina. O primeiro, denominado "Tecnologias 
e técnicas para a prevenção e controle da pré-eclâmpsia e eclâmpsia: uma 
revisão sistemática sem meta análise". Entre os 47 artigos incluídos neste 
estudo, 18 foram revisões sistemáticas e 29 foram ensaio clínico controlado 
aleatório. Os estudos incluídos utilizaram diferentes intervenções para a 
prevenção e tratamento da pré-eclâmpsia, eclampsia. O Sulfato de Magnésio, 
mostrou-se como tratamento de escolha. O segundo manuscrito com o título de 
"Mortalidade materna associada com pré-eclâmpsia e eclâmpsia em Khyber 
Pakhtunkhwa, Paquistão. Os 8 artigos incluídos neste estudo foram 
fundamentados em pesquisa quantitativa e os dados foram coletados em 
documentos de registros hospitalares, 4 estudos foram transversais, 1 foi 
descritivo e 3 foram retrospectivos descritivos. Razão de Mortalidade Materna 
associada à pré-eclâmpsia e eclâmpsia no Khyber Pakhtunkhwa, Paquistão 
continua elevada, destaca-se que 236 das 1.336 mulheres com pré-eclâmpsia ou 
eclâmpsia morreram. O terceiro manuscrito sobre "Práticas de cuidados de 
enfermagem na prevenção e controle da pré-eclâmpsia e eclâmpsia, uma revisão 
integrativa". Inicialmente foram encontrados 2.895 artigos usando os critérios 
de busca de todas as bases de dados selecionadas e através de busca manual 
usando o Google Scholar, nestas 215 foram duplicados. Os títulos dos 2.680 
  
artigos selecionados foram lidos e restaram em 153 estudos para leitura do 
resumo. Após a leitura dos resumos foram lecionados 15 estudos para leitura do 
texto completo, e destes 14 foram incluídos na revisão. O exame físico de 
gestantes, a detecção precoce de sinais e sintomas e as técnicas corretas de 
medição da pressão arterial foram demonstradas como importantes na 
prevenção da pré-eclâmpsia e eclâmpsia. O quarto manuscrito denominado 
"Rede virtual de cuidados de enfermagem para gestantes. Um desenho teórico". 
O modelo de rede foi proposto para melhorar os cuidados a saúde materna. A 
rede pode impulsionar a comunicação entre prestadores de cuidados a saúde e 
aumentar a qualidade dos cuidados durante a gravidez e o parto até o período de 
pós-parto. Conclusões: Uma rede virtual de cuidados de enfermagem é um 
recurso para os enfermeiros prestarem cuidados, de modo que as mulheres 
tenham uma gestação com o cuidado devido. Uma rede virtual de cuidados de 
enfermagem visa, também, fortalecer a comunicação entre enfermeiros e outros 
profissionais de saúde com gestantes. 
 
Palavras-chave: Pré-eclâmpsia. Eclampsia. Mortalidade Materna. Cuidados de 
Enfermagem. Rede de Cuidados de Enfermagem. 
  
  
ABSTRACT 
 
 
Background: Pre-eclampsia and eclampsia, which are the most common 
hypertensive disorder of pregnancy, affects about 5% of all first-time mothers 
and are one of the three causes of maternal mortality worldwide. Pre-eclampsia 
and eclampsia are the cause for 10-15% of maternal deaths, the major part 
occurs in developing countries. Objectives: To design a nursing care virtual 
network for prevention the pre-eclampsia and eclampsia. Method: 
Methodological studies including a systematic review without meta-analysis, 
integrative reviews and theoretical propose of a pregnancy nursing care virtual 
network, were conducted. Results: The results are integrated into studies that 
add information to justify the virtual network proposal. The result are presented 
in four manuscripts according to the Nursing Postgraduate Program of the 
Federal University of Santa Catarina Normative Instructions. The first 
manuscript is, "Technologies and techniques for the prevention and control of 
pre-eclampsia and eclampsia: A systematic review without meta-analysis". 
Among the 47 articles included in this study, 18 were systematic reviews and 29 
were Random Controlled Trials. The included studies used diﬀerent 
intervention for the prevention and treatment of pre-eclampsia, eclampsia and 
its complications in pregnant women. Magnesium Sulfate, however, has shown 
a great success in this regards and can be called as treatment of choice. The 
second manuscript is "Maternal mortality associated with pre-eclampsia and 
eclampsia in Khyber Pakhtunkhwa Pakistan. An integrative review". Among the 
8 articles included in this study where data is collected from hospitals records 
documents, 4 studies were cross-sectional, 1 was descriptive and 3 were 
retrospective descriptive. Maternal Mortality Ratios associated with pre-
eclampsia and eclampsia in Khyber Pakhtunkhwa Pakistan continue to remain 
high (18% - 236 out of 1,336 women with pre-eclampsia or eclampsia died). 
The third manuscript is "Nursing care practices in the prevention and control of 
pre-eclampsia and eclampsia. An integrative review". A total of 2,895 articles 
were initially identified using the search criteria from all the selected databases 
and through manual searching using Google Scholar, where 215 were 
duplicated. The remaining 2,680 articles were selected for title-wise screening 
which resulted in 153 studies to be selected for abstract reading. After the 
abstract screening, 15 studies were selected for full-text reading, of which 14 
were included in the review. Physical examination of pregnant women, early 
detection of signs and symptoms, and correct blood pressure measurement 
techniques have important role in the prevention of pre-eclampsia and 
eclampsia. And finally, the fourth manuscript is " Pregnancy Nursing Care 
Virtual Network: A Theoretical Design". The theoretical model was propose to 
improve maternal health. It is expected that the network will strengthen 
communication links between health care providers and pregnant women and to 
increase awareness, and quality of care during pregnancy and childbirth till the 
period of post-partum. Conclusions: A pregnancy nursing care virtual network 
  
is a technology for nurses in order to play a better role in providing effective 
nursing care to pregnant women. Nursing care virtual network for pregnant 
women is therefore designed to strengthen the communication links between 
nurses and other health care professionals with pregnant women. 
 
Keywords: Pre-eclampsia. Eclampsia. Maternal Mortality. Nursing Care. 
Nursing Care Network. 
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THESIS ORGANIZATION 
 
 
After the chapter one (Introduction), the remaining parts of this 
thesis are organized as follows. In Chapter 2, the focus is on the 
literature review. It begins with presenting an overview about the pre-
eclampsia and eclampsia, maternal mortality pre-eclampsia and 
eclampsia, followed by a discussion on the clinical aspects of pre-
eclampsia and eclampsia and its etiology and risk factors. Besides, it 
includes nursing care in the prenatal or antenatal period, the importance 
of nursing care in the prevention of pre-eclampsia and eclampsia and 
networking in nursing practices. In Chapter 3, we discuss study 
methodology which consists of a systematic review without meta-
analysis, integrative reviews, and a theoretical design of a virtual 
network model for pregnant women. In Chapter 4, we present the 
proposal about the virtual network while Chapter 5 presents the general 
comments and future research directions. 
 
 
  
 
  
INTRODUCTION 
 
 
Woman is the source of all human life on this planet. The 
pleasure and excitement of being a mother cannot be expressed in 
words, and all the people in the world recognize it an important family 
process. In all cultures and societies, being pregnant or to give birth to a 
child is considered as an important, beautiful and divine event (DUTTA, 
2001). Pregnancy, the precious period of every woman’s life requires 
continuous, prompt and supportive care throughout pregnancy and also 
after childbirth for safe motherhood. 
Every day in 2015, about 830 women died due to pregnancy 
complications and childbirth (WHO, 2015a). Almost all of these deaths 
occurred in low-resource settings, where most could have been 
prevented. The primary causes of death are hemorrhage, hypertension, 
infections, and indirect causes, mostly due to the interaction between 
pre-existing medical conditions and pregnancy. Of these 830 daily 
maternal deaths, about 550 occurred in sub-Saharan Africa and 180 in 
Southern Asia, compared to 5 in developed countries. The risk of a 
woman in a low resource setting dying from a pregnancy-related 
complication during her lifetime is about 33 times higher compared to a 
woman living in a developed country (WHO, 2015a). 
Pregnant women die as a result of complications which either 
develop during pregnancy or may exist before pregnancy but are 
aggravated during pregnancy. The major complications that account for 
nearly 75% of all maternal deaths consist of pre-eclampsia and 
eclampsia (together 14%), Severe bleeding (27%) and Infections (11%) 
(SAY et al., 2014) (See Figure 1). 
Most maternal deaths are preventable, as the health-care solutions 
to prevent or manage these complications are well-known (WHO, 
2015a). WHO recommends that all pregnant women should have access 
to antenatal care in pregnancy, skilled care during childbirth, and care 
and support in the weeks after childbirth. It is particularly important that 
all births are attended by skilled health professionals, as timely 
management and treatment can make the difference between life and 
death for both the mother and the baby (WHO, 2015a). Nurses need to 
study and develop technologies to prevent and control the major 
complications associated with toxemia or without toxemia, highlighted 
below: 
 
 
28 
 
Figure 1 - World Wide Maternal Death Causes. 
 
 
Source: Say et al., (2014). 
 
Severe bleeding after birth can kill a healthy woman within hours 
if she is unattended. She need injecting oxytocin immediately after the 
labor.  
Infection after childbirth can be eliminated if good hygiene is 
practiced and if early signs of infection are recognized and treated in a 
timely manner. 
Pre-eclampsia should be detected and appropriately managed 
before the onset of convulsions (eclampsia). Administering drugs such 
as Magnesium Sulfate for pre-eclampsia can lower a woman’s risk of 
developing eclampsia. 
On the other hand, to avoid maternal deaths, it is also vital to 
prevent unwanted and too-early pregnancies. All women, including 
adolescent girls, need access to contraception, safe abortion services to 
the full extent of the law, and quality post-abortion care (WHO, 2015a). 
In 2015, Maternal Mortality Ratio in developing countries was 
239 per 100,000 live births and in developed countries was 12 per 
100,000 live births. In south-east Asia 166 maternal deaths per 100,000 
live births occurred, in western pacific 41 maternal deaths per 100,000 
live births occurred, in Africa 542 maternal deaths per 100,000 live 
births occurred, in Europe 16 maternal deaths per 100,000 live births 
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occurred, in America 52 maternal deaths per 100,000 live births 
occurred and in Eastern Mediterranean 166 maternal deaths per 100,000 
live births occurred. Figure 2 shows the graph of Maternal Mortality 
Ratio (maternal deaths per 100,000 live births) globally by WHO 
region,1990-2015. It is important to understand the disparities between 
countries included within countries, and between women with high and 
low income and those women living in rural versus urban areas. The 
number of women dying due to complications during pregnancy and 
childbirth has decreased by 43% from an estimated 532,000 in 1990 to 
303,000 in 2015 (WHO, 2015a). 
 
Figure 2 - Maternal deaths per 100,000 live births, globally and by WHO 
region (1990-2015). 
 
 
Source: WHO, (2015b). 
 
WHO is supporting countries to deliver integrated, evidence-
based and cost-effective nursing care for all mothers during pregnancy, 
childbirth and the postpartum period. Improvement in health systems, 
particularly in training midwives and in making emergency obstetric 
care available 24/7, is very important to reduce maternal mortality. 
Globally, the reduction in maternal deaths between 1990 and 2015 was 
43% (WHO, 2015a). Maternal Mortality Ratio (maternal deaths per 
100,000 live births) globally and by WHO region from 1990 to 2015, is 
shown in Figure 3. 
Pre-eclampsia is a hypertensive disorder of pregnancy that 
usually occurs after 20 weeks of pregnancy, determined by many 
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factors, most of which are preventable, particularly in prenatal care. 
Preeclampsia is a combination of hypertension (high blood pressure) 
and proteinuria (protein in the urine) (DULEY; HENDERSON-
SMART; WALKER, 2009). 
 
 
Figure 3 - Maternal Mortality Ratio (maternal deaths per 100,000 live births) 
globally by country, 2015. 
 
 
Source: Alkema et al., (2016). 
 
But this condition is also associated with abnormalities of the 
coagulation system, liver failure, renal and cerebral ischemia. Most 
women with pre-eclampsia give birth without problems. However, 
severe pre-eclampsia can cause problems such as stroke, kidney failure, 
liver failure and blood clotting (DULEY; HENDERSON-SMART; 
WALKER, 2009). 
Similarly, eclampsia, which is usually rare, but potentially fatal 
characterized by the presence of a seizure associated with pre-eclampsia, 
weight gain, headaches and dizziness (DULEY et al., 2010a). Research 
has shown that about 1 in 200 women who had pre-eclampsia, possibly 
progress to a more dangerous condition of eclampsia, which is 
responsible for about 50,000 maternal deaths each year (KHAN et al., 
2006). 
Pre-eclampsia and eclampsia together are one of the three leading 
causes of maternal mortality in the world (GHULMIYYAH; SIBAI, 
2012). Pre-eclampsia and eclampsia are associated with substantial 
maternal complications, both acute and long-term. (GHULMIYYAH; 
SIBAI, 2012). Over the past 50 years, there has been a significant 
reduction in rates of eclampsia and maternal mortality in developed 
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countries. In contrast, most maternal deaths and complications are due 
to lack of prenatal care, lack of access to services of hospitals, lack of 
resources and inadequate diagnosis and treatment of patients with pre-
eclampsia. Similarly, the lack of protocols for disease management or 
failure to follow clinical protocols of care contributes toward high 
maternal mortality. Clear protocols for management of hypertension in 
pregnancy at all levels of health care is required for better maternal as 
well as perinatal outcome (MIKO et al., 2013). 
The term eclampsia was first coined by a French physician 
Francois Boissier de Sauvages de Lacroix in 1739, as an acute form of 
convulsion, and contrasted with the chronic condition now known as 
epilepsy (CHESLEY, 1974). Similarly, proteinuria in the context of 
eclamptic seizures was first described in 1840, and high blood pressure 
shortly after that. By 1894, it was reported that high blood pressure and 
proteinuria could occur in pregnant women, without eclamptic seizures, 
and the term pre-eclampsia was thus born (CHESLEY, 1984). 
Approximately 10% of pregnant women have blood pressure 
recorded above normal at some point during pregnancy. Pre-eclampsia, 
which is now known to be a multisystem disorder of pregnancy, 
complicates 2-8% of pregnancies in the western world and 5% of first-
time mothers (NORTH et al., 2011). The effect of pre-eclampsia and 
eclampsia in the developing world is staggering and about 10-15% of 
maternal deaths are attributed to pre-eclampsia, of which 99% occur in 
the developing world (DULEY, 2009). 
 
 
Table 1 - Complications of pre-eclampsia. 
 
System Complications 
Central nervous 
system 
Eclampsia, Cerebral haemorrhage, Cerebral edema, 
Retinal edema, Cortical blindness 
Renal system Renal tubular necrosis, Renal cortical necrosis 
Respiratory system Pulmonary edema, Laryngeal edema 
Hepatic system Disseminatedintravascular coagulation, Haemolysis 
Liver Haemolysis, elevated liver enzymes, low platelets, 
(HELLP) syndrome, Jaundice 
Placenta Placental abruption, Placental infarction 
Baby Growth restriction, Preterm delivery, Death 
Source: Adapted from Duley (2009, p.132). 
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Hypertension is not always associated with pre-eclampsia. The 
difficult and often delayed diagnosis is due to the fact that most women 
with pre-eclampsia are symptom-free. Women with more severe forms 
of pre-eclampsia often complain of a headache, abdominal pain and 
visual disturbance, and can suffer complications to virtually all the 
body’s systems, as summarized in Table 1. The disease does not just 
affect the mother and about one-third of babies born to women with pre-
eclampsia are born premature, and one-quarter is growth restricted. 
 
 
1.1 MOTIVATION AND PROBLEM STATEMENT 
 
Nursing knowledge represents the science of nursing, and nursing 
care represents the art of nursing. The knowledge of nursing and nursing 
care practice, both must be present, and both are important for quality 
nursing care (FINKELMAN; KENNER, 2013). According to WHO, the 
majority of deaths due to pre-eclampsia and eclampsia are avoidable 
through the provision of timely and effective care to the women, 
especially in the prenatal period (WHO, 2011a). 
Maternal mortality associated with eclampsia is high in Brazil, 
especially in low-resource settings and lower income regions. Promoting 
quality maternal health care and improving the availability of obstetric 
emergency care are essential actions to relieve the burden of eclampsia 
in Brazil (GIORDANO et al., 2014; PACHECO et al., 2014). All 
women should have access to antenatal care in pregnancy, skilled 
nursing care during childbirth, and care and support in the weeks after 
childbirth (WHO, 2015a). 
Among the developing countries in Pakistan eclampsia is a 
common cause of maternal deaths (MICHEAL, 2000). In Pakistan each 
year, an estimated 25,000 to 30,000 women die of pregnancy-related 
complications. It shows that the maternal health figure is poor. The main 
factors are access to the health care services, low socioeconomic 
conditions. The poor emergency obstetrical condition is also a reason for 
high maternal mortality (GILLANI; HASSAN, 2011). 
Poor access to health care facilities, poverty, lack of trained 
primary health care providers and local tradition/preference of home 
deliveries are contributing towards higher mortalities in Pakistan 
(BUTT, 2004). 
In Pakistan, maternal mortality is a public health concern which 
needs to be highlighted. There are many factors contributing to maternal 
mortality. Poverty is the most significant determinant that prevents 
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females from receiving education, having nutritious foods and accessing 
reproductive healthcare services. Reducing inequity and promoting 
female education are among the key strategies to empower women and 
balance their status. 
Maternal mortality due to obstetric emergencies can be prevented 
by strengthening the available healthcare facilities and increasing the 
skills of female birth attendants. Moreover, governmental and non-
governmental organizations should implement a focused program for 
female education, which would consequently reduce the rate of early 
marriage. In fact, empowering educated women will consequently 
improve their socio-economic status and will reduce the gender 
inequality, as well. 
Underprivileged women should be encouraged to use antenatal 
care services in order to eliminate financial issues. Food supplements 
and medicines for the correction of anemia should be also provided for 
pregnant women. In addition, reproductive healthcare services including 
post-abortion care and family planning services should be made 
available, accessible and affordable within community settings. 
Civil society organizations, educationists, and healthcare 
professionals should raise awareness regarding Child Marriage Restraint 
Act 1929 and its reinforcement, as child marriage is widely practiced in 
some parts of the country. More skilled birth attendants should be 
trained and employed in order to provide 24-hour healthcare services 
and facilitate timely referral in case of obstetric emergencies (ABBASI; 
YOUNAS, 2015). 
For prevention of pre-eclampsia and other causes of the maternal 
mortality, the prenatal nursing care support is very important. In face the 
rapid improvement in information and communication technologies and 
the growing acceptability of mobile devices, we, therefore, proposed a 
theme of the study that meets both the demands of nursing care and 
women health. So we opt to develop a Pregnancy Nursing Care Virtual 
Network to strengthen links between nurses and pregnant women and 
prevent pre-eclampsia and eclampsia to reduce the maternal mortality. I 
also presented this proposal when I applied for TWAS-CNPq (The 
World Academy of Sciences and National Council for Scientific and 
Technological Development Brazil) Postgraduate fellowship in 2012. 
 
1.2 RESEARCH QUESTION 
What components should be integrated into a network model of 
nursing care for prevention of pre-eclampsia and eclampsia? 
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1.3 OBJECTIVES 
 
To design a nursing care virtual network for prevention pre-
eclampsia and eclampsia. 
 
 
1.3.1 Specific Objectives 
 
- To assess the technologies and techniques for prevention of 
pre-eclampsia and eclampsia; 
- To show the maternal mortality associated with pre-eclampsia 
and eclampsia in Khyber Pakhtunkhwa province of Pakistan, 
from the scientific literature published between 2000 to 2015; 
- To assess the nursing care practices for prevention and control 
of pre-eclampsia and eclampsia; 
- To define the requirement for designing a nursing care virtual 
network for pregnant women.  
 
 
2 BACKGROUND AND LITERATURE REVIEW 
 
 
A number of different definitions related to eclampsia are used in 
literature. Some of them are more detailed than others, some are more 
inclusive than others, and in some cases, the same term has been used to 
describe different disorders by different authors. This chapter starts the 
discussion by defining the main terms and definitions used in this thesis. 
 
 
2.1 DEFINITIONS 
 
Maternal death is defined as the death of a woman during 
pregnancy or within 42 days of termination of pregnancy, caused or 
aggravated by the pregnancy or its management, irrespective of the 
location or duration (WHO, 2016). 
Live Birth occurs when a fetus, irrespective of the duration of the 
pregnancy, exits the maternal body and subsequently shows any sign of 
life, such as voluntary movement, heartbeat, or pulsation of the 
umbilical cord, for however brief time (WHO, 2016). 
Hypertension is defined as elevation of systolic blood pressure 
by 30mmHg above the normal and/or 15mmHg of diastolic blood 
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pressure above the normal (ACOG, 2002). 
Gestational Hypertension is defined as arterial hypertension 
(systolic BP ≥ 140 mmHg and / or diastolic BP ≥ 90 mmHg on 2 
occasions > 6 hours apart) occurring after gestational week 20, which 
returns to normal post-partum (PILLITTERI, 2010). 
Chronic Hypertension is hypertension diagnosed before the 20th 
gestational week or hypertension which fails to settle post-partum 
(PILLITTERI, 2010). 
Pre-eclampsia is defined as a blood pressure of at least 
140mmHg systolic pressure and 90mmHg diastolic pressure measured 
on two occasions 6 hours apart, accompanied by proteinuria of at least 
300 mg per 24 hours, or dipstick analysis of ≥ + 1, after 20 weeks of 
pregnancy (ACOG, 2002; SIBAI, 2008). 
Pre-eclampsia superimposed on chronic hypertension is defined 
as the appearance of proteinuria starting after gestational week 20. A 
sudden increase in blood pressure or proteinuria or the appearance of 
thrombocytopenia or deranged transaminases is said to be suggestive but 
not diagnostic of superimposed pre-eclampsia (PILLITTERI, 2010). 
Eclampsia refers to the development of grand mal seizures in a 
woman with gestational hypertension or pre-eclampsia (SIBAI, 2005). 
 
Despite this general agreement, many questions remain about 
how the disease should be classified. Some classifications define 
preeclampsia as pregnancy-induced hypertension in association with 
proteinuria, or other complications such as renal insufficiency, liver 
disease, neurological problems, haematological disturbance, or 
intrauterine growth restriction (NORTH et al., 2011). Further definitions 
separate proteinuric from non-proteinuric pre-eclampsia. Proteinuric 
preeclampsia is reported to carry a worse prognosis than non-proteinuric 
pre-eclampsia, which is in turn reported to carry a worse prognosis than 
gestational hypertension alone (HOMER et al., 2008). 
It is also still unknown, whether the early onset which is usually 
defined as that occurring before 34 weeks’ gestation and late-onset 
variants of pre-eclampsia are the same disease, or whether they have 
completely different pathological mechanisms. Similarly, what is the 
difference or how to define severe and mild pre-eclampsia is another 
matter for debate. A further complicating factor is that the association of 
pre-eclampsia with preterm delivery, small for gestational age (SGA) 
babies, or both, appear to have different consequences, particularly for 
the mother’s future cardiovascular health (SMITH; PELL; WALSH, 
2001). 
36 
 
Although the cause of pre-eclampsia remains largely unknown, 
the pathogenesis is thought to occur in two main phases. The first phase 
begins in the placenta while the second stage is characterized by an 
abnormal maternal endothelial response, resulting in hypertension, 
proteinuria, and edema that characterize the condition. 
 
 
2.1 MATERNAL MORTALITY DUE TO PRE-ECLAMPSIA AND 
ECLAMPSIA 
 
Each year worldwide about 300,000 women die due to 
pregnancy-related complications. In these deaths about 50,000 women 
die due to pre-eclampsia and eclampsia, of which 99% occur in 
developing countries (WHO, 2015a). In Brazil, maternal mortality ratio 
was 44 while in Pakistan it was 178 per 100,000 live births in the year 
2015 (WHO et al., 2015). 
Hypertensive disorders of pregnancy are responsible for one out 
of ten maternal deaths in Africa and Asia, and nearly one-quarter in 
Latin America (CAMPBELL et al., 2006). Among the hypertensive 
disorders of pregnancy, pre-eclampsia and eclampsia are the important 
causes of maternal mortality (DULEY, 2009). 
Globally, pre-eclampsia is a leading cause of maternal mortality 
(GHULMIYYAH; SIBAI, 2012). Worldwide an estimated 300,000 or 
more women die each year from complications of pregnancy and 95% 
of these women are in Africa and Asia (WHO, 2015a). Pre-eclampsia 
and eclampsia together affect about 10% of all pregnant women around 
the world (GHULMIYYAH; SIBAI, 2012). In Afghanistan, pre-
eclampsia and eclampsia are the second leading cause of maternal 
deaths (AHADI et al., 2015). Another study conducted in September 
2014 in Tanzania found that in 2011 there were 155 maternal deaths and 
hence MMR of 1,541 per 100,000 live births. In these maternal deaths, 
69.5% were analyzed for direct causes. Of the direct causes, pre-
eclampsia and eclampsia were the major cause (19.9% of all deaths) 
(PEMBE et al., 2014). 
Eclampsia, which is usually rare but potentially life-threatening, 
is characterized by the occurrence of a seizure in association with pre-
eclampsia, headaches, swelling feet, sudden weight gain and changes in 
vision (DULEY et al., 2010a). About 1 in 200 women who had 
preeclampsia, eventually also progress to a dangerous condition known 
as eclampsia which is responsible for about 50,000 maternal deaths each 
year worldwide (KHAN et al., 2006b). 
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Maternal mortality rate and health care quality vary among low 
and middle-income countries (KIDANTO et al., 2012). In developed 
countries due to the provision of effective antenatal care services and 
extensive research now pre-eclampsia and eclampsia have controlled 
and has become rare complication of pregnancy (KEELING et al., 
1991). 
Although the rate of pre-eclampsia and eclampsia and the number 
of maternal deaths associated with it have fallen over recent years but in 
places where maternal mortality is high, most of these deaths are still 
associated with pre-eclampsia and eclampsia. Even in countries with 
low maternal mortality, a substantial proportion is due to preeclampsia 
and eclampsia (GOLDENBERG et al., 2011; DANSO; OPARE-ADDO, 
2010). For example, in the United Kingdom, pre-eclampsia and 
eclampsia together account for 15% of direct maternal deaths and two 
thirds are related to pre-eclampsia (ALTMAN et al., 2002; WALKER, 
2000). 
The rate of pre-eclampsia and eclampsia is higher in the 
developing countries due to the lack of prenatal care and access to 
proper hospital care (GOLDENBERG et al., 2011). For example, 
hospital-based studies in Nigeria have reported that eclampsia accounted 
for up to 32% of all maternal deaths (MAIRIGA; SALEH, 2009). 
Similarly, the lowest rate for eclampsia was reported in the United 
Kingdom as 2.7/10,000 deliveries (KNIGHT, 2007). 
A survey realized in 2003 with approximately 300,000 deliveries 
reported that severe maternal morbidity was associated with 
hypertensive disorders of pregnancy in the United States. The data were 
obtained from the National Hospital Discharge Survey from 1988 to 
1997. The overall incidence of hypertensive disorders in pregnancy was 
5.9%. Eclampsia was reported at 1.0 per 1000 deliveries. The incidence 
of eclampsia, severe pre-eclampsia, and superimposed pre-eclampsia 
remained unchanged during the 10-year period (ZHANG; MEIKLE; 
TRUMBLE, 2003). 
Women with preeclampsia and eclampsia had an increased risk of 
3-25 times of serious complications such as placental abruption, 
thrombocytopenia, disseminated intravascular coagulation, pulmonary 
edema and aspiration pneumonia. African-American women not only 
had a higher incidence of hypertensive disorders in pregnancy but also 
tend to have a higher risk of serious complications (ZHANG; MEIKLE; 
TRUMBLE, 2003). 
These findings suggest that pre-eclampsia and eclampsia 
constitute a worldwide public health problem to be dealt with, especially 
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in developing countries (GOLDENBERG et al., 2011; DANSO; 
OPARE-ADDO, 2010). 
It is well known that pre-eclampsia and eclampsia carry a high 
risk for severe maternal morbidity. Compared to Caucasians, African-
American women have a higher incidence of hypertensive disorders in 
pregnancy and suffer from more severe complications. The dangers of a 
high systolic blood pressure, especially in combination with a low 
platelet count, seem to be much underestimated in relation to 
intracerebral hemorrhage (MARTIN JR et al., 2005). 
As for hospitalizations without hypertensive disorders, the risk of 
serious obstetric complications was 3.3 to 34.8 times for hospitalizations 
with eclampsia or severe preeclampsia and 1.4-2.2 times for gestational 
hypertension (KUKLINA; AYALA; CALLAGHAN, 2009). 
In reviewing all maternal deaths in the United States, among 
almost 1.5 million deliveries within 124 Hospitals, 95 maternal deaths 
occurred in 1,461,270 pregnancies (6.5 per 100,000 pregnancies). The 
leading causes of death were complications of pre-eclampsia, pulmonary 
thromboembolism, amniotic fluid embolism, obstetric hemorrhage, and 
cardiac disease (CLARK et al., 2008). 
Maternal mortality associated with eclampsia is high in Brazil, 
especially in low-resource settings and lower income regions 
(PACHECO et al., 2014).  
A multicenter, cross-sectional study based in 27 centers in all 
regions of Brazil, conducted in 2014, showed that eclampsia is the 
leading cause of maternal death in Brazil, especially in low-income 
areas. The study indicates that obstetric care for women with eclampsia 
has the worst performance in low-income areas in Brazil. Improving the 
quality of maternal care and increasing access to emergency obstetric 
care are essential actions to minimize the mortality associated with 
eclampsia (GIORDANO et al., 2014). 
According to the latest national estimate, pre-eclampsia and 
eclampsia are major contributors to the Maternal Mortality Rate in 
Brazil, which account for about 20% of all maternal deaths in the 
country (BRASIL, 2012a). Hypertensive disorders are also a major 
cause of premature elective deliveries, morbidity and perinatal mortality 
(LANGENVELD et al., 2011; YÜCESOY et al., 2005). Every year, the 
public health system of Brazil spends more than 14 million US dollars 
for the treatment of pre-eclampsia and eclampsia, a considerable 
expense for a developing country (BRASIL, 2011). 
A population-based retrospective descriptive study was 
conducted in the state of Santa Catarina Brazil in 2014. Total 256 
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maternal deaths occurred from 2005 to 2013. Out of 256 maternal 
deaths in the specified period, 32 deaths were associated with pre-
eclampsia and eclampsia, representing 12.5% of the total maternal 
deaths. Pre-eclampsia was 37.5% and eclampsia was 62.5%. The highest 
number of maternal deaths due to pre-eclampsia and eclampsia per year 
was 21.9% in 2010 and the lowest was 3.13% in 2011 and 2013 
(KHANUM et al., 2015). 
Another retrospective descriptive study was made from 1996 to 
2005. During the studied time 79 maternal deaths related to 
hypertension occurred. This number represents 20% of maternal deaths 
in the period. Deaths related to eclampsia were (59,5%) 43.3/100,000 
born alive. Maternal deaths related to hypertension till represent 20% of 
maternal death in Santa Catarina. Gestational hypertension may be 
prevented by the broadening of prenatal coverage, training of personnel, 
early diagnosis of high-risk patients and a quick and efficient reference 
system on the third health-attention level (SAVIATO et al., 2008). 
Demographical, clinical and social risk factors for hypertensive 
disorders are shown in Figure 5. The family history of pre-eclampsia, 
previous pre-eclampsia history, high body man index (BMI), diabetes, 
chronic hypertension, schooling and prenatal were demonstrated to be 
more frequent in hypertensive disorders in pregnancy when compared to 
normotensive women. Regarding nulliparity, multifetal gestation and 
smoking habits, there were no significant differences between patients 
and controls. 
 
 
2.2 CLINICAL ASPECTS OF PRE-ECLAMPSIA AND ECLAMPSIA 
 
2.2.1 Etiology and risk factors of Pre-eclampsia and Eclampsia 
 
Prevention of any disease requires knowledge of its etiology and 
pathogenesis, as well as the availability of methods to predict people at 
high risk for this disease. The mechanisms responsible for the 
development of eclampsia remains poorly understood (WARRINGTON, 
2015). Genetic predisposition, immunology, endocrinology, nutrition, 
abnormal trophoblastic invasion, coagulation abnormalities, vascular 
endothelial damage, cardiovascular maladaptation, dietary deficiencies 
or excess, and infection have been proposed as etiologic factors for 
preeclampsia and eclampsia (GABBE et al., 2016). Furthermore, it is a 
clinical syndrome rather than a single disease. Therefore, the 
pathophysiologic abnormalities of this syndrome are heterogeneous and 
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variable among different women (DEKKER; SIBAI, 1991; 
WARRINGTON, 2015). 
 
 
Table 2 - Risk factors for hypertensive disorders of pregnancy in southern 
Brazil. 
Characteristic Hypertensive disorders 
n = 161 
Control 
n = 169 
p 
Family history of PE 44% 20% < 0.001 
Previous PE history 57% 7% < 0.001 
Multifetal gestation 6% 3% 0.530 
Body Man Index (kg/m²) 32.9 ± 6.1 28.2 ± 4.6 < 0.001 
Null parity 27% 22% 0.300 
Diabetes 26% 6% < 0.001 
Chronic hypertension 30% 5% < 0.001 
Smoking 18% 23% 0.327 
Schooling 34% 57% 0.003 
Prenatal 88% 97% 0.007 
Source: Dalmáz et al., (2011, p.694). 
 
Although accurate prediction of pre-eclampsia remains difficult, 
there are a number of maternal risk factors which can be easily assessed 
in early pregnancy that is known to be associated with an increased risk 
of developing pre-eclampsia. Most risk factors were the previous history 
of pre-eclampsia, pre-existing diabetes, multiple pregnancies, null 
parity, family history, raised blood pressure, raised body mass index 
before pregnancy, or increasing maternal age (SHAMSI; SALEEM; 
NISHTER, 2013). 
 
 
2.2.2 Pregnancy Conditions 
 
Null parity 
Null parity, never having previously given birth, is believed to be 
the most common risk factors for pre-eclampsia. Null parity has been 
shown to almost triple the risk of pre-eclampsia (DUCKITT; 
HARRINGTON, 2005). The protective effect due to a previous birth is 
lost when a subsequent pregnancy is conceived with a new partner, or 
when there is a long interval between pregnancies. This had led to the 
theory that prior exposure to paternal antigens has a protective role 
against pre-eclampsia. This theory was supported by a study of 
nulliparous women, whereby women with the previous termination of 
pregnancy with the same partner as the index pregnancy were nearly 
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half as likely to develop pre-eclampsia as women who had a previous 
termination with a different partner (SALAFIA; SHIVERICK, 1999). 
Reduced exposure to paternal antigen, by limited exposure to their 
sperm, is also a risk factor for pre-eclampsia. Women who conceive 
after a short period of sexual relations, or by alternative techniques such 
as non-partner donor insemination or intracytoplasmic sperm injection 
(ICSI) are also at increased risk of the disease (ILEKIS; REDDY; 
ROBERTS, 2007). 
 
Multiparity 
Change of partners increases the risk of preeclampsia in 
subsequent pregnancies (TUBBERGEN et al., 1999). Poor immune 
adaptation in the maternal-fetal interface may be an underlying 
mechanism. Multiparous women with a new partner must be addressed 
as primigravidas women. Pre-eclampsia was diagnosed in 3.2 % of 
nulliparas, 3.0 % of multiparous with altered paternity and 1.9 % of 
multiparas with no change (TRUPIN; SIMON; ESKENAZI, 1996). The 
adjusted attributable risk of preeclampsia in multiparous women 
connected to a change of paternity was 29 %. Although these results 
partially support the immunologic theory of pre-eclampsia, which also 
suggest that a subsequent pregnancy with a partner is associated with a 
lower risk of preeclampsia. 
 
 
2.2.3 Preexisting Morbidity 
 
Associated with Weight 
Obesity increased body mass index or increased abdominal 
circumference before pregnancy or in early pregnancy are well-
established risk factors for the condition (RODIE et al., 2004). The 
maternal risk of pre-eclampsia increases with increasing degree of 
obesity, which persists after accounting for other potential confounding 
factors (SEBIRE et al., 2001). This is likely to be related to the altered 
metabolic state associated with marked obesity rather than the obesity 
itself. Maternal obesity results in alteration of the plasma lipid profile 
with higher serum triglyceride and VLDL cholesterol, and lower HDL-
cholesterol concentrations than those observed in lean pregnant women. 
This pattern of dyslipidaemia is similar to that of the metabolic 
syndrome described in the non-pregnant population (SATTAR et al., 
1997). Obesity is also associated with chronic low-grade inflammation, 
a feature common to many of the other risk factors for the condition. 
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Diabetes 
The association of pre-gestational diabetes and pre-eclampsia is 
well recognized, and women with a history of diabetes have an up to 4-
fold increased risk of development of pre-eclampsia compared to the 
general population. Recent data from both the UK and the USA suggest 
that 0.5 - 0.75% of pregnant women have pre-existing type 1 or type 2 
diabetes (MIDDLETON et al., 2010). In keeping with the general 
population, rates of gestational, type 1 and type 2 diabetes in pregnant 
women rose significantly between 1994 and 2004 in all age groups 
(ALBRECHT et al., 2010). The increase in rates of type 2 diabetes in 
pregnant women has been the most striking and is likely to be related to 
increased rates of obesity. 
Diabetes in pregnancy increases the risk of poor maternal and 
neonatal outcomes. As well as the increased risk of pre-eclampsia, the 
condition is also associated with elevated risk of pregnancy loss, 
maternal infection, polyhydramnios, premature labor and failure to 
progress in the first or second stage of labor. Fetal and neonatal 
complications associated with diabetes include congenital malformation, 
macrosomia, respiratory distress syndrome, hypoglycaemia and 
jaundice. Further, the babies born to diabetic mothers have been shown 
in long-term follow-up studies to be at increased risk of future obesity 
and type 2 diabetes themselves (MIDDLETON et al., 2010). 
 
Genetic Influences 
There are clearly genetic factors involved in the development of 
pre-eclampsia. Women with a family history of pre-eclampsia in their 
mother or sister are at nearly 3 times higher risk of development of the 
condition compared to those without a family history (DUCKITT; 
HARRINGTON, 2005). A Swedish study examining over 700,000 
pregnancies from 240,000 sibling pairs reported a 35% contribution of 
maternal genes to the risk of development of pre-eclampsia. The fetal 
genes, with the similar contribution of genetic effects from both parents, 
were responsible for 20% of the risk (CNATTINGIUS et al., 2004). 
In a further Swedish family study in which 2.8% of women 
studied were affected by pre-eclampsia, odds ratios of 3.3 (95% CI 3.0-
3.6) for sisters and 2.6 (95% CI 1.6-4.3) for daughters of those affected 
were reported, compared to odds ratios of 1.4 (95% CI 0.9-2.2) for 
maternal half-sisters and 1.0 (95% CI 0.6 to 1.6) for paternal half-sisters 
of those affected. Full sisters of women with pre-eclampsia were also 
reported to be at increased risk of pregnancy-induced hypertension 
without proteinuria, with a reported odds ratio of 2.5 (95% CI 2.2 to 2.8) 
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(NILSSON et al., 2004). 
From these and other epidemiological studies, there is clear 
evidence of a genetic component to the development of pre-eclampsia, 
and several modes of inheritance have been suggested. One of the 
problems of researches in this field, however, is the rarity of the 
condition. The magnitude of genetic influence in disease is often 
assessed using twin studies; the rarity of pre-eclampsia has meant that 
very few twin studies have been possible. The Swedish group did report 
on 928 monozygotic twin pairs, reporting a substantial increase in the 
risk of pre-eclampsia (odds ratio 33.6, 95% CI 7.8 to 145) in the 
identical twins of those affected (NILSSON et al., 2004). 
 
 
2.2.4 Other factors 
 
Ethnicity 
Pre-eclampsia rates vary significantly around the world, whether 
this is related to different diagnostic criteria, or whether there are true 
differences between different ethnic populations remains uncertain. 
Further, whether both maternal and paternal ethnicity play a role in 
determining pre-eclampsia risk is also unclear. A retrospective 
American cohort study of 127,000 low-risk pregnant women reported 
that rates of pre-eclampsia were higher among African-American 
women (5.2%, OR 1.41, 95% CI 1.25-1.62), and lower amongst Latina 
(4.0%, OR 0.9, 95% CI 0.84-0.97) and Asian women (3.5%, OR 0.79, 
95% CI 0.72-0.88) compared to white women (CAUGHEY et al., 2005). 
Paternal ethnicity followed a similar pattern, with highest rates in 
African-American fathers, and lowest rates in Asian fathers. When 
maternal and paternal ethnic discordance were examined, the overall 
rate of pre-eclampsia was higher among mothers whose ethnicity 
differed from the father. 
 
Smoking 
Smokers appear to be relatively protected against pre-eclampsia, 
and the reasons for this remain poorly understood. Smoking is 
associated with reduced levels of sFLT-1 in non-pregnant women 
(SCHMIDT-LUCKE et al., 2005). It has been hypothesized, therefore, 
that reduced levels of sFLT-1 in smoking pregnant women would put 
them at lower risk of pre-eclampsia since sFLT-1 is thought to be a key 
factor in the development of the condition. To examine this relationship 
Kamareinen et al. (2009) compared third-trimester plasma sFLT-1 levels 
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and first-trimester placental sFLT-1 levels (obtained at termination of 
pregnancy) between pregnant smokers and non-smokers; no significant 
differences between the two groups was found. The molecular 
mechanisms regulating the release of sFLT-1 and sENG remain poorly 
understood. This is an important area of research since mechanisms to 
block their release may help to delay or even prevent the onset of pre-
eclampsia, improving both maternal and fetal outcomes. 
 
 
2.2.5 Relative risk of individual risk factors 
 
Established risk factors associated with pre-eclampsia, along with 
relative risk and 95% confidence interval are shown in Table 2. 
In addition to these well-established risk factors, others have 
more recently been reported to be associated with pre-eclampsia. 
Asthma, another condition characterized by chronic inflammation, has 
been implicated; in a study of 650 asthmatics and 1000 non-asthmatic 
pregnant women, women with moderate to severe asthma symptoms had 
an increased risk of developing pre-eclampsia, regardless of treatment, 
compared to those without symptoms (TRICHE et al., 2004). Moreover, 
a history of coronary heart disease in the pregnant woman’s father has 
been recently reported as conferring an almost 2-fold increased risk of 
pre-eclampsia (NORTH et al., 2011). 
 
Table 3 - Maternal risk factors for pre-eclampsia. 
 
Risk Factor Relative Risk (95% CI) 
Null parity 2.91 (1.28 to 6.61) 
Previous pre-eclampsia 7.19 (5.85 to 8.83) 
Age > 40 yrs 1.96 (1.34 to 2.87) 
Body Man Index ≥ 35 kg/m2 1.55 (1.28 to 1.88) 
Twin pregnancy 2.93 (2.04 to 4.21) 
Diastolic BP > 80 at booking 1.38 (1.01 to 1.87) 
Pre-existing diabetes 3.56 (2.54 to 4.99) 
Family history (mother or sister) 2.90 (1.70 to 4.93) 
Antiphospholipid antibody 9.72 (4.34 to 21.75) 
Source: Adapted from Duckitt and Harrington (2005, p.4). 
 
The problem with using these factors to stratify pre-eclampsia 
risk is that many of them are extremely common in the pregnant 
population. Further, the majority of these risk factors are non-
modifiable. The relationship between different risk factors is also 
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uncertain. For instance, it is not known whether a multiparous woman 
with high BMI remains at increased risk of pre-eclampsia if her previous 
pregnancies were uncomplicated. 
As women in modern Western society begin to have children at a 
later stage in life, and as the population as a whole becomes more obese, 
these risk factors will become less useful in risk stratification. There is 
now, therefore, more of a clinical need than ever to identify clinical or 
biochemical parameters that will help to inform clinicians which women 
are at increased risk of developing pre-eclampsia. 
 
 
2.2.6 Diagnostic Tests for Pre-eclampsia / Eclampsia 
 
There have been many screening tests evaluated in the literature 
over the years for predicting pre-eclampsia. These screening tests have 
been comprehensively reviewed in a World Health Organization 
publication (CONDE-AGUDELO; VILLAR; LINDHEIMER, 2004). A 
further summary of predictive tests, including a review of preventative 
interventions and economic modeling, has been published by the UK 
National Institute for Health Research (MEADS et al., 2008). 
 
Figure 4 – Pregnancy, Signs and Symptoms of Pre-eclampsia. 
 
Source: Weebly Preeclampsia (2015). 
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Uterine Artery Doppler 
The advent of ultrasound has revolutionized the practice of 
obstetrics in the past 50 years, offering a window into the uterus through 
which it can assess the anatomical structures of the fetus. The latest 
addition of Doppler flow studies of maternal and fetal vessels provides 
more useful information, allowing the evaluation of maternal-fetal 
physiology unit. Doppler studies are non-invasive and acceptable to 
patients and can be performed at the same time as a detailed anomaly 
scan, and have therefore been widely studied for its role in the detection 
of adverse maternal and fetal outcomes. 
In the non-pregnant state, there is a rapid increase and decrease in 
the rate of flow of the uterine artery during systole and a notch in the 
form of the downward wave at the start of diastole. The remodeling of 
the spiral arteries in early pregnancy is an important step in regulating 
and maintaining placental perfusion. Reducing the resistance of the 
spiral arteries as a result of remodeling during pregnancy can be 
reflected in uterine artery Doppler studies, by a high-speed constant 
flow throughout diastole, and the loss of the diastolic notch at 20 to 24 
weeks’ gestation (SCISCIONE; HAYES; SMFM, 2009). 
In pre-eclampsia, the remodeling of the spiral arteries is impaired. 
This pathological resistance to placental flow can be detected by 
Doppler studies of the maternal uterine vessels, offering the potential to 
detect women at risk not only of pre-eclampsia but also of intra-uterine 
growth restriction. Abnormalities are detectable as early as 12 weeks of 
gestation; for women with abnormal first trimester testing the likelihood 
ratio (LR) for the development of pre-eclampsia is approximately 5, 
while normal Doppler studies carry an LR of 0.5 (SCISCIONE; 
HAYES; SMFM, 2009). Although this relationship persists into the 
second trimester, the optimal timing for performing these studies 
remains uncertain. 
The use of uterine artery Doppler was perhaps best summarized 
in a comprehensive meta-analysis. Cnossen et al., (2008) reviewed 74 
uterine artery Doppler studies including nearly 80,000 pregnant women, 
of whom 2,500 developed pre-eclampsia. The majority of Doppler 
indices had poor predictive characteristics, but this varied with patient 
group studied and severity of the disease. For all women, the overall risk 
of pre-eclampsia was best predicted by an elevated second trimester PI 
accompanied by persistent bilateral uterine artery notching. As a result 
of these findings, the authors concluded that Doppler studies were more 
accurate for prediction of future preeclampsia when performed in the 
second trimester rather than the first trimester. Since the false positive 
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rate was relatively high, they felt that the increased anxiety and expense 
associated with abnormal results could not justify their use for screening 
in low-risk women. 
The majority of studies using uterine artery Doppler studies to 
predict pre-eclampsia have been performed in large centers with 
significant experience and expertise in their use. It remains to be seen 
whether these findings are applicable in smaller centers, or in the 
developing world where they would be more likely to be clinically 
useful. The tests are also relatively time-consuming, taking around 20 
minutes to perform (SCISCIONE; HAYES; SMFM, 2009), which may 
preclude their use in the general pregnant population. The combination 
of these studies with maternal risk factors, or with analysis of serum 
markers such as antiangiogenic factors (YU et al., 2006) may ultimately 
be more clinically useful. 
 
Arterial Stiffness 
Normal pregnancy is associated with a number of changes to the 
maternal circulation, with an increase in heart rate and cardiac output 
and a corresponding reduction in vascular resistance and arterial blood 
pressure. In contrast, pre-eclampsia is characterized by an increase in 
vascular resistance and generalized vasoconstriction (ELVAN-
TASPINAR et al., 2004). 
The traditional measurement of blood pressure using 
sphygmomanometry means that much of the information contained in 
the shape of the arterial waveform is lost. The assessment of central 
pressures and arterial stiffness can give more information on the risk of 
developing preeclampsia. Although the waveform of the arterial pulse 
has been used as an evaluation tool since the late nineteenth century, it 
is only recently that technological advances have enabled the recording 
and detailed analysis of waveforms for clinical use. Applanation 
tonometry is one such technique that allows non-invasive assessment of 
the various components of the pulse wave, which is simple, validated, 
reproducible and non-invasive (MACEDO et al., 2008). 
 
Pulse Wave Analysis in Pre-eclampsia 
It is well established in the non-pregnant population that arterial 
stiffness is associated with traditional risk factors for cardiovascular 
disease. Given that pre-eclampsia and cardiovascular disease share a 
number of common mechanisms, several studies have examined the 
relationship between arterial stiffness and pre-eclampsia. In non-
pregnant women, AIx decreases during the luteal phase of the menstrual 
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cycle and rises at the beginning of the menstrual cycle (ROBB et al., 
2009). AIx is lower in pregnant women compared to non-pregnant 
controls, and within pregnancy, AIx decreases further (MACEDO et al., 
2008). This fall is thought to be related to NO-mediated vasodilatation. 
Several studies have shown that, at term, women with pre-eclampsia 
have increased AIx, indicating increased arterial stiffness, compared to 
non-pregnant controls (SPASOJEVIC et al., 2005). Women with pre-
eclampsia have a higher AIx compared to women with gestational 
hypertension without proteinuria, an increase that persists after 
correction for blood pressure (SPASOJEVIC et al., 2005). No difference 
has been reported by women with pre-eclampsia at term and those with 
pre-eclampsia requiring preterm delivery (ROBB et al., 2009), nor has a 
difference been reported between different ethnic groups studied 
(KHALIL; COOPER; HARRINGTON, 2009). 
 
Uric Acid 
Hyperuricemia has been reported to be elevated in preeclampsia 
in 1917 (SCHACKIS, 2004) and remains one of the most common 
blood tests to assess the condition in clinical practice in the UK. Uric 
acid is a marker of oxidative stress, tissue injury, and renal dysfunction, 
and several studies have reported a positive correlation between high 
levels of uric acid in maternal serum and adverse pregnancy outcomes 
(THANGARATINAM et al., 2006). In view of this, the National Heart, 
Lung and Blood Institute (NHLBI) of the United States, recommends 
measuring serum uric acid in high-risk women with normal blood 
pressure (CNOSSEN et al., 2006). 
A systematic review of the literature, however, examining 18 
studies of 4,000 pregnant women, consistently observed the poor 
performance of uric acid in predicting various maternal and fetal 
outcomes (THANGARATINAM et al., 2006). Furthermore, a study 
designed to examine the impact of the uricosuric agent Probenacid in 
lowering uric acid in 40 women with pre-eclampsia did not demonstrate 
any effect on maternal blood pressure, nor on any other fetal or maternal 
outcomes (SCHACKIS, 2004). It, therefore, appears that while uric acid 
may be of value in the detection of pre-eclampsia, it is not useful in the 
early prediction of disease. 
 
Blood Pressure Measurement 
Although blood pressure measurement is clearly essential for the 
detection of hypertensive disorders of pregnancy, it remains to be seen 
whether measurement of blood pressure in the first or second trimesters 
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can predict which women will develop problems later on. Increased 
diastolic blood pressure is associated with an increased risk of 
preeclampsia (DUCKITT; HARRINGTON, 2005), but studies using 
assessment of blood pressure in the first or second trimester for 
prediction of pre-eclampsia have reported false-positive rates ranging 
from 7 - 52% and detection rates ranging from 8 - 93% (POON et al., 
2008). It is likely that these differences relate to differences in the 
populations studied, different techniques used to measure blood 
pressure, and different definitions of pre-eclampsia. A meta-analysis of 
34 studies evaluated the role of systolic pressure (SBP), diastolic 
pressure (DBP), mean arterial pressure (MAP) and increase in blood 
pressure during the first or second trimester to predict pre-eclampsia in 
low and high-risk women (CNOSSEN et al., 2008). MAP was shown to 
be superior to SBP, DBP and increase in blood pressure between the 
first and second trimester in predicting pre-eclampsia; second trimester 
MAP of ≥ 90 mmHg was associated with a positive likelihood ratio of 
3.5 for pre-eclampsia and a negative likelihood ratio of 0.46. 
Ambulatory blood pressure monitoring (ABPM) allows multiple 
readings to be taken using automated blood pressure devices, in a 
nonclinical environment. As such this may provide a better estimate of 
true blood pressure since it is not confounded by the “white coat” effect 
(HIGGINS et al., 1997). Few studies have examined ABPM in the 
context of pre-eclampsia prediction, and the majority of these are 
suboptimal (CONDE-AGUDELO; VILLAR; LINDHEIMER, 2004). 
One study which examined over 1100 women who had 24 hour 
ABPM between 18 and 24 weeks’ gestation did not find ABPM to be a 
useful predictor of hypertension later on in pregnancy (HIGGINS et al., 
1997) since absolute differences in ABPM measurements were small, 
and overlap between hypertensive and normotensive women was high. 
 
 
2.2.7 Other social determinants of Maternal Death 
 
The probability of women dying during pregnancy and childbirth 
is closely linked to their social and economic status, norms and values of 
their culture and distance from their home. In fact, maternal mortality 
rates reflect the gap between rich and poor countries more than other 
health measures (WHO, 2008). 
The high rate of maternal mortality is an indication of not only a 
substandard health system, but also of deep gender inequalities that 
leave women with limited control over decision-making and limit their 
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access to social support, health, and economic opportunities (WHO, 
2008). 
In many developing countries, legal systems provide little help to 
women and girls to protect their reproductive rights. In some cases, the 
laws deliberately denies such rights, such as laws that prohibit 
adolescent girls from accessing contraception or require permission 
from their parents or husbands (TEMIN; LEVINE, 2009). 
In some communities, women’s health is valued less than that of 
men. Parents may prioritize their sons’ over their daughters’ lives and 
health. Girls and women often do not have control over financial 
resources or access to transportation and are thus dependent on male 
relatives or mothers-in-law for mobility and access to health services 
(WHO, 2008). 
Across the developing world, girls’ health is determined more by 
social forces than biological ones. Poverty and gender inequality put 
girls at risk for exploitation, physical abuse, early pregnancy (TEMIN; 
LEVINE, 2009). 
Education is a critical determinant of women’s health. Education 
allows women to make informed choices and seek proper health care. A 
World Health Organization report on Asia and the Pacific shows that 
female literacy rates are a strong predictor of maternal mortality rates 
(WHO, 2008). 
Pakistan has made progress in achieving the health targets. But 
despite reductions in the Maternal Mortality Rate, Pakistan is still 
behind other developing countries with respect to these indicators. This 
is due to the interplay between various factors such as the low societal 
status of women, poor nutrition, poverty, illiteracy, inappropriate health-
seeking behavior, a poorly functioning health system, poor access to 
health services and a rapidly growing population (MAHMUD et al., 
2011). 
The need for contraception is higher among less educated, 
younger, poor and living in rural areas. In many developing countries, 
women with high income are twice as likely to use modern 
contraceptives than women with low-income (SINGH, 2009). 
Lack of education and poor knowledge about maternal health 
care can contribute to delays in seeking care during pregnancy and 
childbirth. Poor mothers are at high risk of developing pregnancy related 
complications. Almost all maternal deaths that occur in low and middle-
income countries are mainly among the poorest of the poor (WHO, 
2015b). Most obstetric complications cannot be predicted, but it can be 
prevented and treated if women have access to adequate health care. The 
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lack of access to emergency obstetric care and delay for emergency 
referral are factors that contribute to high maternal mortality. 
The lack of access and control of resources, limited educational 
opportunities, poor diet and lack of decision-making ability significantly 
contribute to adverse outcomes related to pregnancy. Factors such as 
cultural beliefs, socio-demographic status, empowerment of women, 
economic conditions, physical and financial accessibility are important 
determinants of use of maternal health services (SHAIKH; HATCHER, 
2005). 
In India, the low utilization of maternity services seems to be due 
to low levels of household income, high illiteracy and ignorance, and a 
host of traditional factors (SHARIFF; SINGH et al., 2002). A study 
realized in Pakistan described the poor socio-economic status, lack of 
physical accessibility, cultural beliefs and perceptions, low literacy level 
of the mothers and large family size as the leading causes of poor 
utilization of primary health care services (SHAIKH; HATCHER, 
2005). 
In India, the low utilization of maternity services appears to be 
due to low levels of household income, high rates of illiteracy and 
ignorance, and a number of traditional factors (SHARIFF; SINGH et al., 
2002; THIND et al., 2008). Similarly, a study (SHAIKH; HATCHER, 
2005) in Pakistan has described the poor socioeconomic status, lack of 
physical accessibility, cultural beliefs and perceptions, the low level of 
literacy of mothers and the large size of the family as the main causes of 
poor utilization of primary health care services (SHAIKH; HATCHER, 
2005). A study (MEKONNEN, Y.; MEKONNEN, A., 2002) in Ethiopia 
observed that the use of maternal health services can be influenced by 
the sociodemographic characteristics of women, the cultural context, 
and the accessibility to these services. 
 
 
2.3 PRENATAL OR ANTENATAL NURSING CARE 
 
Antenatal nursing care includes the care of pregnant women and 
their families at all stages of pregnancy and childbirth, as well as the 
first 4 weeks after birth (ALDEN et al., 2013). The main objective is to 
provide regular check-ups that allow midwives or nurses to prevent 
possible health problems during pregnancy. Throughout the antenatal 
period, nurses provide care to women in primary health centers, clinics, 
and hospitals and prepare them for childbirth. Nurses teach women and 
their families about pregnancy, the process of labor, birth, and recovery 
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and parenting skills. They provide continuity of care throughout the 
childbearing cycle. 
Prenatal nursing may reduce the risk of complications during 
pregnancy. Following a healthy diet, getting regular exercise as advised 
by a nursing care provider, and controlling existing conditions, such as 
high blood pressure and diabetes, is important in order to avoid serious 
complications in pregnancy such as pre-eclampsia. The prenatal visits 
are designed to increase checkup frequency later in the pregnancy, 
which increases the assessment of blood pressure, urine tests, and other 
nursing care activities. 
If the blood pressure is increased at any time before the delivery, 
the nursing care emphasizes on more frequent blood pressure readings. 
They might be asked to stay until the blood pressures are taken for a few 
hours rather than a one-off reading. 
If only blood pressure is increased, nursing care may start tablets 
( definied in protocols) to lower it and prevent it from further increase. If 
other features of preeclampsia occur, such as headaches or liver pain, 
the nurse forwards the woman to the hospital and suggest support from 
other professionals. 
Prenatal care is a program of care for a pregnant woman before 
she gives birth to her baby. It’s very important for women to start their 
prenatal care in the first trimester of pregnancy followed by at least 4 
antenatal visits (WHO, 2015b). The nursing care improves the access to 
antenatal care and promotes all the support in the networking care. 
Appropriate nursing care during pregnancy and childbirth is essential to 
reduce the maternal mortality. One-quarter of maternal deaths are due 
1/4 to inadequate delivery of health care from the beginning of 
pregnancy (CHRESTANI et al., 2008). 
In developed countries, mostly pregnant women receive visits to 
the nurse or midwifery about once a month during the first six months. 
The frequency of visits increases to every two or three weeks for the 
remainder of the pregnancy. In the prenatal period, pregnant women 
need nursing care for her, her baby and the family. During prenatal 
nursing care visits, nurse or nurse-midwife will make sure the pregnant 
women, developing fetus are healthy and strong. These regular checkups 
are necessary for pregnancy because, if there are any danger signs, it 
will be easy to manage at the initial stage. The prenatal period provides 
an excellent opportunity for nurses to influence family health. During 
this period, essential healthy women seek regular care and guidance. 
The nurse’ s health promotion interventions can affect the well-being of 
the pregnant women (CORBETT; CALLISTER, 2000). 
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Caring of a primary pregnancy with eclampsia is a challenge to 
any nurse and interdisciplinary team. The nurse’s keen observation and 
prompt decision-making ability to use lifesaving procedures and referral 
to the right place, at the right time, can save the mother. Skilled 
midwives are valuable members of the community. They are more than 
a nursing care provider they are educators, mentors, and guardians of 
new life. A nurses needs to know the danger signs of pregnancy and 
educate women about these risks: 
- Dizziness: hypertension, low blood pressure, malnutrition; 
- Visual disturbance: Pre-eclampsia; 
- Epigastric pain: Pre-eclampsia, heartburn; 
- Reduced urine out: Pre-eclampsia, dehydration; 
- A severe headache, Pre-eclampsia. 
- Edema of hands of feet, Pre-eclampsia, diastolic blood 90 mm 
Hg or more after 20 weeks’ gestation, Pre-eclampsia, 
convulsions, Pre-eclampsia, epilepsy; 
- Fever, chills, muscle joint pain, infection, history of malaria, 
meningitis. 
 
Nurses have the opportunity to identify women at risk of 
pregnancy and create a plan for their care that will reduce mortality of 
women (DAVIS, 2004). Ongoing prenatal care is important in achieving 
a healthy pregnancy and birth, and positively influencing the health of 
the child in the early years. It provides a pregnant woman with the 
opportunity to access health information and identify risks and 
underlying factors that can influence her health and the health of her 
fetus. 
The purpose of prenatal care is to identify existing risk factors 
and other deviations from normal so that pregnancy outcomes may be 
enhanced. Major emphasis is placed on preventive aspects of care, 
primarily to motivate the pregnant women to practice optimal self-care 
and to report unusual changes early so that the problem can be 
minimized or prevented. If health behavior must be modified in early 
pregnancy, the nurse needs to understand psychosocial factors that may 
have an influence on the women (CHOU et al., 2003). 
In Brazil, the Unified Health System provides universal, 
integrated and free health care services. Antenatal care has been given 
high priority since 2000 when implemented many programs (BRASIL 
2012a,b; 2013; SERRUYA; LAGO; CECATTI, 2004). 
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2.3.1 Importance of nursing care to prevent pre-eclampsia 
 
All pregnant women should have proper access to effective 
nursing antenatal care irrespective of their social, economic, cultural and 
geographical background. Appropriate care during pregnancy and 
childbirth is essential to reduce the maternal mortality. One-quarter of 
maternal deaths are due to inadequate delivery of health care from the 
beginning of pregnancy (CHRESTANI et al., 2008). 
Prenatal care visits are the proper time for nurses to advise 
pregnant women about their diet, exercise, and other lifestyle changes 
during pregnancy. Prenatal care visits are the proper time for nurses to 
advise pregnant women to change her lifestyle during pregnancy and 
promote awareness to improve the well-being of the pregnant women 
(CORBETT; CALLISTER, 2000; DAVIS, 2004). 
Major emphasis is placed on preventive aspects of nursing care, 
especially to encourage the pregnant women to practice optimal self-
care and to report unusual changes early so that the problem can be 
minimized or avoided. 
Nursing management plays a vital role in the care of the mother 
during pregnancy related complications. According to (WAGNER, 
2004), pre-eclampsia affects approximately 5-7% of pregnancies and 
complications of hypertension and are together the third leading cause of 
pregnancy-related deaths. Early recognition of the signs and symptoms 
of this syndrome is vital for an optimal outcome for both mother and 
fetus. Because this the nursing observation is very important throughout 
the course of pregnancy. 
Nurses must understand the pathophysiology of pre-eclampsia to 
provide an optimal nursing care management (ARAFEH, 2006). Once 
the diagnosis of pre-eclampsia is confirmed, nurses must utilize 
assessment skills, proper nursing interventions, and patient teaching to 
promote a safe environment for labor and delivery. 
Nursing management is a key variable in promoting a positive 
outcome for the mother. It begins with a review of prenatal records and 
an interview with the patient to clarify the history and observation of 
any severe headaches, visual disturbances or severe pain. The physical 
examination and observation by the nurses must be consistent when 
taking and recording blood pressure. Assessing edema, deep tendon 
reflexes, breath sounds for crackles, the level of consciousness, and 
intake and output is essential when caring for a pre-eclamptic patient 
(PERRY et al., 2014). 
Furthermore, nursing care includes assessing uterine toxicity for 
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signs of abruption. Nursing care is essential to monitor cervical changes 
to evaluate and document the progression of labor. The nurse should be 
aware of ongoing laboratory results, taking into account any changes 
compared to the previous levels. It is also essential that the nurse is 
prepared at any time for an emergency delivery due to the risk of 
complications. 
The most common antihypertensive used during labor is 
hydralazine IV in five to ten-milligram doses or labetalol IV twenty 
milligram bolus, followed by forty milligrams after ten minutes. 
Magnesium Sulfate is the drug of choice to prevent and treat eclamptic 
seizures during labor (SCHROEDER et al., 2002). Many authors 
suggest administering Magnesium Sulfate piggyback with a loading 
dose of four to six grams diluted in a hundred milliliters of intravenous 
fluid infused over fifteen to thirty minutes, followed by a maintenance 
dosage according to the provider’s orders (PERRY et al., 2014). 
In the inpatient setting, educating the patient and her significant 
other on the disease process and the management rationale is a primary 
nursing action. It is important for the woman and her family to 
understand what is physiologically happening within the body to have a 
greater understanding of the treatment plan and the compromise with her 
pregnancy. 
In the context of hospital admission, educating the patients and 
their families about the disease process and management is one of the 
primary nursing care actions. It is important for the woman and her 
family to understand what is happening physiologically inside the body 
to have a greater understanding of the treatment plan and commitment to 
her pregnancy. 
The nurse should review the signs and symptoms of pregnant 
women that require immediate attention and assess current patient 
knowledge about pre-eclampsia and other pregnancy related 
complications and add more information to an extent which patient can 
understand. The nurse should explain the treatment plan in progress and 
the variables that will change the care plan. This ensures that the patient 
will be prepared for any other complications that may arise. Women and 
her partner should be involved in managing and controlling the 
situation. In turn, this can help reduce the anxiety associated with the 
complication in pregnancy. 
The nurse is responsible for taking care of the mother and fetus 
during labor and delivery, which requires nursing care to promote the 
most favorable outcome. Understanding maternal and fetal effects of 
preeclampsia help nurses to perform comprehensive assessments. The 
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information provided by the network of nursing care that is in the 
evaluation will determine nursing care and the steps needed to support 
the woman and fetus. 
 
 
2.3.2 Nursing Care During Pregnancy 
 
Nursing care for women has contributed to making the health 
system more responsive to the needs of women. Nurses have been 
crucial to the development of strategies to improve the welfare of 
women and their babies and have led the efforts to implement the 
guidelines of clinical practice. Nurses can have a voice in setting 
standards and influence health policy, actively participating in public 
education (ALDEN et al., 2013). 
The prenatal period is a time of physical and psychological 
preparation for childbirth and motherhood. The nurse’s interventions 
can improve the well-being of the pregnant woman and her unborn child 
for many years. The ideal regular prenatal visit starts immediately after 
the first menstrual period. Prenatal health care allows the discovery, 
diagnosis and treatment of pre-existing maternal diseases and other 
disorders that develop during pregnancy. Prenatal care is designed to 
monitor the growth and development of the fetus and detects 
abnormalities that interfere with the normal course of labor. Prenatal 
care also provides education and support for self-management. 
Healthcare professionals refer to early, middle, and late pregnancy as 
trimesters. The first trimester lasts from weeks 1 to 13, the second from 
weeks 14 to 26 and the third, from weeks 27 to 40 (ALDEN et al., 
2013). 
 
Health Needs during Pregnancy 
 
Adaption to Pregnancy 
Pregnancy affects all family members, and each family member 
has to adapt to the pregnancy and interpret its meaning in light of his or 
her own needs. This process of family adaptation to pregnancy takes 
place within a cultural environment influenced by societal trends. 
According to the cultural background, nurse must be prepared to support 
not only traditional families in the childbirth experience but also single-
parent families, reconstituted families, and alternative families (ALDEN 
et al., 2013). 
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Maternal Adaptation 
During pregnancy, all women adapt to the maternal role, a 
complex process of social and cognitive learning. Early in pregnancy 
nothing seems to be happening but with the perception of fetal 
movement in the second trimester, the woman focus on her pregnancy 
and her relationships with her mother and other women who have been 
or who are pregnant. Nurses being aware and knowledgeable can play a 
vital role in fulfilling the information need of women regarding the 
pregnancy and motherhood (ALDEN et al., 2013). 
 
Care Management 
The purpose of prenatal care is to identify existing risk factors 
and other anomalies so that pregnancy outcomes may be enhanced 
(GREGORY; NIEBYL; JOHNSON, 2016). Emphasis is placed on the 
preventive aspects of care, especially to motivate pregnant women to 
practice good self-management and report unusual changes early so that 
problems can be avoided or minimized. If health behaviors need to be 
changed early in pregnancy, nurses need to understand the psychosocial 
factors that can affect a woman. In holistic care, nurses provide 
information and guidance on not only the physical but also the 
psychological and social impact of pregnancy on women and family 
members (ALDEN et al., 2013). 
The current conventional model to provide prenatal care has been 
used for over a century. The first visit usually occurs in the first 
trimester, with monthly visits until the 28th week of pregnancy. The 
visits are then scheduled every 2 weeks until week 36 and then every 
week until the birth (AAP; ACOG, 2012). 
Prenatal care is ideally a multidisciplinary task in which nurses 
work with nutritionists, physicians, social workers, and others in order 
to provide a integral care to pregnant women. To emphasize the nursing 
role, care management for the initial visit and follow-up visits is 
organized around the central elements of the nursing process which is 
assessment, nursing diagnoses, expected outcomes, plan of care and 
interventions, and evaluation (ALDEN et al., 2013). 
 
Nursing Assessment of Pregnant Women - Initial Visit 
Nursing care needs to be guided by the current scientific evidence 
since nurses are the first professionals to have contact with pregnant 
women during pregnancy (WHO, 2015b). Prenatal care begins when the 
presence of pregnancy and the desire of its continuation is confirmed. 
The assessment process starts from the first prenatal visit and is 
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continued throughout the pregnancy. Assessment techniques include 
interview, physical examination, and laboratory tests. The therapeutic 
relationship between the nurse and the woman is established during the 
initial assessment interview (ALDEN et al., 2013). 
History 
The history of health includes those physical conditions, use of 
medications or procedures that may affect the pregnancy or that may be 
affected by the pregnancy. The dietary assessment shows special dietary 
practices, food allergies and eating behaviors. Similarly, a woman’s past 
and present use of drugs and prescription medications are assessed. In 
addition, the family history provides information about the woman’s 
immediate family, including parents, siblings, and children. These data 
help identify genetic disorders or conditions that could affect the present 
health status of the woman or her fetus. Situational factors such as the 
family’s ethnic background, cultural trends, and socio-economic status 
are also assessed (ALDEN et al., 2013). 
Interview 
Women should be interviewed about their psycho-social and 
mental health symptoms they are experiencing. During interviews 
throughout the pregnancy, nurses should be alert to the emergence of 
potential problems, such as depression, lack of family support and 
inadequate living conditions. Nurses should assess women’s attitudes to 
health, particularly during fertility, their expectations of health care 
providers, and their view of the relationship between women and the 
nurse. At the beginning of pregnancy, the nurse must determine the 
knowledge and awareness of pregnant women regarding pregnancy, 
maternal changes, fetal growth, self-care, dangerous signs, and food. 
Before planning nursing care, the nurse needs information about 
women’s lifestyle, exercise habits, sleep pattern, diet, interests, personal 
hygiene and clothing behaviors Similarly, the nurse should ask the 
woman to identify and characterize existing or simultaneous problems in 
all systems of the body and assess their mental state (ALDEN et al., 
2013). 
Physical Examination 
Physical examination includes reviewing the body systems, vital 
signs, weight, pelvic examination, and fetal heart rate. The initial 
physical examination provides the baseline for assessing subsequent 
changes. The nurse should fulfill the information need of the woman 
and should explain the basic information along with a demonstration of 
the equipment and procedure that may be used. The interaction requires 
a hassle-free, sensitive, and gentle approach. The physical examination 
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begins with the assessment of vital signs and body mass index. During 
the examination, the nurse should remain attentive to the woman’s 
suggestions that provide guidance for further evaluation. Each time a 
pelvic exam is performed, the tone of the pelvic muscles and the 
woman’s knowledge of Kegel exercises is assessed. Particular attention 
is paid to the size of the uterus because this is an indication of the 
duration of pregnancy. During the examination, the nurse can coach the 
woman in breathing and relaxation techniques, as needed (ALDEN et 
al., 2013). 
Laboratory Tests 
The laboratory data obtained from the analysis of the samples 
obtained during the examination, provide important information about 
the symptoms of pregnancy and the health status of the women. Samples 
are collected at the initial visit so that the cause of any potential risks 
can be treated. Blood and urine may be collected for several tests. The 
finding of risk factors during pregnancy may indicate the need to repeat 
some laboratory tests at different times (ALDEN et al., 2013). 
 
Nursing Assessment of Pregnant Women - Follow-up Visit 
In traditional prenatal care, monthly visits are scheduled during 
the first and second trimesters, although women may set up additional 
appointments if necessary. During the third trimester, however, the risk 
of complications increases, and the need for closer follow-up become 
necessary. From week 28, maternity visits are scheduled every two 
weeks until week 36 and then every week until birth. Visits can occur 
more or less frequently, often depending on the individual needs, 
complications and risks of pregnant women (ALDEN et al., 2013). 
Follow-up visits are less intense than the first prenatal visit. At 
each of these follow-up visits, the woman is asked to summarize 
relevant developments since the previous visit. All suspicious signs or 
symptoms and review of the physical systems of women are performed 
in detail. Subsequent evaluation is a constant procedure in the care of a 
pregnant woman. Physiological changes are documented as the 
pregnancy progress and are checked for any deviation from the normal 
course. At each visit, physical parameters are measured. The weight of 
the woman is evaluated and the adequacy of a weight gain during 
gestation is evaluated in relation to her body mass index. Urine may be 
checked by dipstick, and the presence and degree of edema are noted 
(ALDEN et al., 2013). 
The number of routine laboratory tests performed during follow-
up visits in pregnancy is limited. A clean urine sample is collected to 
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measure glucose, proteins, nitrites and leukocytes at each visit. Urine 
samples are obtained for culture and sensitivity, and vaginal and blood 
samples are taken to repeat a test, if necessary. The nurse-client 
relationship is essential to set the tone for further interaction. The 
techniques of listening with an attentive expression, using eye contact 
and recognizing the woman’s feelings and her right to express these 
feelings, is very important. The interaction can take place in diverse 
formal and informal contexts. A clinical setting, home visits or 
telephone conversations provide opportunities which can be used 
effectively (ALDEN et al., 2013). 
The nurse can help a woman to gather relevant information, 
explore her options, decide on a course of action, and take responsibility 
for the results. These options may include living with a problem, as it is, 
to alleviate the effects of a problem so that it can be more easily 
accepted, or eliminate the problem. Educational literature describing 
fetal and maternal changes is available and can be used to explain the 
changes as that occur. A knowledgeable and observant nurse knows the 
typical concerns of the prospective parents, anticipate the questions that 
will be asked and encourage women to discuss what is in their minds. 
Often, printed literature and brochures can be used to complement 
individualized nursing education related to the women experience 
(ALDEN et al., 2013). 
Assessing the nutritional status of a woman and providing 
information about nutrition are part of the responsibilities of nurses in 
prenatal care. This includes assessing weight gain during pregnancy and 
prenatal nutrition. Education may include discussion about iron-rich 
foods, prenatal vitamins, and recommendations to moderate or limit 
caffeine intake and smoking (ALDEN et al., 2013). Most studies on 
pregnancy in humans showed no association between caffeine intake 
and birth defects or low birth weight, however, some studies have 
documented an increase in the risk of miscarriage with increased 
caffeine consumption at 200 mg/d (WENG; ODOULI; LI, 2008). 
 
 
2.3.3 Interventions for a woman with mild pregnancy induced 
hypertension 
 
Women with mild pre-eclampsia can be managed at home with 
frequent follow-up care. Regardless of the setting, the care is similar. 
Monitor Antiplatelet Therapy 
Due to the increasing trend of platelets aggregation along the 
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arterial walls, an antiplatelet agent such as low-dose aspirin may prevent 
or delay the development of preeclampsia (DULEY et al., 2007). 
Promote Bed Rest 
When the body is in the supine position, sodium tends to be 
excreted at a higher rate during activity. Bed rest is the best way to help 
increase sodium evacuation and promote diuresis. Rest should always be 
in a lateral recumbent position in order to prevent uterine pressure on the 
vena cava and avoid supine hypotension syndrome (GABBE et al., 
2016). 
Promote Good Nutrition 
Women needs to continue their normal pregnancy nutrition. At 
one time, rigorous salt restriction was recommended to reduce edema. 
However, it is no longer true, because heavy sodium restriction can 
activate the reninangiotensin-aldosterone system and cause an increase 
in blood pressure (PERRY et al., 2014). 
Provide Emotional Support 
It is difficult for a woman with preeclampsia to assess the 
possible severity of the symptoms, as they are so uncertain. Neither high 
blood pressure nor protein level in urine is something she can see or feel 
(PERRY et al., 2014). It is not always easy to follow the instruction of 
getting an additional rest during the day on the basis of a few uncertain 
symptoms since most women contribute financially to the running of 
their household (GABBE et al., 2016). Therefore, stress, anxiety, and 
ups and downs often develop during the course of pregnancy. Family, 
friends and health care providers can play their role in comforting 
women if they are feeling vulnerable. 
 
 
2.3.4 Nursing interventions for a woman with severe pregnancy 
induced hypertension 
 
Support Bed Rest 
In the case of severe pre-eclampsia, most women are hospitalized 
so the rest can be enforced and a woman can be more closely observed. 
Visitors in such a case are generally restricted to husband, father or 
older children. Because a loud noise such as a baby’s crying or a 
dropped tray may be enough to trigger a seizure initiating eclampsia 
(GABBE et al., 2016). A dark and quiet room is highly recommended 
because a bright light can also trigger seizures. However, the room 
should not be so dark that healthcare professionals have to use a 
flashlight to do evaluations. Flashlight targeting into the woman’s eyes 
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is the kind of sudden stimulation to be avoided. Stress is another 
stimulus capable of increasing blood pressure and cause seizures in a 
woman with severe pre-eclampsia. Make sure that women are given 
clear explanations of what is happening and what is expected (PERRY 
et al., 2014). 
Monitor Maternal Well-being 
Blood pressure should be measured at least every 4 hours, or with 
a continuous monitoring device to detect any increase. Blood tests such 
as blood count, platelet count, liver function, blood urea nitrogen and 
creatinine and fibrin degradation products should be obtained in order to 
assess renal and hepatic function and development of ICD. Since a 
woman is at high risk of premature separation of the placenta and 
resulting hemorrhage, a blood sample for type and cross-match is 
usually also obtained (PERRY et al., 2014). 
Daily hematocrit levels are used to observe blood concentration. 
This level will increase if more fluid is leaving the bloodstream for 
interstitial tissue (edema). On the other hand, anticipating the need for 
frequent plasma estriol levels (a test of placental functioning) and 
electrolyte levels is also essential. A woman’s optical fundus should be 
evaluated daily for signs of arterial spasm, edema, or hemorrhage. 
Obtain daily weights at the same time in order to re-assess fluid 
retention (GABBE et al., 2016). 
A permanent urinary catheter may be inserted to allow accurate 
recording of output and comparison with intake. Urine output should be 
greater than 600 ml per 24 hours. Proteins in urine and specific gravity 
are measured and recorded. A 24-hour urine sample can be collected for 
protein measurements and creatinine clearance to assess renal function. 
A woman with mild pre-eclampsia that spills from 0.5g to 1g protein for 
24 hours (1+ a random sample). Similarly, a woman with severe pre-
eclampsia spills approximately 5 g for 24 hours (3+ to 4+ an exemplary 
individual) (PERRY et al., 2014). 
Monitor Fetal Well-being 
In general, a single doppler auscultation at intervals of 
approximately 4 hours is sufficient at this stage of treatment. However, 
fetal heart rate can be measured continuously with an external fetal 
monitor. A woman can have a stress test or a biophysical profile done 
every day to assess utero-placental sufficiency. Administration of 
oxygen to the mother may be necessary to maintain adequate 
oxygenation and prevent fetal bradycardia (PERRY et al., 2014). 
Support a Nutritious Diet 
A woman needs a diet rich in protein and moderate in sodium to 
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compensate for the protein she is losing in urine. An intravenous fluid 
line is usually initiated and maintained to serve as an emergency route 
for drug administration as well as to administer fluid to reduce 
hemoconcentration and hypovolemia (ALDEN et al., 2013). 
Administer Medications to Prevent Eclampsia 
A hypotensive drug such as hydralazine (Apresoline), labetalol 
(Normodyne), or nifedipine may be prescribed to minimize 
hypertension. These medications work to reduce blood pressure by 
peripheral dilatation and thus do not interfere with placental circulation. 
Pulse and blood pressure should be assessed since these medications can 
cause maternal tachycardia. Diastolic pressure should not be lowered 
below 80 to 90 mm Hg or inadequate placental perfusion could occur. 
Even with these new drugs, magnesium sulfate, however, still remains 
the drug of choice to prevent eclampsia (SHILVA SAHA; KALRA; 
PRASAD, 2007). This medication reduces edema by causing a change 
in fluid from the extracellular spaces into the intestine. It also acts as a 
central nervous system depressant which lowers the possibility of 
seizures (KARCH, 2015). To lower the blood pressure immediately, 
magnesium sulfate is first administered intravenously in a loading or 
bolus dose. The drug acts almost immediately but its effect remains only 
for 30 to 60 minutes, so administration must be continuous. 
 
 
2.3.5 Nursing interventions for a woman with eclampsia 
 
Severe pre-eclampsia deteriorates to eclampsia when cerebral 
irritation from increasing cerebral edema becomes so acute that a seizure 
occurs. This usually occurs at the end of pregnancy, but can also happen 
up to 48 hours after delivery. Immediately before a seizure, a woman’s 
blood pressure and temperature increase suddenly. She also experiences 
blurring of vision or a severe headache and her reflexes become 
hyperactive. Vascular congestion of the liver or pancreas may lead to 
severe epigastric pain and nausea. The urinary output may drop sharply 
to less than 30 mL/hour. Eclampsia, however, actually occurs only when 
a woman experiences a seizure (ALDEN et al., 2013). 
Tonic-Clonic Seizures 
 An eclamptic seizure occurs in stages. After the preliminary 
signal that something is happening, all the muscles of the woman’s body 
contract. Its arches her back, stiffen her arms and legs. Respirations may 
stop since her thoracic muscles get contracted. This phase of the seizure 
is called the tonic phase which happens approximately for 20 seconds 
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(ALDEN et al., 2013). 
During the second stage of seizure which is called the clonic 
stage, the woman’s bladder, and bowel muscles contract and relax which 
result in the incontinence of urine and feces. Breathing is not quite 
effective even if the woman is breathing during this stage. The clonic 
stage of a seizure lasts up to 1 minute. The primary care for a woman 
with a tonic-clonic seizure is to maintain her airway and supply oxygen 
by face mask to protect the fetus. To prevent aspiration, lie woman on 
her side in order to drain the secretions from her mouth. Magnesium 
sulfate or diazepam may be given intravenously as an emergency 
measure. Apply an external fetal heart monitor if one is not already in 
place to assess fetal status. If labor is required to progress despite the 
seizure, fetal heart sounds and uterine contractions should be 
continuously assessed (ALDEN et al., 2013). 
The third phase of the seizure is called postictal stage. During this 
phase, a woman is semi-comatose and cannot be awakened, except for 
painful stimuli of 1 to 4 hours. Extremely close observation is as 
important during the third stage as during the first two phases. If the 
seizure causes premature separation of the placenta, labor may begin 
during this period, but woman will not be able to report the sensation of 
contraction. In addition, painful stimulation of contractions may initiate 
another seizure. Hold the woman’s hand so that the secretions from the 
mouth can be drained. Do not give him anything to eat or drink. 
Remember that in coma, hearing is the last sense to be lost and the first 
one to be regained. Conversation with patient may be helpful as she may 
be able to listen, even if she does not respond (ALDEN et al., 2013). 
Nursing Interventions During the Postpartum Period. 
Postpartum hypertension can occur within 10 to 14 days after birth, 
although it usually does not occur more than 48 hours after birth 
(CANTEY; TECKLENBURG; TITUS, 2007). Monitoring blood 
pressure in the postpartum period and making sure that eclampsia can 
occur up to 2 or 3 weeks after birth is essential residual hypertensive or 
renal disease (CANTEY; TECKLENBURG; TITUS, 2007). 
 
 
2.3.6 Networking 
 
Networking is defined as “the exchange of information or 
services among individuals, groups, or institutions” (MERRIAM-
WEBSTER.COM, 2016). It describes interactions and communication 
activities between individuals, groups, communities and organizations 
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operating in a variety of settings and contexts. 
Information and knowledge is a valuable resource and has 
become the key to success in all fields of life. Communities, 
organizations, and companies need to understand precisely what 
information and knowledge will give them a competitive advantage. 
They then need to keep this knowledge, use it, share it and evolve it 
across the organization. Information and knowledge need to be 
managed, used, shared and evolved like a key asset. Gathering 
information and transforming it into useful knowledge require a great 
deal of collaboration, networking and focus on the community of 
practice (CoP) (WENGER; MCDERMOTT; SNYDER, 2002). 
Since the boom in communication and information technologies 
(ICT), the field of eHealth has emerged into many forms and its 
potential has been discussed globally. eHealth has increasingly become 
part of people’s everyday lives and has the ability to change how health 
care is delivered, the quality of the patient experience, and the cost of 
health care (WANG; LIU, 2009). It enables, among other things, the 
exchange of healthcare and administrative data and the transfer of 
medical images and laboratory results. The use of ICT in the health 
sector has the potential to change the face of global health systems and 
can deliver life-saving information even in the most remote and 
resource-poor settings (WHO, 2011). It is now reasonable to expect that 
by 2020 every inhabitant of our planet will, from any location and at any 
time, be able to access the medical information necessary to maintain his 
or her health or seek a cure for his or her illness. Improvement in ICT, 
development of smaller components with higher levels of security, 
decreasing costs and increasingly user-friendly features are the main 
reasons for adopting eHealth solutions in our daily lives (PIETTE et al., 
2012). 
Nurses need to adapt to the new ways of communication using 
information technology. This will not only enhance nurse-to-nurse 
collaboration but also nurse-to-patient interaction and will improve 
quality and safety of healthcare (VAN DE CASTLE et al., 2004). 
Collaboration means interpersonal interaction or collective action 
toward a common goal (D’AMOUR et al., 2005). It enables the sharing 
of knowledge and expertise and improves timeliness, quality and access 
to a broad range of health care services for individuals, families, and 
communities. In order for nursing to develop and excel as a profession, 
professional networking and interaction between nurses need to be 
strengthened. Such collaboration can help move the profession forward 
and ultimately improve clinical care (WASHER, 2002). 
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Networking provides access to countless opportunities for nurses 
and patients and allows them to communicate, interact and collaborate 
with each other in order to enhance nursing care practice and improve 
health. The ubiquity of information and communication technologies 
have the potential to improve access to both health information and 
services in health care. Networking tools play a central and supportive 
role in nursing practices and patient well-being. These tools can be 
divided into three main categories based on the nature of collaboration 
and their potential users. These categories are: “Collaboration between 
Health Professionals”, “Nurse-to-Patient interaction” and “Patient-to 
Patient interaction”. (text already published by the author in Societies. 
For more detail please refer to (KHANUM et al., 2016). 
 
  
 
 
 
3 METHODOLOGY 
 
 
In this chapter the author described the aspects related to the 
study designs and methodology of the research work developed. 
 
 
3.1 A SYSTEMATIC REVIEW WITHOUT META-ANALYSIS 
 
PRISMA guidelines (MOHER et al., 2009) were used as a basis 
for the overall study approach. A systematic search was conducted from 
May 2015 to May 2016 to answer the research question of: What are the 
available best technologies and techniques for the prevention and 
control of pre-eclampsia and eclampsia? PubMed / MEDLINE, 
CINAHL, and COCHRANE were searched for articles published 
between 1985 to 2015, reporting on the available technologies and 
techniques for the prevention and control of pre-eclampsia and 
eclampsia in pregnant women. The question was adjusted according to 
the PICO acronyms; P (population/participants) representing all 
pregnant women; I (intervention) represent the use of available 
technologies and techniques; C shows comparison in the control group, 
the placebo group or non-existence of the comparison group; and O 
represented the outcomes of interest which was prevention and control 
of pre-eclampsia and eclampsia and reduction in maternal mortality. The 
search strategy was based on a number of medical subject headings 
MESH terms and text words. 
 
Inclusion Criteria 
Systematic Reviews and RCTs published in the English language 
between 1985 to 2015 based on the prevention and control of pre-
eclampsia and eclampsia were eligible for inclusion in this review. 
 
Exclusion Criteria 
Studies, except systematic reviews and RCT’s, were excluded. 
Studies not published in the English language, or whose topics were 
irrelevant to the objective of this study were also excluded. 
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Search Outcome 
A total of 1,808 articles were initially identified using the search 
criteria from all the three databases, of which 14 were duplicate. Titles 
screening of the remaining 1,794 articles resulted in 330 relevant articles 
being selected for abstract screening. The abstracts of these 330 papers 
were then examined resulting in 58 papers being examined in full. Of 
these, 11 were excluded after quality assessment. The remaining 47 
studies were fully read and were included in the review. 
Each article was screened by two independent reviewers and 
disagreement between them was resolved by discussion. The aim was to 
identify as many articles as possible which have reported the use of 
different techniques and technologies for the prevention of  
pre-eclampsia and eclampsia in past 30 years. 
 
Quality Appraisal 
We assessed the quality of each paper meeting the inclusion 
criteria using the following: (a) relevance to the systematic review (b) 
validity and appropriateness of methodology (c) quality of evidence 
generalizability of results (d) quality of reporting (e) limitations of the 
study and how it was adjusted. The quality of the outcome was assessed 
using the Evidence Level: Joanna Briggs from Level I to II. 
 
Data Extraction and Synthesis 
All 47 papers were independently assessed by two reviewers. The 
following information was extracted from the included studies. General 
information about authors, journal, publication date, country, research 
design, location, participants, aim, sample size, evidence of use of the 
available technologies and techniques in pregnant women for the 
prevention of pre-eclampsia or eclampsia, results and descriptive 
summaries of numerical data. Synthesis of the studies involved 
categorizing technologies and techniques by their characteristics, 
narrating and summarizing its effectiveness and presenting data visually. 
 
 
3.2 INTEGRATIVE REVIEW 
 
This review was conducted from February 2015 to December 
2015 to answer the research question: what does the scientific literature 
published between 2000 to 2015 report about the maternal mortality 
associated with pre-eclampsia and eclampsia in KPK Pakistan? 
PUBMED/MEDLINE, CINAHL, and COCHRANE databases were 
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searched for the articles reporting on the maternal mortality associated 
with pre-eclampsia and eclampsia in KPK Pakistan. The search was 
limited to articles published between January 2000 and December 2015 
in the English language. The search strategy was based on a number of 
medical subject headings MESH terms and text words aiming to include 
as many relevant articles as possible. 
 
Inclusion Criteria 
Studies published in the English language between 2000 to 2015 
which were reporting on the maternal mortality associated with 
preeclampsia and eclampsia in KPK Pakistan were eligible for inclusion 
in this review. 
 
Exclusion Criteria 
Articles that were published in a language other than English; 
studies reporting on maternal mortality associated with other 
complications of pregnancy and studies reporting on maternal mortality 
in other provinces of Pakistan were excluded. 
 
Search Outcome 
A total of 621 articles were initially identified using the search 
criteria from all the selected databases, of which 25 were duplicated. 
Title screening of the remaining 596 studies was completed which 
resulted in 95 studies to be selected for abstract reading. After abstract 
screening 08 studies were selected for full-text reading, of which all 
were included in the review, as shown in PRISMA flowchart. Each 
article was screened by two independent reviewers and disagreement 
between them was resolved by discussion. The aim was to identify as 
many relevant articles as possible which have reported on maternal 
mortality associated with pre-eclampsia and eclampsia in KPK Pakistan. 
 
Quality Assessment 
We assessed the quality of each paper using the following: (a) 
relevance to this review (b) validity and appropriateness of the study 
methodology (c) quality of evidence (d) sampling method and quality of 
reporting (e) and limitations of the study. The quality of the outcome 
was assessed using the Evidence Level from Joanna Briggs Institute 
(from Level I to V). 
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Data Extraction and Synthesis 
Extracting and synthesizing data from heterogeneous sources is a 
complex process (GOLDSMITH; BANKHEAD; AUSTOKER, 2007). 
All selected studies were independently assessed by two reviewers. The 
information was extracted from the included studies: general 
information about authors, journal, publication date, country and region; 
research design, location, participants, aims; maternal mortality 
associated with pre-eclampsia and eclampsia in KPK Pakistan; results 
and descriptive summaries of numerical data. 
Synthesis of the data involved categorizing and tabulating data 
and presenting it visually. 
 
 
3.3 INTEGRATIVE REVIEW 
 
This review was conducted from October 2015 to March 2016 to 
answer the research question of; what does the scientific literature 
published between 2005 to 2016 report about the nursing care practices 
in the prevention and control of pre-eclampsia and eclampsia? 
PUBMED/MEDLINE, CINAHL and COCHRANE databases were 
searched for relevant studies on nursing care practices in the prevention 
and control of pre-eclampsia and eclampsia. The search was limited to 
articles published between January 2005 to March 2016 in the English 
language. The search strategy was based on a number of medical subject 
headings MESH terms and text words aiming to include as many 
relevant articles as possible. 
 
Inclusion Criteria: All types of qualitative and quantitative 
studies published in the English language between 2005 to 2016 which 
were reporting on nursing care practices for the prevention and control 
of pre-eclampsia and eclampsia, were eligible for inclusion in this 
review. 
 
Exclusion Criteria: Studies that were published before 2005, 
reporting on nursing care practices in pregnancy-related complications 
other the pre-eclampsia and eclampsia and studies not reporting on the 
nursing care practices, were excluded. 
 
Search Outcome: A total of 2,895 articles were initially 
identified using the search criteria from all the selected databases and 
through manual searching using Google Scholar, where 215 were 
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duplicated. The remaining 2,680 articles were selected for title-wise 
screening which resulted in 153 studies to be selected for abstract 
reading. After the abstract screening, 15 studies were selected for full-
text reading, of which 14 were included in the review. All screening was 
done by three independent reviewers. Each article was screened by three 
reviewers and disagreement between them was resolved by discussion. 
The aim was to identify all relevant articles which have reported on the 
nursing care practices in the prevention and control of pre-eclampsia and 
eclampsia. 
 
Quality Assessment: It is always difficult to analyze the quality 
of heterogeneous and distinctive primary sources in an effective manner 
(WHITTEMORE; KNAFL, 2005). The methodological quality 
assessment was not conducted in this review because the assignment of 
such quality score in different studies is an arbitrary and unscientific 
process (MEADE; RICHARDSON, 1997). However, tools like (CASP, 
2002) and the Joanna Briggs Institute (JBI) were used to assess the 
quality of included studies. Similarly, assessment of studies was not 
summarized due to the inherited methodological complexity 
(WHITTEMORE; KNAFL, 2005). Articles were classified according to 
(MELNYK; FINEOUT-OVERHOLT, 2011). 
 
Data Extraction and Synthesis: Extracting and synthesizing 
data from heterogeneous sources is a complex process (GOLDSMITH; 
BANKHEAD; AUSTOKER, 2007). All selected studies were 
independently assessed by two reviewers. The following information 
was extracted from each included study: general information about 
authors, journal, publication date, country and region; research design, 
location, participants, aims; nursing care practices in the prevention of 
pre-eclampsia and eclampsia; results and descriptive summaries of 
numerical data. 
Synthesis of the data involved categorizing and tabulating data 
and then narrating, summarizing and presenting it visually. 
 
 
3.4  THEORETICAL DESIGN  
 
The application development life-cycle is a term used in systems 
engineering, information systems, and software engineering to describe 
a process for planning, creating, testing, and deploying an information 
system. It is a splitting of software development work into distinct 
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phases (or stages) containing activities with the intent of better planning 
and management. The iterative and incremental development 
(LARMAN; BASILI, 2003) methodology is to be followed in this work. 
The basic idea behind this method is to develop a system through 
repeated cycles (iterative) and in smaller portions at a time 
(incremental), allowing developers to take advantage of what was 
learned during the development of earlier parts or versions of the 
system. Learning comes from both the development and use of the 
system, where possible key steps in the process start with a simple 
implementation of a prototype and then iteratively improving the 
system. At each iteration, design modifications are made and new 
functional capabilities are added. 
It must be noted that during this thesis, I have focused and 
completed only the first two phases (Requirements and Design) of the 
development process of this network model. The others phases are 
intended to be completed in partnership with my advisor in a future 
research project. 
The development of Pregnancy Nursing Care Virtual Network 
(PNCN) will involve a process consisted of the following steps 
(LARMAN; BASILI, 2003): 
Requirements: This phase consist of gathering information about 
the target population, determining the needs or conditions to meet, 
deciding the contents and knowledge to be delivered, the tasks and 
function to be completed, and analysis of available technologies feasible 
for development and implementation. 
Design: The design phase consists of planning, creating 
specifications, conceptualizing and framing material and production of 
content, preparing the storyboard and layout design and user interface 
(color, fonts, images and buttons). 
Develop: The third phase, development, involves the creation of 
the activities that will be implemented. It consists of developing and 
programming the navigation structure, user interface, settings, images, 
content, and animations. 
Test: Testing ensures that the materials achieved the desired goals 
and basic functionality. It is used to verify whether the component meets 
the requirements decided earlier, responds correctly to all kinds of 
inputs, performs its functions in an acceptable manner, is sufficiently 
usable, can be installed and used in its intended environments, and 
achieves the general result its end users require. 
Debug: Debugging is the process of identifying and removing 
errors that prevent correct operation of computer software or a system. 
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Deployment: This stage consists of the installation of PNCN files 
to a central server and making available the client app through different 
mobile platforms. 
Evaluate and Maintain: This phase involves review, evaluation 
and modification in a component after deployment to correct faults, add 
features, improve the performance or other attributes.  
 
Expected Results 
It will make possible, easy and useful communication between 
pregnant women, community, and nurses and will improve women 
knowledge and awareness regarding pre-eclampsia, eclampsia and other 
pregnancy-related complications and maternal health. It will increase 
antenatal care visits through application reminders and enable access / 
call to emergency obstetric care when complications arise and will 
improve referral communication and will increase access to quality care. 
This network will make it possible for pregnant women to communicate 
with midwives/nurse for useful information. It will improve antenatal, 
postnatal care and record keeping and will serve as maternal health 
indicators for policy makers. This network will enable monitoring, 
follow-up, referrals and interactive information for pregnant women 
along with continuity of care from the start of the pregnancy all the way 
through her post-partum period. 
However, it must be noted that during this thesis, I have focused 
and completed only the first two phases (Requirements and Design) of 
the development process of this network model. The others phases are 
intended to be completed in partnership with my advisor in a future 
research project. 
 
 
3.5 ETHICAL CONSIDERATIONS 
 
This study was developed in the context of project TO 
13075/2012 - FAPESC, Opinion Nº. 120.343 and Nº. 169.110 of the 
year 2012 (Annexes A and B) and for that reason, it respects what is set 
out the Resolution no. 466/2012 of the Ministry of Health Brazil 
(BRASIL, 2013). However, the completion of this research work did not 
involve any human subjects. Financial support was also granted by the 
CNPq and TWAS (CNPq process 190141/2012-3) to pursue PhD study 
in the Postgraduate Program in Nursing at Federal University of Santa 
Catarina (PEN-UFSC), Brazil. 
  
  
  
 
 
 
4 RESULTS 
 
 
Considering the goals previously set for the study, the result and 
discussion obtained are presented in four manuscripts according to the 
PEN/UFSC Normative Instruction 01/PEN/2016 atending the criteria for 
the format of presentation of work for completion of Doctoral degree in 
Nursing. Titles of the manuscripts are: 
 
- Technologies and techniques for the prevention of pre-
eclampsia and eclampsia: a systematic review without meta-
analysis; 
- Maternal mortality associated with pre-eclampsia and 
eclampsia in Khyber Pakhtunkhwa province of Pakistan: an 
integrative review; 
- Nursing care practices in the prevention and control of pre-
eclampsia and eclampsia: an integrative review; 
- Pregnancy nursing care virtual network: a theoretical design. 
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4.1 MANUSCRIPT 1 - TECHNOLOGIES AND TECHNIQUES FOR 
THE PREVENTION OF PRE-ECLAMPSIA AND ECLAMPSIA. A 
SYSTEMATIC REVIEW WITHOUT META-ANALYSIS 
 
 
TECHNOLOGIES AND TECHNIQUES FOR THE PREVENTION 
OF PRE-ECLAMPSIA AND ECLAMPSIA. A SYSTEMATIC 
REVIEW WITHOUT META-ANALYSIS 
 
 
Sabiha Khanum1 
Maria de Lourdes de Souza2 
 
 
Abstract. Pregnancy, the most valuable period of every woman’s life, 
requires continuous, prompt and supportive care throughout during 
pregnancy and also after childbirth for safe motherhood. Objectives. To 
assess the technologies and techniques used for the prevention of pre-
eclampsia and eclampsia. Methods. The standard methodology of 
systematic review without meta-analysis was followed and only 
Random Controlled Trials and Systematic Reviews were included in this 
systematic review. Three electronic data sources (PubMed/Medline, 
Cinahl, and Cochrane) were searched for studies, published between 
1985 and 2015 on the prevention and control of pre-eclampsia and 
eclampsia. Results. 47 studies were included in the review, of which 18 
were systematic reviews and 29 were Random Controlled Trials. 
Technologies and techniques used in the included studies for the 
prevention and control of pre-eclampsia and eclampsia are Magnesium 
Sulfate, Aspirin, Antioxidant (Vitamin C, E and Lycopene), Calcium 
supplementation, Chinese Herbal Medicine, Physical Activities, Nitric 
Oxide, Marine Food Oils, Low Salt Diet, Garlic, Plasma Volume 
Expansion, Low-dose Dopamine, Progesterone, Smoking, and Diuretics. 
Conclusion. Magnesium Sulfate appears to be the most promising 
technique which reduces the risk of eclampsia by more than 50%. 
However, its best dose and route is still controversial and need further 
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research. The knowledge and experience in properly using the protocols 
and evidence-based interventions are necessary for patient care. 
 
Keywords: Pre-Eclampsia. Eclampsia. Maternal Mortality. Women’s 
Health. Pregnancy. 
 
 
BACKGROUND 
 
Women are the source of all human life on this planet. The 
pleasure and excitement of being a mother cannot be expressed in 
words. In all cultures and societies being pregnant or to give birth to a 
child is considered as an important, beautiful and divine event (DUTTA, 
2001). Pregnancy, the most precious period of every woman’s life, 
requires continuous, prompt and supportive care throughout during 
pregnancy and also after childbirth for safe motherhood. 
Pre-eclampsia is a hypertensive disorder of pregnancy, a serious 
condition that occurs typically after 20 weeks of pregnancy. It is a 
combination of hypertension (raised blood pressure) and proteinuria (the 
presence of protein in the urine) (DULEY; HENDERSON-SMART; 
WALKER, 2009). Most women with pre-eclampsia give birth without 
problems. However, severe pre-eclampsia can cause problems such as 
stroke, kidney failure, liver failure, and blood clotting (DULEY; 
HENDERSON-SMART; WALKER, 2009). 
On the other hand, eclampsia, which is usually rare but 
potentially life-threatening, is characterized by the occurrence of a 
seizure in association with pre-eclampsia, swelling feet, sudden weight 
gain, headaches, and changes in vision (DULEY et al., 2010a). 
Approximately 1 out every 200 women who had pre-eclampsia, 
eventually develop more serious condition of eclampsia which causes 
about 50,000 maternal deaths each year (KHAN et al., 2006). 
Globally 300,000 women die each year from complications of 
pregnancy and more than 95% of these women are in Africa and Asia 
(WHO, 2015). Pre-eclampsia and eclampsia together affect about 10% 
of all pregnant women around the world (MYLES; BENNETT; 
BROWN, 1993; GHULMIYYAH; SIBAI, 2012). In Africa and Asia, 
about one-tenth of all maternal deaths and in Latin America one-quarter 
of all maternal deaths are associated with hypertensive disorders of 
pregnancy. More than half of the maternal deaths occur in sub-Saharan 
Africa and about one third occur in South Asia (WHO, 2015). Among 
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the hypertensive disorders of pregnancy, pre-eclampsia and eclampsia 
remain one of the major causes of maternal mortality (DULEY, 2009; 
WHO, 2015). In Australia alone, it was estimated that between 4% to 
10% of pregnant women develop pre-eclampsia, causing four to five 
maternal deaths and up to 300 to 500 perinatal deaths per year 
(ROBERTS et al., 2011). 
 
 
OBJECTIVES 
 
To assess the technologies and techniques for prevention of pre-
eclampsia and eclampsia. 
 
 
MATERIALS AND METHODS 
 
Design 
PRISMA guidelines (MOHER et al., 2009) was used as a basis 
for the overall study approach. A systematic review without meta-
analysis search was conducted from May 2015 to May 2016 to answer 
the research question of: What are the available technologies and 
techniques for the prevention and control of pre-eclampsia and 
eclampsia? PubMed / MEDLINE, CINAHL, and COCHRANE were 
searched for articles published between 1985 to 2015, reporting on the 
available technologies and techniques for the prevention and control of 
pre-eclampsia and eclampsia in pregnant women. The question was 
adjusted according to the PICO acronyms; P (population/participants) 
representing all pregnant women; I (intervention) represent the use of 
available technologies and techniques; C shows comparison in the 
control group, the placebo group or non-existence of the comparison 
group; and O represented the outcomes of interest which were 
prevention and control of pre-eclampsia and eclampsia and reduction in 
maternal mortality. The search strategy was based on a number of 
medical subject headings MESH terms and text words, summarized in 
Table 1. 
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Inclusion Criteria 
Systematic Reviews and Random Controlled Trials (RCT’s) 
published in the English language between 1985 to 2015 based on the 
prevention and control of pre-eclampsia and eclampsia were eligible for 
inclusion in this review. 
 
Exclusion Criteria 
Papers whose topics were irrelevant to the objective of this study 
were excluded and all qualitative research. 
 
 
Table 1 - Database, Filters and Keywords. 
 
Database Filters Keywords 
PUBMED Text: Complete; 
Publication Date: 
19850101-20150131; 
Language: English; 
Sex: Female; 
Age: 19-44 years 
(”eclampsia/prevention and
control”[Mesh]) 
OR “pre-eclampsia/prevention and 
control”[Mesh] 
COCHRANE Total review 1,085 
Complete review 179 
Prevention and control of pre-
eclampsia or eclampsia 
CINAHL Text: Complete; 
Publication Date: 
19850101-20150131; 
Language: English; 
Sex: Female; 
Age: 19-44 years 
Prevention and control of pre-
eclampsia or eclampsia) 
Source: Made by the author (2016). 
 
Search Outcome 
A total of 1,808 articles were initially identified using the search 
criteria from all the three databases, of which 14 were duplicate. Titles 
screening of the remaining 1,794 articles resulted in 330 relevant articles 
being selected for abstract screening. The abstracts of these 330 papers 
were then examined resulting in 58 papers being examined in full. Of 
these, 11 were excluded after quality assessment. The remaining 47 
studies were fully read and were included in the review as shown in 
Figure 1. 
Each article was screened by two independent reviewers and 
disagreement between them was resolved by discussion. The aim was to 
identify as many articles as possible which have reported the use of 
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different techniques and technologies for the prevention of pre-
eclampsia and eclampsia in past 30 years. 
 
Figure 1 - Flow diagram showing the process of identification and screening for 
this systematic review. 
 
 
Source: Made by the author (2016). 
 
Quality Appraisal 
We assessed the quality of each paper meeting the inclusion 
criteria using the following: (a) relevance to the systematic review (b) 
validity and appropriateness of methodology (c) quality of evidence 
generalizability of results (d) quality of reporting (e) limitations of the 
study and how it was adjusted. The quality of the outcome was assessed 
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using the Evidence Level: Joanna Briggs from Level I to II as outlined 
in Table 2. 
 
Table 2 - Level of Evidence. 
 
Level Description 
I Evidence obtained from a systematic review of all relevant 
randomized controlled trials. 
II Evidence obtained from at least one properly deigned 
randomized controlled trial. 
III.1 Evidence obtained from well-designed controlled trials, not 
randomized. 
III.2 Evidence obtained from comparative studies such as cohort 
studies, case-control studies preferably from more than one 
center or research group. 
III.3 Evidence obtained from multiple time series with or without the 
intervention. Dramatic results in uncontrolled experiments. 
IV Evidence from the opinion of respected authorities, based on 
clinical experience, descriptive studies, or reports of expert 
committees. 
Source: Adapted from the Joanna Briggs Institute (2002). 
 
 
Data Extraction and Synthesis 
All 47 papers were independently assessed by two reviewers. The 
following information was extracted from the included studies. General 
information about authors, journal, publication date, country, research 
design, location, participants, aim, sample size, evidence of use of the 
available technologies and techniques in pregnant women for the 
prevention of pre-eclampsia or eclampsia, results and descriptive 
summaries of numerical data. Synthesis of the studies involved 
categorizing technologies and techniques by their characteristics, 
narrating and summarizing its effectiveness and presenting data visually. 
 
Ethical Considerations 
This study was developed in the context of project TO 
13075/2012 - FAPESC, Opinion No. 120.343 and No. 169.110 of the 
year 2012 (Annexes A and B) and for that reason, it respects what is set 
out the resolution no. 466/2012 of the Ministry of Health Brazil 
(BRASIL, 2013). However, the completion of this research work did not 
involve any human subjects. 
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RESULTS 
 
Among the 47 articles included in this study, 18 were systematic 
reviews, 29 were RCTs, including 9 multicenter RCTs. All the identified 
articles for systematic review were based on quantitative research 
studies. All included studies in this systematic review, restricted 
sampled participants to nulliparous or multiparous pregnant women 
(between 12 and 34 weeks of gestation), with hypertension, pre-
eclampsia or eclampsia. Age of the participants vary between 14 to 45 
years and sample size of the selected studies vary from 30 in 
(NIROMANESH; LAGHAII; MOSAVI-JARRAHI, 2001) to 37,560 in 
(DULEY et al., 2007) participants. 
The included 29 RCTs were conducted and based in countries; 
UK=3, Italy=1, Brazil=1, Iran=1, South Africa=2, Barbados=1, India=2, 
Finland=2, USA=4, Mexico=1, Japan=1, Australia=1. Similarly, the 
multicenter studies were conducted in countries; 1 Multicenter RCT in 
South Africa, Turkey, Brazil, Argentina, Philippine, Dominican, 
America; 1 Multicenter RCT in France and Belgium; 1 Multicenter RCT 
in America and Europe; 1 Multicenter RCT in India, Peru, South 
Africa, Vietnam; 1 Multicenter RCT in Argentina, Brazil, 
Colombia, Ghana, India, Uganda, Venezuela, Zimbabwe; 1 Multicenter 
RCT in England, Ireland, Scotland; 1 Multicenter RCT in Peru, 
Argentina, India, Egypt, South Africa, UK; 1 Multicenter RCT in 
Australian and New Zeeland; 1 Multicenter RCT in Canada and Mexico. 
The included studies used different technologies and techniques 
to intervention for the prevention and treatment of pre-eclampsia, 
eclampsia and its complications in pregnant women. These include 
Magnesium Sulfate (8 studies), Aspirin (9 studies), Antioxidant 
including Vitamin C and E (9 studies), Calcium Supplementation (4 
studies), Physical Activity and Exercise (3 studies), Nitric Oxide (3 
studies), Marine Food Oils (2 studies), Low Salt Diet (1 studies), Garlic 
(1 studies), Chinese Herbal Medicine (1 studies), Plasma Volume 
Expansion (1 studies), Low-dose Dopamine (1 studies), Progesterone (1 
studies), Antioxidant Lycopene (1 studies), Smoking (1 studies) and 
Diuretics (1 studies). A detail discussion on these interventions is 
presented in section 4 while their summarized results are provided from 
Table 3 to Table 8. 
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DISCUSSION 
 
This study gives an overview of the available technologies and 
techniques for the prevention of pre-eclampsia and eclampsia in the past 
30 years. The review has identified evidence about the central and 
supportive role of Magnesium Sulfate in the prevention of pre-eclampsia 
and eclampsia in pregnant women (BELFORT et al., 2003; DULEY; 
GULMEZOGLU; CHOU, 2010; DULEY et al., 2010b). Although, there 
is little evidence about the size of the effective dose, in order to draw 
any firm conclusions. Technologies and techniques including 
Magnesium Sulfate and many others identified in this study used for the 
prevention of pre-eclampsia and eclampsia are discussed in details, as 
follows. 
It is generally believed that anticonvulsant is effective in 
managing eclampsia and that why Magnesium Sulfate, the most 
commonly used anticonvulsants, is considered a treatment of choice for 
eclampsia (DULEY et al., 2010b; SIBAI, 1990). Table 3 shows the 
summary of magnesium sulfate related studies included in this 
systematic review. 
Magnesium Sulfate is the most promising technique and reduces 
the risk of eclampsia by more than 50%, as concluded by a systematic 
review (DULEY et al., 2010b) with 15 trials and more than 12,000 
women. Similarly, Magnesium Sulfate is also effective in reducing the 
incidence of eclampsia in women with severe pre-eclampsia 
(COETZEE; DOMMISSE; ANTHONY, 1998). Magnesium Sulfate 
performs better than a lytic cocktail (DULEY; GULMEZOGLU; 
CHOU, 2010) and is more effective than nimodipine (BELFORT et al., 
2003) in preventing maternal death, further seizures and other serious 
maternal morbidity in pregnant women with eclampsia. 
Magnesium Sulfate had a 52% lower risk of recurrent 
convulsions (95% CI 64% to 37% reduction) than that allocated 
diazepam (60 (13.2%) vs 126 (27.9%). Similarly, Magnesium Sulfate 
had a 67% lower risk of recurrent convulsions (95% CI 79% to 47% 
reduction) than that allocated phenytoin (22 (5.7%) vs 66 (17.1%) 
(WHICH ANTICONVULSANT…, 1995). Low dose i.v. Magnesium 
Sulfate regimen is equally effective in the prevention of convulsion 
recurrence and maternal deaths in eclamptic women compared with an 
i.m. magnesium sulfate regimen (CHOWDHURY et al., 2009). 
Despite the strong evidence in favor of Magnesium Sulfate for 
prevention of eclampsia, trials comparing alternative techniques 
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regimens are too small for a reliable conclusion. There was not enough 
evidence to show what is the best dose for Magnesium Sulfate for 
women with pre-eclampsia or eclampsia, and what is its best route. 
Magnesium Sulfate has also been associated with increased risk of PPH 
and respiratory difficulties (BELFORT et al., 2003), flushing (DULEY 
et al., 2010b) and overdose adverse effects (primarily from medication 
and administration errors) and may increase the rates of cesarean 
delivery (RANTONEN et al., 2001). 
Antiplatelet agents, in particular, Aspirin, are among the most 
promising candidates for prevention of pre-eclampsia. They keep a good 
balance between prostacyclin, a vasodilator, and thromboxane, a 
vasoconstrictor, and stimulant of platelet aggregation (VILLA et al., 
2013). However, according to the studies included in this review, 
Aspirin does not show any significant benefits in the incidence of 
proteinuric pre-eclampsia, preterm delivery, birthweight or of stillbirth, 
placental abruption, and neonatal death (ROTCHELL et al., 1998; 
HAAPSAMO et al., 2010; SUBTIL et al., 2003; YU et al., 2003; 
CARITIS et al., 1998). 
Although, a meta-analysis suggested that low-dose Aspirin 
initiated before 16 weeks of gestation reduces the risk of pre-eclampsia 
(RR 0.6, 95% CI 0.4-0.8) and severe pre-eclampsia (RR 0.3, 95% CI 
0.1-0.7) (VILLA et al., 2013). Similarly, the results obtained in another 
review (DULEY et al., 2007) shows that antiplatelet agents, mostly low-
dose Aspirin, have little benefits when used for prevention of pre- 
eclampsia and its complications. The role of Aspirin in the prevention of 
pre-eclampsia continues to be debatable and unclear. Its benefits and 
effectiveness are from small to moderate depending on the outcome. 
Table 4 shows the summary of Aspirin-related studies included in this 
review. 
There are several evidences which support the hypothesis that 
oxidative stress, an imbalance between pro-oxidant and antioxidant 
forces, plays a key role in the development of pre-eclampsia during 
pregnancy (XU et al., 2010). However according to the results of this 
review no promising results has yet been shown by antioxidants 
including vitamin C and E in reducing the complications of pre-
eclampsia or eclampsia. Table 5 shows the summary of antioxidants 
related studies included in this systematic review. 
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Table 3 - Summary of Magnesium Sulfate related studies (SR=Systematic 
Review; RCT=Randomized Control Trial; MgSo4=Magnesium sulfate). 
Ref. Study 
Type 
Intervention Population/ 
Sample Size 
Results/Benefits Adverse 
Effects 
(WHICH 
ANTICONV
ULSANT…, 
1995) 
Multicenter 
RCT 
MgSo4 Versus 
Diazepam
Versus 
Phenytoin 
1,680 
women with 
eclampsia 
from 9 
countries 
MgSo4 has 52% and 
67% lower risk of 
recurrent convulsions 
than diazepam and 
phenytoin 
respectively 
Not 
Reported 
(COETZEE; 
DOMMISSE; 
ANTHONY, 
1998) 
RCT IV magnesium 
sulfate (4g) 
versus Placebo 
685 Women 
with Severe 
pre-
eclampsia 
IV MgSo4 is 
effective in reducing 
the incidence of 
eclampsia 
Not 
Reported 
(BELFORT 
et al., 2003) 
Unblinded 
Multicenter 
Trial 
Nimodipine 
(60mg/4h 
orally) and IV 
MgSO4 of 2g/h 
and 1g/h 
1,650 
women with 
severe pre-
eclampsia 
MgSo4 is more 
effective and has 
lower mortality rate 
than Nimodipine in 
women with severe 
pre-eclampsia 
Increases 
the risk of 
PPH and 
respiratory 
difficulty 
(LIVINGST
ON et al., 
2003) 
RCT IV MgSo4 (6g), 
followed by 
2g/h 
222 Women 
with mild 
pre-
eclampsia 
No major impact on 
disease progression. 
Does not seem to 
increase rates of 
cesarean delivery, 
infectious morbidity, 
obstetric hemorrhage. 
Not 
Reported 
(CHOWDHU
RY et al., 
2009) 
Prospective 
Trial 
4g IV MgSO4 
followed by 
i.m. injections 
or IV 0.6g/h 
630 women 
with 
eclampsia 
Both interventions are 
equally effective in 
the prevention of 
convulsion recurrence 
and maternal deaths 
Not 
Reported 
(DULEY et 
al., 2010a) 
SR MgSo4 with 
different dose 
6 RCTs - 
with 866 
women 
Strong evidence in 
favor of MgSo4. Lack 
of clarity for best 
dose size/route 
Not 
Reported 
(DULEY et 
al., 2010b) 
SR MgSO4 and 
Other 
Anticonvulsant
s 
15 RCTs 
with more
than 12000 
women 
MgSo4 reduce (50%) 
the risk of eclampsia 
and is more effective 
than phenytoin, 
diazepam or 
nimodipine 
Flushing 
(DULEY; 
GULME-
ZOGLU; 
CHOU, 
2010) 
SR MgSo4 
Compared with 
Lytic Cock-tail 
3 small trials 
involving 
397 women 
MgSo4 is more 
effective in reducing 
MM and serious 
maternal morbidity 
than Lytic cocktail. 
Recurrence 
of seizures. 
Source: Made by the author (2016). 
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Table 4 - Summary of Aspirin-related studies included in this review 
(SR=Systematic Review; RCT=Randomized Control Trial; PC = placebo-
controlled; DB = double blinded). 
Ref. Study Type Intervention Population/ 
Sample Size 
Results/Benefits Adverse 
Effects 
(SIBAI et al., 
1993) 
RCT 60 mg 
Aspirin per 
day 
3,135 
nulliparous 
women (13–
26 week 
pregnancy) 
Low-dose aspirin 
decreases the incidence 
of pre-eclampsia among 
nulliparous women 
Increasing 
the risk of 
abruption 
placentae 
(ROTCHELL et 
al., 1998) 
Randomized 
PC Trial 
75 mg 
controlled 
release 
Aspirin 
3,647 
women (12–
32 week 
pregnancy) 
Do not support the 
routine use of low-dose 
aspirin for prevention of 
pre-eclampsia or its 
complications. 
Not 
Reported 
(CARITIS et 
al., 1998) 
Randomized 
DB PC Trial 
60 mg 
Aspirin per 
day 
2,503 
women (13–
26 week 
pregnancy) 
Low-dose aspirin did not 
reduce the incidence of 
pre-eclampsia 
significantly or improve 
perinatal outcomes in 
pregnant women. 
Not 
Reported 
(SUBTIL et al., 
2003) 
Randomized 
DB PC Trial 
100 mg low-
dose Aspirin 
per day 
3,294 
women (14–
20 week 
pregnancy) 
Does not reduce the 
incidence of pre-
eclampsia in nulliparous 
women 
increase 
in 
bleeding 
complicati
ons 
(YU et al, 2003) RCT 150mg low-
dose Aspirin 
per day 
560 Women 
(22– 24 week 
pregnancy) 
No significant 
differences between the 
aspirin and placebo 
groups 
Not 
Reported 
(CHIAFFARINO 
et al., 2004) 
Randomized 
Trial 
100 mg low-
dose Aspirin 
per day 
40 women 
(14 week 
pregnancy) 
Limited data show some 
support for early 
treatment with Aspirin in 
pregnant women 
Not 
Reported 
(DULEY et al., 
2007) 
SR Antiplatelet 
Agents (low-
dose aspirin) 
59 trials with 
37,560 
women 
Antiplatelet Agents, 
largely low-dose aspirin, 
have moderate benefits 
when used for prevention 
of pre-eclampsia 
Not 
Reported 
(HAAPSAMO 
et al., 2010) 
Randomized 
DB PC Trial 
100 mg low-
dose Aspirin 
per day 
487 Women No statistical difference 
between low-dose 
aspirin and placebo 
groups 
Not 
Reported 
(VILLA et al., 
2013) 
Randomized 
DB PC Trial 
100 mg low-
dose Aspirin 
per day 
152 women 
(12 week 
pregnancy) 
Showed no statistically 
significant effect of 
aspirin in preventing pre-
eclampsia 
Not 
Reported 
Source: Made by the author (2016). 
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Table 5 - Summary of Antioxidant and Vitamin C, E related studies 
(SR=Systematic Review; PC = placebo-controlled; DB = double blinded). 
Ref. Study Type Intervention Population/ 
Sample Size 
Results/Benefits Adverse 
Effects 
(GÜLMEZOĞLU; 
HOFMEYR 
OOSTHUISEN, 
1997) 
Randomized 
DB PC Trial 
(800IU 
Vitamin E, 1g 
Vitamin C 
and 200g 
allopurinol) 
daily 
54 women 
with severe 
pre-eclampsia 
(24–32 weeks 
pregnancy) 
Do not encourage 
the routine use of 
antioxidants 
against pre-
eclampsia 
Increase in 
acne, 
transient 
weakness 
and skin 
rash 
(POSTON et al., 
2006) 
Randomized 
PC Trial 
1g vitamin C 
and 400IU of 
Vitamin E or 
placebo 
2,410 
Women (14–
22 weeks 
pregnancy) 
does not prevent 
preeclampsia in 
women at risk 
Increase 
rate of low 
birth-
weight 
babies 
(RUMBOLD et al., 
2006) 
Multicenter 
PC Trial 
1g vitamin C 
and 400IU of 
Vitamin E or 
placebo daily 
1,877 women 
from two 
countries 
(14–22 weeks 
pregnancy) 
No reduction in 
the risk of pre-
eclampsia, 
intrauterine 
growth restriction, 
or other serious 
outcomes in their 
infants. 
Not 
Reported 
(SPINNATO et al., 
2007) 
Randomized 
DB PC Trial 
1g vitamin C 
and 400IU 
Vitamin E or 
placebo 
739 Women 
(12– 19 
weeks 
pregnancy) 
No benefits in 
reducing the rate 
of pre-eclampsia 
among patients 
with chronic 
hypertension 
Not 
Reported 
(RUMBOLD et al., 
2008) 
  Antioxidant 
(with Vitamin 
C , E, 
selenium and 
lycopene) 
10 RCT with 
6,533 women 
(12–28 eeks 
pregnancy) 
No reduction in 
the risk of pre-
eclampsia and its 
complications 
Not 
Reported 
(VILLAR et al., 
2009) 
Multicenter 
PC Trial 
1g vitamin C 
and 400 IU of 
Vitamin E or 
placebo daily 
687 women 
(14– 22 
weeks 
pregnancy) 
No reduction in 
the rate of pre-
eclampsia high-
risk pregnant 
women with low 
nutritional status 
Not 
Reported 
(MCCANCE et al., 
2010) 
Multicenter 
PC Trial 
1g vitamin C 
and 400IU of 
Vitamin E or 
placebo 
762 diabetic 
pregnant 
women (8–22 
weeks) 
No reduction in 
the risk of pre-
eclampsia in 
women with type 
1 diabetes 
Not 
Reported 
(ROBERTS et al., 
2010) 
Multicenter 
PC Trial 
1g vitamin C 
and 400IU of 
Vitamin E or 
placebo 
10,154 
Women (9–
16 weeks 
pregnancy) 
No reduction in 
the rate of adverse 
maternal or 
perinatal outcomes 
Not 
Reported 
Continues… 
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Ref. Study Type Intervention Population/ 
Sample Size 
Results/Benefits Adverse 
Effects 
Conclusion 
(XU et al., 2010) Multicenter 
RCT 
1g vitamin C 
and 400 IU of 
Vitamin E or 
placebo daily 
2,647 women 
from 27 
centers 
No reduction in 
the rate of pre-
eclampsia 
increased 
fetal loss 
and 
preterm 
rupture of 
membrane 
Source: Made by the author (2016). 
 
 
Table 6 - Summary of Calcium related studies included in this review (PC = 
placebo-controlled; DB = double blinded). 
Ref. Study Type Intervention Population/ 
Sample Size 
Results/Benefits Adverse 
Effects 
(LEVINE et al., 
1997) 
Randomized 
DB PC Trial 
2g 
calcium/day or 
placebo 
4,589 women 
(13–21 weeks 
pregnancy) 
No prevention in 
preeclampsia, or 
its severity or 
delay its onset 
Not 
Reported 
(NIROMANESH; 
LAGHAII; 
MOSAVIJARRAHI, 
2001) 
Randomized 
DB PC Trial 
2g 
calcium/day or 
placebo 
30 women 
(28 to 32 
weeks of 
gestation) 
Limited data 
shows reduction 
in the risk of pre-
eclampsia 
Not 
Reported 
(VILLAR et al., 
2006) 
Randomized 
DB PC Trial 
1.5g 
calcium/day or 
placebo 
8,325 women 
of 20 week 
pregnancy 
did not prevent 
pre-eclampsia but 
did reduce its 
severity and 
maternal 
morbidity 
Not 
Reported 
(HOFMEYR; 
DULEY; 
ATALLAH, 2007) 
Systematic 
Review 
1.5g to 2 g 
calcium/day 
12 RCTs 
with 15,528 
women 
Appears to reduce 
the risk of pre-
eclampsia and 
serious morbidity 
No other 
clear 
benefit or 
harms 
Source: Made by the author (2016). 
 
Results obtained in (XU et al., 2010; GÜLMEZOĞLU; 
HOFMEYR; OOSTHUISEN, 1997; VILLAR et al., 2009; RUMBOLD 
et al., 2006; 2008; MCCANCE et al., 2010; POSTON et al., 2006; 
ROBERTS et al., 2010; SPINNATO et al., 2007) fails to demonstrate 
the benefits of antioxidant supplementation in reducing the rate of pre-
eclampsia and hence do not encourage its routine use against pre-
eclampsia. Previous research also does not support the use of vitamin C 
and E supplementation in pregnancy to reduce the risk of pre-eclampsia 
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or its complications (ROBERTS et al., 2010). However, the possibility 
that vitamin supplementation might be beneficial in women with a low 
antioxidant status at baseline needs further research and trials. 
Historically, a relationship between calcium deficiency and 
homeostasis and pre-eclampsia was suggested (VILLAR; BELIZÁN, 
2000). In this regard, nutrient supplements consisting of calcium are 
prescribed to treat deficiencies or for pharmacologic effects during 
pregnancy. The use of calcium supplementation in the light of this 
review did not show strong evidence in favor of it routine use (VILLAR 
et al., 2006; LEVINE et al., 1997). However, a systematic review 
(HOFMEYR; DULEY; ATALLAH, 2007) with 12 good quality RCTs 
involving 15,528 women and an RCT in (NIROMANESH; LAGHAII; 
MOSAVI-JARRAHI, 2001) show promising results in favor of calcium 
supplementation in the prevention of preeclampsia and related problems.  
Overall it seems that calcium supplementation appears to reduce 
the risk of pre-eclampsia and reduce the rare occurrence of the serious 
morbidity. However, further research is needed in different settings and 
trials to explain its role in the prevention of pre-eclampsia. Table 6 
shows the summary of calcium related studies included in this 
systematic review. 
It can be possibly believed that increased physical activities and 
exercise may help pregnant women in the prevention of developing 
preeclampsia as it benefits are many for non-pregnant people (MEHER; 
DULEY, 2006a). There are, however, also concerns that there may be 
adverse effects of exercise taken during pregnancy and hence the role of 
increased physical activity and exercise is controversial and not clear. 
Table 7 shows the summary of physical activities and exercise related 
studies included in this review. 
For inactive pregnant women, a stretching exercise may be more 
effective than walking in mitigating the risk of pre-eclampsia due to 
higher adherence and possible cardiac-physiologic effects (YEO, 2009). 
However, the results do not deny the effects of walking exercise on risk 
of pre-eclampsia. In the light of this review, no firm conclusion can be 
drawn about recommending rest or increased activity to women, due to 
the insufficient evidence obtained in (MEHER; DULEY, 2006a,c). 
However, further research is needed in different settings and trials to 
explain its role in the development and prevention  
In the Table 8 show the summary of included studies related to 
miscellaneous interventions. 
The salt consumption during pregnancy should remain a matter of 
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personal choice. The effects of salt consumption during pregnancy were 
assessed in a systematic review (DULEY; HENDERSON-SMART; 
MEHER, 2005) with two trials involving 603 women. Both trials 
compared reduce dietary salt intake with normal diet. However, the 
review did not show any evidence of benefit for the mother or baby. 
Traditional Chinese Medicine (TCM) believes that during 
pregnancy most of the blood of the mother flows to the placenta to 
provide the fetus with the required blood circulation and nutrition and as 
a result, other organs of the mother get weak. The effectiveness of TCM 
in pre-eclampsia was assessed in a systematic review (ZHANG; WU; 
LIU, 2006) in which the authors identified 45 studies but none could be 
classified as a randomized controlled trial. The usefulness of Chinese 
herbal medicines for treating pre-eclampsia hence remains unclear due 
to insufficient evidence. 
Population studies have shown that higher intakes of marine 
foods during pregnancy are associated with higher infant birth weights 
and a low incidence of pre-eclampsia (MAKRIDES; DULEY; OLSEN, 
2006). The Marine food contains fatty acids which are believed to be 
helpful in preventing the incidence of pre-eclampsia. However, there is 
insufficient evidence to support the routine use of marine food and oil 
during pregnancy in order to minimize the risk of pre-eclampsia and its 
related complications (ZHOU et al., 2012; MAKRIDES; DULEY; 
OLSEN, 2006). 
Similarly, there is insufficient evidence to recommend increased 
garlic intake for preventing pre-eclampsia and its complications during 
pregnancy as evident from a systematic review (MEHER; DULEY, 
2006b) with one included trial (100 women). Further large randomized 
trials evaluating the effects of garlic are needed before any 
recommendations can be made to guide clinical practice. 
Nitric oxide drugs (glycerol trinitrate) or their 
precursors(Arginine) relaxing the walls of the blood vessel and may 
play an effective role in the prevention of pre-eclampsia. However, there 
is insufficient evidence to draw reliable conclusions about whether nitric 
oxide drugs or their precursors prevent pre-eclampsia and its related 
complications (LEES et al., 1998; MEHER; DULEY, 2007). 
Although, one randomized, blinded, placebo-controlled clinical 
trial (VADILLO-ORTEGA et al., 2011) show some evidence of a 
reduction in the incidence of pre-eclampsia. Participants in this trial 
were pregnant women with a history of a previous pregnancy pre-
eclampsia. 222 women were allocated to the placebo group, 228 
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received L-arginine plus antioxidant vitamins, and 222 received 
antioxidant vitamins alone. The incidence of pre-eclampsia was reduced 
significantly (X2 = 19.41; P<0.001) in L-arginine plus antioxidant 
vitamins compared with placebo (absolute risk reduction 0.17 (95% CI 
0.12 to 0.21). L-arginine plus antioxidant vitamins compared with 
antioxidant vitamins alone resulted in a significant effect (P = 0.004; 
absolute risk reduction 0.09, 0.05 to 0.14). Supplementation with L-
arginine plus antioxidant vitamins needs to be further evaluated in a 
low-risk population in order for the firm conclusion to be drawn. 
Blood plasma volume increases gradually in women during the 
second half of pregnancy and is reduced in women with pre-eclampsia 
(DULEY; WILLIAMS; HENDERSON-SMART, 2000). It is possible 
that women with pre-eclampsia might benefit from expanded plasma 
volume if it were to increase blood circulation for the mother and baby. 
However, the results of a systematic review (DULEY; WILLIAMS; 
HENDERSON-SMART, 2000) are inconclusive about the effects of 
plasma volume expansion for the treatment of women with pre-
eclampsia. 
Cigarette smoking adversely affects every organ system (SHEA; 
STEINER, 2008). However very strangely, smoking during pregnancy 
has been associated with a reduction in the risk of pre-eclampsia 
(ENGLAND; ZHANG, 2007). 
A review based on the relation between smoking and pre-
eclampsia was conducted from 1959 to March 2006 with a total of 48 
epidemiologic studies (ENGLAND; ZHANG, 2007). Overall, smoking 
during pregnancy reduces the risk of pre-eclampsia by up to 50% with a 
dose-response pattern. This result was consistent with all nulliparous 
and multiparas women, singleton and multifetal pregnancies, and in all 
cases of mild and severe pre-eclampsia. However, the underlying 
mechanisms and the exact ingredients in cigarette smoke that influence 
the risk preeclampsia is unclear. Further research may enhance our 
understanding of the disease and contribute to the development of 
prevention strategies. 
The role of low-dose dopamine in the management of pregnant 
women with severe pre-eclampsia was assessed in a systematic review 
in (STEYN, D. W.; STEYN, P., 2007). Only one Randomized placebo-
controlled trial of six hours’ duration, including 40 postpartum women, 
was found. However, it remained unclear whether low-dose dopamine 
therapy for pre-eclamptic women with oliguria is beneficial. 
According to one theory the shortage of progesterone might be 
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the cause of pre-eclampsia, hence it is believed that progesterone during 
pregnancy might help them to avoid pre-eclampsia. However, no 
reliable conclusions could be made about the effects of progesterone in 
preventing pre-eclampsia and its complications according to the result of 
a review in (MEHER; DULEY, 2006d). 
 
 
Table 7 - Summary of physical activities & exercise related studies included in 
this review. 
Ref. Study 
Type 
Intervention Population/ 
Sample Size 
Results/Benefits Adverse 
Effects 
(MEHER; 
DULEY, 
2006a) 
Systematic 
Review 
Physical 
Activity and 
Exercise 
2 small, good 
quality trials 
with 45 
women 
Insufficient evidence 
for reliable 
conclusions 
Insufficient 
evidence 
(MEHER; 
DULEY, 
2006c) 
Systematic 
Review 
Physical 
Activity and 
Exercise 
2 small, low 
quality trials 
(106 women) 
Insufficient evidence 
for reliable 
conclusions 
Insufficient 
evidence 
(YEO, 
2009) 
Randomiz
ed Control 
Trial 
Physical 
Activity and 
Exercise 
124 women 
(¡ 14 weeks 
Pregnancy) 
Stretching exercise 
may be more 
effective than 
walking in reducing 
the risk of pre-
eclampsia. 
Not 
Reported 
Source: Made by the author (2016). 
 
 
Table 8 - Summary of other interventions related studies (SR = systematic 
review; PC = placebo-controlled; DB = double blinded). 
Ref. Study 
Type 
Intervention Population/ 
Sample Size 
Results/Benefits Adverse 
Effects 
(LEES et al., 
1998) 
Randomi-
zed DB 
PC Trial 
glyceryl 
trinitrate 5mg 
daily 
40 women (24– 
26 weeks 
pregnancy) 
No reduction in 
preeclampsia, 
preterm delivery or 
fetal growth 
restriction 
Not Reported 
(DULEY; 
WILLIAMS; 
HENDERSON
-SMART, 
2000) 
SR Plasma Volume 
Expansion 
3 trials with 61 
women 
Insufficient 
evidence to draw 
reliable conclusions 
Not Reported 
(DULEY; 
HENDERSON
- SMART; 
MEHER, 
2005) 
SR Low Salt Diet 2 Trials with 603 
women 
No Effect 
(Insufficient Data) 
Not Reported 
Continues… 
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Ref. Study 
Type 
Intervention Population/ 
Sample Size 
Results/Benefits Adverse 
Effects 
Conclusion 
(ZHANG; 
WU; LIU, 
2006) 
SR Chinese herbal 
medicines 
No trials suitable 
for inclusion 
Insufficient 
evidence 
Insufficient 
evidence 
(MAKRIDES; 
DULEY; 
OLSEN, 
2006) 
SR Marine oil & 
prostaglandin 
precursor 
6 trials with 
2,783 women 
Not enough 
evidence to support 
the routine use of 
marine oil, or other 
prostaglandin 
precursor 
Not Reported 
(MEHER; 
DULEY, 
2006b) 
SR Garlic 1 trial (100 
women) 
Insufficient 
evidence 
Odor 
(CHURCHILL 
et al., 2007) 
SR Diuretics 5 studies (1,836 
women) 
Insufficient 
Evidence 
Nausea, 
Vomiting 
(ENGLAND; 
ZHANG, 
2007) 
SR Cigarette 
smoking 
48 epidemiologic 
studies 
Smoking during 
pregnancy reduces 
the risk of pre-
eclampsia by up to 
50% 
Not Reported 
(MEHER; 
DULEY, 
2007) 
SR nitric oxide 
donors or 
precursors 
6 trials with 310 
women 
Insufficient 
evidence to draw 
reliable conclusions 
Headache 
with little 
evidence 
(STEYN, D. 
W.; STEYN, 
P., 2007) 
SR Low-dose 
dopamine 
1 trial (40 
women) 
Insufficient 
Evidence 
Not Reported 
(BANERJEE; 
JEYASEELAN; 
GULERIA, 
2009) 
Randomize
d DB PC 
Trial 
Lycopene oral 
2mg daily 
159 Women (12 
to 20 weeks of 
gestation) 
No significant 
difference between 
the two groups in 
developing pre-
eclampsia 
Increased 
preterm labor 
(MEHER; 
DULEY, 
2006d) 
SR progesterone 4trials (1,445 
women) 
Insufficient 
Evidence 
Not Reported 
(VADILLO-
ORTEGA et 
al., 2011) 
Randomize
d DB PC 
Trial 
L-arginine plus 
antioxidant 
vitamins 
672 pre-
eclamptic 
women (14–32 
weeks 
pregnancy) 
Reduced the 
incidence of pre-
eclampsia. 
Not Reported 
(ZHOU et al., 
2012) 
DB RCT n-3 LCPUFA 
(fish oil) 
2399 Pregnant 
women of ¡21 
week pregnancy 
No meaningful 
effect on the risk of 
pre-eclampsia 
Not Reported 
Source: Made by the author (2016). 
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Diuretic drugs result in reducing the blood pressure by excreting 
more urine and hence relaxing blood vessels. Due to these effects, it has 
been believed that Diuretic drugs might lower the risk of pre-eclampsia 
in pregnant women. However, the result drew in a systematic review 
(CHURCHILL et al., 2007) (5 studies involving 1,836 women), showed 
insufficient evidence to draw reliable conclusions about the effects of 
diuretics on prevention of pre-eclampsia and its related complications. 
The risk of nausea and vomiting was also increased, therefore the use of 
diuretics for the prevention of pre-eclampsia and its related 
complications cannot be suggested. 
A randomized double-blind placebo-controlled trial 
(BANERJEE; JEYASEELAN; GULERIA, 2009) with 159 
primigravidas (similar physical and social parameters) was conducted in 
India to evaluate the efficacy of antioxidant lycopene in preventing pre-
eclampsia. 77 women received 2mg/day oral lycopene until delivery. 
There was no significant difference in developing pre-eclampsia. The 
results confirm that lycopene is not effective in preventing pre-
eclampsia in healthy primigravidas. Rather, they result in the incidence 
of the adverse effects of preterm labor and low birth weight babies. 
 
 
CONCLUSIONS 
 
There are a number of evidences that have been identified and 
assessed for its role in the prevention of pre-eclampsia and eclampsia. 
Magnesium Sulfate so far has shown a great success in this regards and 
can be called as treatment of choice. It is more effective than diazepam, 
phenytoin, aspirin, calcium supplementation or lytic cocktail. However, 
despite the strong evidence, trials comparing alternative techniques are 
too small for reliable conclusions. There is insufficient evidence to show 
what is the best dose and route for magnesium sulfate for women with 
pre-eclampsia or eclampsia. 
Similarly, the role of Aspirin, Calcium supplementation, and 
Larginine plus antioxidant vitamins continues to be controversial. Its 
benefits and effectiveness range from small to moderate depending on 
the outcome. Further research is needed to assess which women are 
most likely to benefit. There is also insufficient evidence about whether 
to recommend rest or increased physical activity to women during 
pregnancy. Further research is highly desirable in different settings to 
explain its role in the development and prevention of pre-eclampsia and 
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its complications. 
There is evidence in the light of the included studies in this 
review as well as previous studies that supplementation with vitamins C 
and E did not reduce the risk of pre-eclampsia in both nulliparous and 
multiparous women. However, further research is needed to analyze the 
possibility that vitamin supplementation might be helpful in women 
with a low antioxidant status. 
Another puzzling evidence we obtained from this review is that 
smoking during pregnancy reduces the risk of pre-eclampsia by up to 
50% with a dose-response pattern. This result was consistently found in 
both nulliparous and multiparas, singleton and multifetal pregnancies for 
both mild and severe pre-eclampsia. Current literature does not give us a 
clear explanation for this supportive effect of smoking in pregnant 
women. More epidemiologic studies are needed to further clarify this 
puzzling relationship. Understanding the underlying mechanisms and 
finding which ingredients in cigarette smoke influence the risk of 
preeclampsia can enhance our understanding and can contribute to the 
development of prevention strategies. 
We also recommend further research into assessing the role and 
importance of current and new technologies and techniques in the 
reduction of pre-eclampsia and eclampsia. All nurses or midwives 
should know the evidence about the prevention and treatment of pre-
eclampsia and eclampsia to identify the nursing care that is essential to 
guide the pregnant woman and family and prevent adverse events 
related to the use of techniques and technologies. 
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4.2 MANUSCRIPT 2 - MATERNAL MORTALITY ASSOCIATED 
WITH PRE-ECLAMPSIA AND ECLAMPSIA IN KHYBER 
PAKHTUNKHWA PROVINCE OF PAKISTAN: AN 
INTEGRATIVE REVIEW 
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Abstract. Background: Pre-eclampsia and eclampsia are pregnancy-
related disorders, associated with significant maternal mortality. They 
are the second leading causes of maternal deaths particularly in 
developing countries. Objective: To show the maternal mortality 
associated with pre-eclampsia and eclampsia in Khyber Pakhtunkhwa 
province of Pakistan, from the scientific literature published between 
2000 to 2015. Method: An integrative review was conducted. Three 
electronic databases, PUBMED/MEDLINE, COCHRANE, CINAHIL, 
were searched for published studies on the maternal mortality related to 
pre-eclampsia or eclampsia in the Khyber Pakhtunkhwa province of 
Pakistan. Synthesis of the data involved categorizing and tabulating data 
and presenting it visually. Results: After identification and screening, 
eight studies were included in the review, of which four were cross-
sectional and 4 were descriptive. These studies were conducted in 
Khyber Pakhtunkhwa in Gynecology and Obstetrics Units of the four 
tertiary care hospitals. Maternal mortality associated with pre-eclampsia 
and eclampsia reported in the included studies vary between 8% in Lady 
Reading Hospital and Medical Teaching Institute Peshawar to 30% in 
Ayub Medical and Teaching Institution Abbottabad. Conclusion: 
Maternal mortality associated with pre-eclampsia and eclampsia 
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continue to remain high in one Province of Pakistan. Low-
socioeconomic status, accesses to health care services and quality of 
nursing care of the obstetrics emergency were the main causes. 
Provision of adequate, timely and effective nursing care for the safe 
motherhood are vital for the prevention of pre-eclampsia and eclampsia. 
 
Keywords: Pre-eclampsia. Eclampsia. Maternal Mortality. Nursing 
Care. Khyber Pakhtunkhwa. Pakistan. 
 
 
INTRODUCTION 
 
Maternal mortality indicates the quality of women’s health and 
the life quality of a population and provides a measure of human and 
social development (MAGALHAES; BUSTAMANTE-TEIXEIRA, 
2012). Information on maternal mortality is essential for setting 
priorities for policy making and research strategies. 
Every day in 2015, about 830 women died due to pregnancy 
complications and childbirth complications (WHO, 2015b). Of these 
830 daily maternal deaths, 550 occurred in sub-Saharan Africa and 180 
in Southern Asia, compared to 5 in developed countries. Almost all of 
these deaths occurred in low-resource settings, and most could have 
been prevented. The risk of a woman in a developing country dying 
from a pregnancy-related complication during her lifetime is about 33 
times higher compared to a woman living in a developed country 
(WHO, 2015b). 
Pregnant women die as a result of complications which either 
develop during pregnancy or may exist before but are aggravated during 
pregnancy. The primary causes of death are hemorrhage, hypertension 
and infections. The major complications that account for nearly 75% of 
all maternal deaths consist of pre-eclampsia and eclampsia (together 
14%), Severe bleeding (27%) and Infections (11%) (SAY et al., 2014). 
Hypertensive disorders of pregnancy are causing one out of ten 
maternal deaths in Africa and Asia, and nearly one-quarter in Latin 
America (CAMPBELL et al., 2006). Ten million women develop 
preeclampsia each year around the world (KUKLINA; AYALA; 
CALLAGHAN, 2009). About 1 in 200 women who had pre-eclampsia, 
eventually also progress to a dangerous condition known as eclampsia 
which is responsible for about 50,000 maternal deaths each year 
worldwide (KHAN et al., 2006). 
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Maternal Mortality Rate and health care quality vary among low 
and middle-income countries (KIDANTO et al., 2012; WHO, 2015b). 
Preeclampsia and eclampsia are one of the leading cause of maternal 
mortality in pregnant women in the developing countries. Among the 
developing countries in Pakistan eclampsia is a common cause of 
maternal deaths (MAHMUD et al., 2011). 
Organized data on routine health outcomes do not exist in most 
part of Pakistan. The World Health Organization’s estimate of maternal 
mortality in Pakistan (350 per 100,000 live births in 1995) which was 
lowered to 178 in 2015 (WHO, 2015a). According to the Pakistan 
Demographic and Health Survey, 73% of mothers receive antenatal care 
from skilled health care providers, 1% of mothers receive prenatal care 
from a traditional birth attendant, and 25% of women no received 
antenatal care at all (NIPS, 2014). Nevertheless, there is a large 
difference between urban and rural women. Urban women are more than 
twice (88%) as likely to seek antenatal care compared with rural women 
(67%) (NIPS, 2014). In Pakistan, the Maternal Mortality Rate is 
associated with, low skilled birth attendance, illiteracy, malnutrition and 
insufficient access to emergency obstetric care services. Hemorrhage 
(32.7%), eclampsia (10.4%) and sepsis (13.7%) are the main direct 
causes of maternal deaths according to (MAHMUD et al., 2011) as 
shown in Figure 1. 
 
 
Figure 1 - Causes of maternal mortality in Pakistan (2006-7). 
 
Source: Mahmud et al., (2011). 
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There has been a significant improvement over the past 20 years 
in the proportion of mothers who receive prenatal care from a health 
care provider, increasing from 33% in 1996 to 61% percent in 2006-07 
and 73% in 2013 (ZAFAR; ANWAR, 2006; NIPS, 2013; 2014). More 
than 35% of pregnant women make four or more antenatal visits during 
pregnancy. The urban population has more tendency to have four or 
more visits than the rural population. The median duration of pregnancy 
at the first prenatal care visit is 3.7 months. The most common reasons 
reported for not receiving prenatal checkups are a lack of concern, 
problems of accessibility and costs of services (NIPS, 2013; 2014). 
Although the overall health status of Pakistan’s population has 
improved over the past few decades, however, it is still poor when 
compared to most low-income countries. The slow pace of improvement 
in the health sector is largely due to poverty, low literacy rate, and lack 
of civic facilities such as proper sanitation (NIPS, 2014). 
This study aims to investigate the available scientific literature 
published between 2000 to 2015 and estimate the cases of maternal 
mortality associated with pre-eclampsia and eclampsia in the Khyber 
Pakhtun Khwa (KPK) province of Pakistan. 
 
 
MATERIALS AND METHODS 
 
Search Strategies and Sources 
This review was conducted from February 2015 to December 
2015 to answer the research question of; how the maternal mortality 
associated with pre-eclampsia and eclampsia in KPK Pakistan, was 
showed in the scientific literature published between 2000 to 2015? 
PUBMED/MEDLINE, CINAHL and COCHRANE databases were 
searched for the articles reporting on the maternal mortality associated 
with pre-eclampsia and eclampsia in KPK Pakistan. The search was 
limited to articles published between January 2000 and December 2015 
in the English language. The search strategy was based on a number of 
medical subject headings MESH terms (shown in Table 1) and text 
words aiming to include as many relevant articles as possible. 
 
Inclusion Criteria 
Quantitative studies published in the English language between 
2000 to 2015 which were reporting on the maternal mortality associated 
with preeclampsia and eclampsia in KPK Pakistan were eligible for 
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inclusion in this review. 
 
 
Table 2 - Search strategies for the identification of selected studies published in 
2000-2015. 
 
Database Keywords and Descriptors 
PUBMED ((”eclampsia”[Mesh] OR ”Preeclampsia”[Mesh]) AND (”Maternal 
Mortality”[Mesh] OR ”Maternal Death”[Mesh]) AND 
(”Pakistan”[Mesh])) 
Cochrane (Maternal mortality or maternal death) and (Preeclampsia or 
eclampsia) and (Khyber Pakhtunkhwa or Pakistan) 
CINAHL (Maternal mortality or maternal death) and (Preeclampsia or 
eclampsia) and (Khyber Pakhtunkhwa or Pakistan) 
Source: Made by the author (2016). 
 
 
Exclusion Criteria 
Articles that were published in a language other than English; 
studies reporting on maternal mortality associated with other 
complications of pregnancy and studies reporting on maternal mortality 
in other provinces of Pakistan were excluded. 
 
Search Outcome 
A total of 621 articles were initially identified using the search 
criteria from all the selected databases, of which 25 were duplicated. 
Title screening of the remaining 596 studies was completed which 
resulted in 95 studies to be selected for abstract reading. After abstract 
screening 08 studies were selected for full-text reading, of which all 
were included in the review, as shown in PRISMA flowchart (see Figure 
2). Each article was screened by two independent reviewers and 
disagreement between them was resolved by discussion. The aim was to 
identify as many relevant articles as possible which have reported on 
maternal mortality associated with pre-eclampsia and eclampsia in KPK 
Pakistan. 
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Figure 2 - Flowchart showing the process of identification and screening of 
studies. 
 
 
Source: Made by the author (2016). 
 
 
Quality Assessment 
We assessed the quality of each paper using the following: (a) 
relevance to this review (b) validity and appropriateness of the study 
methodology (c) quality of evidence (d) sampling method and quality of 
reporting (e) and limitations of the study. The quality of the outcome 
was assessed using the Evidence Level from Joanna Briggs Institute 
(from Level I to V). 
 
Data Extraction and Synthesis 
Extracting and synthesizing data from heterogeneous sources is a 
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complex process (GOLDSMITH; BANKHEAD; AUSTOKER, 2007). 
All selected studies were independently assessed by two reviewers. The 
information was extracted from the included studies: general 
information about authors, journal, publication date, country and region; 
research design, location, participants, aims; maternal mortality 
associated with pre-eclampsia and eclampsia in KPK Pakistan; results 
and descriptive summaries of numerical data. 
 
Synthesis of the data involved categorizing and tabulating data 
and presenting it visually. 
 
Ethical Considerations. 
The development of this research work did not involve any 
human subject. Thus it is considered that Resolution 466/2012 was 
respected (Brazil 2013). 
 
 
RESULTS 
 
The included 8 articles in this study were based on quantitative 
research where data is collected from hospitals records documents. 
Among them 4 studies were cross-sectional, 1 was descriptive and 3 
were retrospective descriptive. All included studies were based on data 
collected from four tertiary care hospitals, named Medical Teaching 
Institute Lady Reading Hospital Peshawar (MTILRH), Khyber Teaching 
Hospital Peshawar (MTIKTH), Hayatabad Medical Complex Peshawar 
(HMCTI), and Ayub Medical and Teaching Institution Abbottabad 
(AMTI). 
Two studies were based in each of these four hospitals. All 
studies restricted sampled participants to pregnant women with 
hypertension, pre-eclampsia or eclampsia. The sample size of the studies 
reviewed varied from 25 to 740 patients. All these studies were 
conducted in the period of 2000 to 2015, the first being in 2001 
(GILLANI; HASSAN, 2011) and the latest being in 2013 (IQBAL et al., 
2014). Maternal mortality associated with pre-eclampsia and eclampsia 
reported in the included studies vary between 8% in Lady Reading 
Hospital and Medical Teaching Institute Peshawar (JAMIL; AKHTAR, 
2005) to 30% in Ayub Medical and Teaching Institution Abbottabad 
(BEGUM, S.; AZIZ-UM-NISA; BEGUM, I., 2003). Summary of the 
included studies are presented in Table 2. 
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Studies Conducted in Peshawar Region 
Peshawar is the capital of Khyber Pakhtunkhwa Province and one 
of the biggest cities in Pakistan. This city has modern and excellent 
health facilities. It has three government hospitals and accommodates 
patients from all around the province. Peshawar is known for its good 
health system. It has created many new well-equipped hospitals in the 
last decade. The leading hospitals in Peshawar city are Medical 
Teaching Institute Lady Reading Hospital Peshawar (MTILRH), 
Medical Teaching Institute Khyber Teaching Hospital Peshawar 
(MTIKTH), and Hayatabad Medical Complex Peshawar Teaching 
Institute (HMCTI). They are all modern public health care organizations 
that provide high-quality health services to the community. They 
provide acute hospital services and specialist services to people living in 
KPK, Federally Administered Tribal Areas (FATA) and adjoining areas 
of Afghanistan. These hospitals offer a full range of emergency and high 
dependency care in Maternity, Pediatrics, Surgery and much more. 
A cross-sectional study (GILLANI; HASSAN, 2011) was 
conducted in Hayatabad Medical Complex Teaching Institute (HMCTI) 
Peshawar in 2000 to evaluate maternal mortality from eclampsia. It 
reported that out of 30 eclamptic women 5 women died. The prevalence 
of eclampsia was 10.4% per 1,000 and case fatality of eclampsia was 
16.66% which accounted for 29.4%of total maternal deaths. Most of the 
patient (56%) were less than 20 years. 
A Cross-sectional study (SHAHEEN; HASSAN; OBAID, 2003) 
was conducted in the same institute of Hayatabad Medical Complex 
Teaching Institute (HMCTI) Peshawar in 2001-2002 to observe 
pregnancy outcome in eclamptic women and to explore the avoidable 
factors contributing to the adverse outcome. The study reported that 
according to the results, 12 out of 71 patients died due to eclampsia. 
Mortality rate was 16.9% and it accounted for 48% of total mortality. 
Reasons were poverty, illiteracy, and poor access to health facility. 
A Cross-sectional study (NAIB; SIDDIQUI; AJMAL, 2011) was 
done in Medical Teaching Institute Khyber Teaching Hospital 
(MTIKTH) Peshawar from Jan 2001 to Dec 2001 to estimate the 
maternal mortality and due to eclampsia. It shows that 4 women died out 
of 25 eclamptic patients. It reported that maternal mortality rate was 4 
(28.57%) related to eclampsia. The majority of the patient (60%) were 
17 to 30 years. 
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Table 2 - Summaries of included studied from 2000 to 2015 in KPK Pakistan. 
 
Ref. Design Objectives Sample Size Outcome 
(GILLANI; 
HASSAN, 
2011) 
Cross-sectional To estimate maternal 
mortality due to 
eclampsia 
30 eclamptic 
women 
5(16.6%) 
eclamptic 
women died 
(SHAHEEN; 
HASSAN; 
OBAID, 2003) 
Cross-sectional To explore the 
avoidable factors in 
pregnancy outcome in 
eclamptic patients 
71 eclamptic 
women 
35(16.9%) 
eclamptic 
women died 
(JAMIL; 
AKHTAR, 
2005) 
Cross-sectional To study the 
determinants of 
maternal outcome 
50 eclamptic 
women 
4(8%) 
eclamptic 
women died 
(MALIK et al., 
2015) 
Retrospective 
descriptive 
To evaluate maternal 
mortality and identify 
causes with age 
groups 
277 maternal 
deaths 
analyzed 
44(15.8%) 
eclamptic 
women died 
(NAIB; 
SIDDIQUI; 
AJMAL, 2011) 
Cross-ectional 
2001 
To estimate maternal 
mortality due to 
eclampsia 
25 eclamptic 
patients 
4(28.5%) 
eclamptic 
women died 
(IQBAL et al., 
2014) 
Descriptive To determine the 
perinatal mortality 
rate and its related 
obstetric risk actors 
740 perinatal 
deaths 
analyzed 
118 (15.9%) 
eclampsia and 
preeclampsia 
80 (10.8%) 
(BEGUM, S.; 
AZIZ-UM-
NISA; 
BEGUM, I., 
2003) 
Retrospective 
descriptive 
To determine 
preventable factors 
responsible for 
maternal mortality. 
27 maternal 
deaths 
analyzed 
8(30%) 
eclamptic 
women died 
(JAMIL; 
ABBASI; 
ZAMAN, 
2013) 
Retrospective 
descriptive 
To determine the 
outcome of eclampsia 
patients 
116 eclamptic 
patients 
18(15.5%) 
eclamptic 
women died 
Source: Made by the author (2016). 
 
A cross-sectional study (comprising of six months) (JAMIL; 
AKHTAR, 2005) was conducted in Medical Teaching Institute Lady 
Reading Hospital Peshawar (MTILRH) in 2003. In 50, eclamptic 
women, total 19 maternal deaths occurred of which 4 were due to 
eclampsia. Maternal mortality rate due to eclampsia was 4(8%) and 
eclampsia accounted for 21% of maternal deaths. Prevalence of 
eclampsia was 2.2%. Main causes were poor antenatal care, emergency 
obstetric care, and referral system. 
A retrospective descriptive study (MALIK et al., 2015) was done 
in Medical Teaching Institute Lady Reading Hospital (MTILRH) in 
2009-2011 to find the occurrence of maternal mortality and identify 
causes with age groups in tertiary care hospital of Peshawar, Pakistan. It 
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reported that out of 277 maternal deaths 44 (15.88%) women deaths 
were due to eclampsia. Most of the maternal deaths were in the age 
group 26 to 35 years. 
Another descriptive study (IQBAL et al., 2014) was conducted in 
2014 in Medical Teaching Institute Khyber Teaching Hospital 
(MTIKTH) Peshawar to determine the perinatal mortality rate and its 
related obstetric risk factors. Out 11,260 perinatal there were 740 
perinatal deaths, where (26.7%) were due to hypertensive disorders of 
pregnancy. Eclampsia was 118 (15.9%) and severe pre-eclampsia was 
80 (10.8%). The study reported that inadequacy and inaccessibility of 
maternity services and the poor socio-economic status and cultural 
pattern are the main reason of high maternal mortality. 
 
Studies Conducted in Abbottabad Region 
Abbottabad is a city located in the Khyber Pakhtunkhwa 
province, in northeastern Pakistan. Ayub Medical Teaching Institution 
Abbottabad is a 1,000-bedded tertiary care hospital in Abbottabad and is 
the largest health care facility in the Northern region receiving patients 
from all districts of the northern side of the province. 
A Retrospective descriptive study (BEGUM, S.; AZIZ-UM-
NISA; BEGUM, I., 2003) was conducted in Ayub Medical and 
Teaching Institution (AMTI) Abbottabad in 2000-2001 to identify the 
causes and preventable factors of maternal mortality. The study reported 
that 26 maternal deaths occurred of which 8(30%) were due to 
eclampsia. There were 16 (61.5%) patients with age > 30 years. The age 
was between 18–42 years. Main reasons for maternal mortality were 
age, high parity, lower socioeconomic status, illiteracy, socio-cultural 
factors and poor access to health facility. 
Similarly, another retrospective descriptive study (JAMIL; 
ABBASI; ZAMAN, 2013) was conducted in Ayub Medical and 
Teaching Institution (AMTI) Abbottabad in 2010-2011. It determines 
the outcome of eclampsia patients admitted to intensive care unit (ICU). 
It reported that total 18 patients died out of 116 eclamptic patients. 
Maternal mortality rate due to eclampsia was 15.52%. 
 
 
DISCUSSION 
 
This review gives an overview about maternal mortality related to 
pre-eclampsia and eclampsia in KPK Pakistan. Pre-eclampsia and 
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eclampsia remain a major cause of maternal mortality in the KPK region 
of Pakistan. The combined figure of Maternal Mortality Rate associated 
with pre-eclampsia and eclampsia in KPK, from all included studies turn 
out to be 18% (236 out of 1,336 women with pre-eclampsia or 
eclampsia died). Most of the mother died at the age of 20 to 30 years. 
The low socio-economic condition, poor access to the health care 
services, and low quality of health care of the obstetrics emergency, 
were the main causes. 
The information revealed from the included studies truly reflect 
the situation in the community, and highlights the continuing high ratios 
of maternal mortality associated pre-eclampsia and eclampsia. All 
included studies report no decrease in the Maternal Mortality Rate due 
to pre-eclampsia and eclampsia over different time periods during the 
last fifteen years. This is of deep concern for government officials and 
health care providers in the region. 
However, there is a need for large and high quality studies to be 
reporting on maternal mortality. Studies need to conform to a uniform 
standard of reporting. More data, at the provincial and national level, 
need to be readily available. It is of vital importance that all births and 
deaths at each district and province are registered. 
Maternal health policy should be carefully revised and should 
consist of comprehensive short and long-term goals. All motherhood 
programs, both in the public and private sector, need to be critically 
evaluated. Health awareness, particularly about mothers and newborn 
should be increased at the community level. Nurses and midwives 
should be appropriately trained in order to provide maternal care during 
pregnancy, labor and the postpartum period (TABASSUM; UMBER; 
KHAN, 2010). In addition to proper education and training, nurses and 
midwives need to be motivated to work in the rural and remote areas of 
the province. 
No matter how trained and knowledgeable a nurse and midwife 
is, very little can be done when serious complications arise during 
delivery and labor if access to emergency care or drugs, essential 
supplies and equipment are not available. Support services like a blood 
bank, laboratories and proper referral system should be in place and 
readily available to pregnant women. 
The maternal mortality is high in the developing countries and the 
major cause of those deaths are pre-eclampsia and eclampsia. In those 
countries where maternal mortality is low, pre-eclampsia and eclampsia 
are the cause of a substantial proportion of deaths (GOLDENBERG et 
114 
 
al., 2011). The incidence of pre-eclampsia and eclampsia can be 
minimized by introducing comprehensive programs with a focus on 
health education and a network of easily available healthcare facilities. 
Deaths associated with pre-eclampsia and eclampsia are preventable by 
the provision of effective antenatal nursing care to the pregnant women 
in all health care services (KHANUM; SOUZA, 2016). 
 
Limitations 
This is study based on the limited and small number of studies 
conducted in KPK, Pakistan. Since organized data on routine health 
outcomes in KPK do not exist and there is also a scarcity of published 
studies on the subject matter, this small but equally representative study 
gives a glimpse of the high maternal mortality ratio associated with pre-
eclampsia and eclampsia in the KPK province. 
 
 
CONCLUSION 
 
Available data shows that the Maternal Mortality Ratio associated 
with pre-eclampsia and eclampsia in KPK Pakistan continue to remain 
high. To address the unacceptable state of maternal health, a systematic 
and organized data collection of all births and deaths and other health 
outcome at the district and province level is of utmost importance. 
Qualifying emergency obstetric nursing care and increasing the number 
of well-equipped health care facilities are a more viable and fastest way 
to cope with pregnancy-related complications. 
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4.3 MANUSCRIPT 3 - NURSING CARE PRACTICES IN THE 
PREVENTION AND CONTROL OF PRE-ECLAMPSIA AND 
ECLAMPSIA: AN INTEGRATIVE REVIEW 
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CONTROL OF PRE-ECLAMPSIA AND ECLAMPSIA. AN 
INTEGRATIVE REVIEW 
 
 
Sabiha Khanum1 
Maria de Lourdes de Souza2 
 
 
Abstract: Background: Deaths associated with pre-eclampsia and 
eclampsia are preventable by the provision of effective antenatal nursing 
care to the pregnant women in all health care services. Effective nursing 
care practices, including the confidence of decision-making and timely 
referrals of the pregnant women in emergency cases to the right place, to 
higher level facilities can prevent pre-eclampsia and eclampsia and 
reduce maternal mortality. Objective: To assess the nursing care 
practices for the prevention and control of pre-eclampsia and eclampsia. 
Method: An integrative review was conducted. Google Scholar and 
three electronic databases of Pubmed/Medline, Cochrane and Cinahl 
were searched for articles published between 2005-2016, on nursing 
care practices for the prevention of pre-eclampsia and eclampsia. 
Numerical and descriptive data from included studies was extracted, 
categorized, tabulated and presented visually. Results: A total of 2,895 
articles were initially identified using the search criteria from all the 
selected databases where 14 studies were finally selected to be included 
in the review. Several key aspects of nursing care practices which play 
an important role in the prevention of pre-eclampsia and eclampsia were 
identified. These includes a physical examination of pregnant women, 
early detection of signs and symptoms of pre-eclampsia and eclampsia, 
monitoring laboratory tests, fetal assessment, blood pressure 
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measurement techniques, early identification and treatment of 
hypertension through institutional protocols, standardization of care and 
instruments and decision-making abilities. Conclusion: Nursing 
practices have an important role in the prevention of pre-eclampsia and 
eclampsia. Midwives and nurses are the main antenatal care providers. 
Professional training and continuing education, as well as review of 
cases and work processes, are necessary for nurses in order to play a 
better role in providing quality nursing care to pregnant women. 
 
Keywords: Pre-eclampsia. Eclampsia. Maternal Mortality. Nursing 
Care. Nursing Practice. 
 
 
INTRODUCTION 
 
Pre-eclampsia is defined as high blood pressure and the presences 
of protein in the urine after 20 weeks of pregnancy. Pre-eclampsia is one 
of the three main cause of death in pregnant women (WHO, 2015b). 
Detection of pre-eclampsia in early stages is important and helpful to 
manage it effectively and prevent its further development to eclampsia 
(DULEY, 2009). Eclampsia is a serious complication of pregnancy 
characterized by a serious condition of life-threatening acute tonic-
clonic seizures in a pregnant woman (DULEY, 1992). Worldwide pre-
eclampsia affects up to 7.6% of pregnancies (BARTSCH et al., 2015) 
and eclampsia occurs in 1.4% of pregnancies. Globally, pre-eclampsia 
and eclampsia are the primary cause of more than 10% of maternal 
deaths (WHO, 2015a; SAY et al., 2014). 
Maternal Mortality Ratio in developing countries is high than the 
developed countries due to the provision of differences in quality of 
health care among low and middle-income countries (KIDANTO et al., 
2012). In developed countries due to the provision of timely and 
effective nursing care services and extensive research now pre-
eclampsia and eclampsia are in control and has become a rare 
complication of pregnancy (KEELING et al., 1991). 
Deaths associated with pre-eclampsia and eclampsia are 
preventable by provision of effective antenatal nursing care to the 
pregnant women in all health care services (WHO, 2015a,b). A skilled 
nurse’s effective nursing practice, the confidence of decision-making 
and timely referral of the pregnant women in emergency cases to the 
right place, to higher level facilities can prevent pre-eclampsia and 
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eclampsia and reduce maternal mortality (WHO, 2011). 
Prenatal nursing care is a program for pregnant woman until she 
gives birth to her baby. Some pregnant women received prenatal care in 
the first trimester of pregnancy, some received later in pregnancy and 
some pregnant women could not receive Prenatal nursing care because 
of several factors. But for a safe childbirth, all pregnant women should 
have proper access to elective antenatal care, whatever of their social, 
economic, cultural and geographical background. Effective nursing care 
throughout pregnancy and during childbirth is essential for reduction of 
maternal mortality. One-quarter of maternal deaths are due to inadequate 
delivery of nursing care from the onset of pregnancy (CHRESTANI et 
al., 2008). 
The Nurse’s eager observation, quick decision-making ability to 
use lifesaving procedures and referral to the right place, at the right time, 
can save the pregnant women (FULLERTON, 2011). Skilled Nurses are 
valuable members of the community. They are more than a healthcare 
provider - they are educators, mentors, and guardians of new life. Nurses 
need to know the danger signs of pregnancy and educate women about 
these risks. 
The skilled and effective nursing care in the antenatal period can 
help, to prevent pre-eclampsia and eclampsia and reduce maternal 
mortality rates (DAVIS, 2004). Nurses are providing health care 
services in primary health care centers. They are the frontline health care 
providers. So they are expected to provide skilled and effective nursing 
care to the pregnant women. They should have the ability to detect any 
pregnancy complications, initial management, and referral of maternal 
and newborn complications to higher level facilities. 
The objective of this study is to assess the nursing care practices 
for the prevention and control of pre-eclampsia and eclampsia. 
 
 
MATERIALS AND METHODS 
 
Search Strategies and Sources 
This integrative review was conducted from October 2015 to 
March 2016 to answer the research question of; what does the scientific 
literature published between 2005 to 2016 report about the nursing care 
practices in the prevention and control of pre-eclampsia and eclampsia? 
PUBMED/MEDLINE, CINAHL and COCHRANE databases were 
searched for relevant studies on nursing care practices in the prevention 
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and control of pre-eclampsia and eclampsia. The search was limited to 
articles published between January 2005 to March 2016 in the English 
language. The search strategy was based on a number of medical subject 
headings MESH terms (see Table 1) and text words aiming to include as 
many relevant articles as possible. 
 
 
Table 1 - Search terms used to identify studies. 
 
Database Descriptors Set 
PUBMED ((“eclampsia”[Mesh] OR ”Pre-eclampsia” [Mesh]) AND 
(”Nursing Care” OR ”Nursing Practic”[Mesh] OR ”Obstetric 
Nursing and Nursing”[Mesh])) 
Cochrane (Pre-eclampsia or eclampsia) and (Nursing Care or Obstetric 
Nursing or Nursing Practice) 
CINAHL (Pre-eclampsia or eclampsia) and (Nursing Care or Obstetric 
Nursing or Nursing Practice) 
Google 
Scholar 
Nursing care or nursing practices or Obstetric Nursing for the 
prevention of Pre-eclampsia or eclampsia 
Source: Made by the author (2016). 
 
Inclusion and Exclusion Criteria 
All types of qualitative and quantitative studies published in the 
English language between 2005 to 2016 which were reporting on 
nursing care practices for the prevention and control of pre-eclampsia 
and eclampsia, were eligible for inclusion in this review. 
Studies that were published before 2005, reporting on nursing 
care practices in pregnancy-related complications other the pre-
eclampsia and eclampsia and studies not reporting on the nursing care 
practices, were excluded. 
 
Search Outcome 
A total of 2,895 articles were initially identified using the search 
criteria from all the selected databases and through manual searching 
using Google Scholar, where 215 were duplicated. The remaining 2,680 
articles were selected for title-wise screening which resulted in 153 
studies to be selected for abstract reading. After the abstract screening, 
15 studies were selected for full-text reading, of which 14 were included 
in the review (see Figure 1). All screening was done by three 
independent reviewers. Each article was screened by three reviewers and 
disagreement between them was resolved by discussion. The aim was to 
122 
 
identify all relevant articles which have reported on the nursing care 
practices in the prevention and control of pre-eclampsia and eclampsia. 
 
 
Figure 4 - Flowchart showing the process of identification and screening of 
studies (Manuscript 3). 
 
 
Source: Made by the author (2016). 
 
 
Quality Assessment 
It is always difficult to analyze the quality of heterogeneous and 
distinctive primary sources in an effective manner (WHITTEMORE; 
KNAFL, 2005). The methodological quality assessment was not 
conducted in this review because the assignment of such quality score in 
different studies is an arbitrary and unscientific process (MEADE; 
RICHARDSON, 1997). However, Joanna Briggs Institute (JBI) were 
used to assess the quality of included studies. Similarly, assessment of 
studies was not summarized due to the inherited methodological 
complexity (WHITTEMORE; KNAFL, 2005). Articles were classified 
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according to (MELNYK; FINEOUT-OVERHOLT, 2011) as defined in 
Table 2. 
 
 
Table 2 – Levels of Evidence for identification studies. 
 
Level Description 
I Evidence from systematic review and meta-analysis of all relevant 
RCTs 
II Evidence derived from well-designed evidence RCTs 
III Evidence obtained from well-designed clinical trials without 
Randomization 
IV Evidence from well-designed cohort studies and case control studies 
V Evidence from systematic review of descriptive and qualitative studies 
VI Evidence derived from a single descriptive or qualitative study 
VII Evidence from opinion of authorities or expert committees report 
Source: Melnyk and Fineout-Overholt, (2011). 
 
 
Data Extraction and Synthesis 
Extracting and synthesizing data from heterogeneous sources is a 
complex process (GOLDSMITH; BANKHEAD; AUSTOKER, 2007). 
All selected studies were independently assessed by two reviewers. The 
following information was extracted from each included study:general 
information about authors, journal, publication date, country and region; 
research design, location, participants, aims;nursing care practices in the 
prevention of pre-eclampsia and eclampsia; results and descriptive 
summaries of numerical data. 
Synthesis of the data involved categorizing and tabulating data 
and then narrating, summarizing and presenting it visually. 
 
Ethical Considerations 
This study was developed in the context of project TO 
13075/2012 - FAPESC, Opinion No. 120.343 and No. 169.110 of the 
year 2012 (Annexes A and B) and for that reason, it respects what is set 
out the Resolution no. 466/2012, of the Ministry of Health Brazil 
(BRASIL, 2013). However, the completion of this research work did not 
involve any human subjects. 
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RESULTS 
 
Total 14 studies were included in the review, of which 3 were 
case report, 1 was randomized controlled trial, 2 were methodological 
studies, 1 was descriptive qualitative studies, 2 were prospective cohort 
studies, 1 observational, 1 quasi-experimental study, 1 was retrospective 
descriptive study and 2 were cross-sectional studies. The included 14 
studies were conducted and based in countries shown in Table 3. 
 
Table 3 - Countries where the selected 14 studies were conducted. 
Country Number of Studies 
Australia 2 
USA 5 
UK 2 
India 1 
Egypt 1 
Brazil 1 
Nigeria 1 
Netherland 1 
Source: Made by the author (2016). 
 
The characteristics of the primary 14 studies are summarized in 
Table 4. All the 14 included studies in this integrative review, were 
classified into four categories, on the basis of nursing practices. The 
details of all these four categories are discussed as follow. 
 
 
Table 4 - Summaries of included studied from 2005 to 2016 on nursing 
practices for prevention pre-eclampsia and eclampsia.  
Ref. 
Country, 
Year 
Evidence 
Level 
Objectives 
Nursing  
Practice 
(ELLIS et al., 
2008) 
UK, 2008 RCT, Level II To compare the 
effectiveness of training 
assistance to eclampsia 
with and without the 
teamwork theory 
Measurement and 
monitoring of BP, early 
magnesium sulfate, 
Oxygen Saturations, 
Vaginal examination 
(CHRISTIAN; 
KRUMWIEDE, 
2013) 
USA, 
2013 
Quasi 
experimental 
study, Level 
III 
To assess whether 
training with realistic 
simulation is an effective 
strategy in the training of 
nurses caring for pre-
eclampsia or eclampsia 
Physical examination of 
women, Measurement and 
monitoring of BP, 
administration of 
Magnesium Sulfate, intake 
output record 
Continues… 
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Ref. 
Country, 
Year 
Evidence 
Level 
Objectives 
Nursing  
Practice 
Continuation 
(REINDERS 
et al., 2006) 
Australia, 
2006 
Observational
, Level IV 
To compare two BP 
scouting measures with 
quickly mercury release 
Measurement and 
monitoring of BP 
(IYENGAR, 
K.; IYENGAR, 
S. D., 2009) 
India, 
2009 
Prospective 
Cohort, Level 
IV 
To document the 
experiences of nurses 
and midwives and detect 
their decision-making 
abilities 
Detect pregnancy 
complications and 
decision-making about the 
referral to further facility 
(DANIELS et 
al., 2010) 
USA, 
2010 
Prospective 
cohort study, 
Level IV 
To compare results of 
simulated training and 
theoretic training to deal 
with emergencies in the 
delivery room 
Assessing sign and 
symptoms, diagnose of 
preeclampsia, 
administration of 
Magnesium Sulfate, 
monitoring of blood 
pressure, monitor 
necessary fits. 
(MOUSA; 
ALI; 
ADAWY, 
2013) 
Egypt, 
2013 
Cross-
sectional, 
Level IV 
To analyze nurse’s 
knowledge about pre-
eclampsia 
Measurement of BP, 
physical examination, 
administration of 
Magnesium Sulfate 
(BLACK; 
MORIN, 
2014) 
USA, 
2014 
Methodologic
al study, 
Level, IV 
To refine psychometric 
properties of an 
instrument to assess 
symptoms 
Assessing sign and 
symptoms measurement 
and monitoring of BP, 
urine tests for proteinuria 
(MOHAMMED 
et al., 2016) 
Nigeria, 
2015 
Cross-
sectional, 
Level IV 
To assess the knowledge 
of nurse-midwife  
Detecting and diagnosing 
pre-eclampsia, 
administration of 
Magnesium Sulfate 
(NOBLE, 
2005) 
USA, 
2005 
Case study, 
Level VI 
To describe a case of 
preeclampsia in the 
puerperium 
Measurement and 
monitoring of BP, urine 
tests for proteinuria 
(CUNHA; 
OLIVEIRA; 
NERY, 2007) 
Brazil, 
2007 
Qualitative 
study, Level 
VI 
To assess the opinion of 
women with pre-
eclampsia on nursing 
care received 
Measurement and 
monitoring of BP and 
administration of 
Magnesium Sulfate 
(SCHUTTE et 
al., 2008) 
Netherlan
d, 2008 
Retrospective 
descriptive 
study, Level 
VI 
To assess quality of care 
in cases of maternal 
death by hypertensive 
disorders 
Measurement and 
monitoring of BP, urine 
tests for proteinuria, 
administration of 
Magnesium Sulfate 
(AMEH; 
EKECHI; 
TUKUR, 
2012) 
UK, 2012 Methodologic
al study, 
Level VI 
To develop a chart to 
track the care of pregnant 
women with pre-
eclampsia and eclampsia 
Measurement and 
monitoring of BP, 
Monitoring of proteinuria 
level, number of ﬁts, level 
of consciousness, ad 
administration Magnesium 
Sulfate, Calcium Gluconate 
Continues… 
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Ref. 
Country, 
Year 
Evidence 
Level 
Objectives 
Nursing  
Practice 
Conclusion 
(MARTIN; 
MCINTOSH, 
2013) 
Australia, 
2013 
Case report, 
Level VI 
To describe pre-
eclampsia frame care 
simulation and eclampsia 
in the labor room 
Measurement and 
monitoring of BP, early 
Magnesium Sulfate 
(STEPHENS- 
HENNESSY; 
SENN, 2014) 
USA, 
2014 
Case report, 
Level VI 
To report the experience 
of an intervention 
program to reduce 
maternal mortality 
Measurement and 
monitoring of BP 
Source: Made by the author (2016). 
 
Blood Pressure Measurement Technique 
An observational study (REINDERS et al., 2006) was conducted 
in Australia in 2006, to compare two Blood pressure scouting measures 
with quickly mercury release. Two Blood pressure readings were 
obtained, one quickly (>5 mm Hg/sec) and the other with slow (≤2 mm 
Hg/sec) lowering of mercury. The Blood pressure measurement was 
made by nurses. The results reported that the slow descent of the 
mercury is the recommended method to measure blood pressure while 
rapid cuff deflation underestimates blood pressure. 
In Stephens-Hennessy and Senn, (2014), a series of different 
techniques was adopted by a multidisciplinary team of a hospital to 
improve nursing care for pregnant women at risk of developing pre-
eclampsia. The implications for nursing care indicate the need for 
standardization of the blood pressure measurement technique, 
identification of hypertensive serious condition, urgent call for the 
multidisciplinary team, rapid administration of the drug and review of 
work processes. 
 
Training of nurses in the prevention of pre-eclampsia and 
eclampsia 
In Ellis et al., (2008) a randomized controlled trial was conducted 
in the United Kingdom to compare the effectiveness of training for 
eclampsia in a simulation center, with and without teamwork theory. 
The results reported that, after training with the teamwork theory, there 
was a significant decrease in the mean duration of techniques in the 
management of eclampsia and also a significant increase in the number 
of professionals who performed basic nursing care actions and 
additional assistance in eclampsia. The main nursing care actions for 
eclamptic patients observed in this study includes measurement and 
monitoring of blood pressure, administration of the correct loading dose 
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of magnesium sulfate, call for help in emergency cases during attending 
an eclamptic patient, supporting and making access to the airways, 
lowering the bed to reduce the risk of falls of patients, administration of 
oxygen, monitoring heart rate of fetal, and establishing quality venous 
access. 
In Martin and Mcintosh, (2013), a simulation scenario of nursing 
care in pre-eclampsia and eclampsia in the labor room was proposed. 
The simulated scenarios consist of oral administration of nifedipine, 
labor induction, anesthesia, insertion of the airway, oxygen therapy 
facility with a facial mask, establishing IV access, blood pressure 
measurement and early does of magnesium sulfate. The study reported 
that the simulation training helped participants in understanding the 
different perspectives and different priorities for nurses in dealing with 
pre-eclampsia and them to better understand the different skill set 
required in different situations. 
In Daniels et al., (2010) prospective cohort study was conducted 
in the United States of America, in 2010 to investigated the impact of 
human simulation on the self-efficacy of nurses in the management of 
pre-eclampsia and eclampsia. One group was given only theoretical 
instructions while the second group received training instructions with 
simulations. During scenario, essential nursing care actions, provided to 
the pregnant women with pre-eclampsia were; recognizing signs 
symptoms of pre-eclampsia; diagnose of pre-eclampsia; administration 
of accurate loading dose of magnesium sulfate; monitoring of blood 
pressure measurement; monitoring of mother and newborn condition; 
monitor necessary seizure precautions. The performance of the group 
which was trained with simulation performed much better than the 
group which received only theoretical training. 
Similarly, another study (CHRISTIAN; KRUMWIEDE, 2013) 
was conducted in the United States of America in 2013 to evaluated the 
skills of nurses in women with pre-eclampsia and eclampsia, after 
practical training. The results reported that the training significantly 
boosted the skill of nurses and other health professionals, particularly 
with regard to the early identification and adoption of appropriate 
nursing behaviors. Nursing practices observed and found essential for 
prevention of pre-eclampsia and eclampsia were recognizing the signs 
and symptoms of pre-eclampsia, Blood pressure monitoring, Oxygen 
saturations, physical examination, airway monitoring, correct dose of 
magnesium sulfate, maintenance of IV line, call for assistance, 
anesthesia and urine tests for proteinuria. 
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Instruments for Standardization Care 
A study in Black and Morin, (2014) was conducted in the United 
States of America in 2014 to assess and refine the psychometric 
properties of an instrument designed to assess a comprehensive range of 
pre-eclampsia symptoms. The study reported that the use of a scale to 
evaluate the symptoms of pre-eclampsia during pregnancy, assists in the 
prediction and cause complications, allowing early implementation of 
nursing care. The results revealed that this instrument would be useful in 
nursing practice for detecting and diagnosing of pregnant women with 
pre-eclampsia. 
Similarly, a chart was developed to track the care of pregnant 
women with pre-eclampsia and eclampsia in a study (AMEH; EKECHI; 
TUKUR, 2012) conducted in UK in 2012. The chart contains the data 
regarding the fetal heart rate, blood pressure, respiratory rate, proteinuria 
levels, number of fits, level of consciousness, water balance, deep 
tendon reflexes, administration of anti-hypertensives drugs, and 
administration of magnesium sulfate and calcium gluconate, and a 
summary of hospital treatment and complications in the admission and 
discharge. The results showed that most participants reported the 
graphic chart is a great alternative for monitoring women, and 
emphasized its usefulness in improving nursing care of pregnant women 
with pre-eclampsia, especially, in monitoring and provision of evidence-
based nursing care and treatment. 
 
Knowledge and Quality of Nursing Care 
The standard of quality of nursing care was assessed in a study 
(SCHUTTE et al., 2008) in Mortality cases that occurred in the 
Netherlands between 2000 and 2004. In 135 deaths cases, 27 (20%) 
women died as a result of hypertensive disorders. All women met the 
criteria for the diagnosis of pre-eclampsia, of which 16 (60%) resulted in 
eclampsia. In 60% of cases, prenatal nursing care was performed by 
traditional midwives, and 96% compliance was considered low-level or 
below required. Late onset of prenatal nursing care and lack of blood 
pressure check up in the first quarter were reported. In 46% of cases, 
laboratory tests of urine were not carried out for the detection of 
proteinuria, and in all of these pregnant women, the risk factors for pre-
eclampsia were present during pregnancy. There was a delay in referral 
(15%) and in-hospital care, and 41% did not make the relevant 
diagnostic tests, 85% had inadequately reported hypertension and 74% 
were a misdiagnosis of mild pre-eclampsia when, in fact, they would be 
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classified as severe cases. It was found that the low quality of nursing 
care was present in almost all cases of maternal death resulting from 
hypertensive disorders. 
A pregnant woman faces physiological changes in virtually every 
organ of her body and hence demands specialized training to meet the 
requirements of her nursing care. Administration of drugs and blood 
products, as well as prior knowledge of the pathophysiology of pre-
eclampsia and explanation of pathological changes occurring in the 
pregnant women body, contributes to improvement in the nurse’s care 
for the pregnant women with pre-eclampsia (NOBLE, 2005). 
Similarly, a study was conducted to describe and evaluate the 
nursing care received by pregnant women, hospitalized for pre-
eclampsia. It is concluded that nursing care must be more human in 
addition to meeting the physical, social and psycho emotions needs of 
the patient (CUNHA; OLIVEIRA; NERY, 2007). 
A cross-sectional study was conducted in Egypt in 2011 to update 
nurses’ knowledge regarding the care of pre-eclamptic patients 
(MOUSA; ALI; ADAWY, 2013). A structured pre and post-test 
questionnaire were used on 25 nursing staff working in the Obstetrics 
and Gynecology Department. The result showed that regarding the 
definition and signs and symptoms of pre-eclampsia, 72% of the nurses 
have a correct answer but incomplete in pre-test and 72% of nurses have 
a correct and complete answer in post-test. The correct and complete 
answers are 16% and 0% for each question respectively in the pre-test. 
In relation to the time of urine collection, 48% and 64% of nurses have 
the right answer in pre and post-test respectively. Regarding time of 
blood pressure measuring, 80% of the nurses have a correct answer in 
both pre and post-test. In relation to deep tendon reflexes making, only 
20% and 76% of the nurses have a correct answer in pre and post-test 
respectively. Regarding Edema, 76% and 88% of the nurses have a 
correct answer in pre and post-test respectively. Regarding Magnesium 
Sulfate administration, 96% of the nurses have a correct answer in both 
pre and post-test. The mean of knowledge in pre-test is 19.88 (59%) and 
in post-test 24.80 (74%). Data analysis revealed that in the pre-test a 
large proportion of the participants have incorrect, improper knowledge 
about pre-eclampsia, and they did not know that how to do nursing care 
of pregnant women with pre-eclampsia. While in the post-test 
knowledge of nurses, regarding pre-eclampsia was significantly 
improved. 
A cross-sectional study was conducted in 2015 in Nigeria to 
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assess the knowledge of nurse educators about the major causes of 
maternal mortality (MOHAMMED et al., 2016). In this study 57.2% of 
educators could diagnose pre-eclampsia and 62.7% of educators could 
diagnose severe pre-eclampsia. 86% of nurse educators knew about 
magnesium sulfate as the “gold standard” for treating eclampsia, only 
16.8% knew of calcium gluconate as an antidote to magnesium sulfate 
toxicity. The results indicate that Nurse/midwife educators in Nigeria 
are not as knowledgeable as previously thought, especially concerning 
the causes of maternal mortality. 
Similarly, a prospective cohort study was conducted in India to 
document nurse’s experience in providing maternal and newborn 
nursing care (IYENGAR; IYENGAR, 2009). From 2000 to 2008, nurses 
attended about 2,771 women in labor and 202 women in maternal 
emergencies. The nurses independently detected and managed 
pregnancy-related complications and independently made decisions 
about the referral to the nearest hospital. Among the women in labor, 
21% were in critical condition and had life-threatening complications 
and 16% were advised referral. The referral decision was made by the 
nurses, higher for maternal conditions than fetal conditions. Among the 
202 women who came with maternal complications antenatally, post-
abortion or post-partum, the referral was advised for 70%, of whom 
72% were arranged. The referral system included counseling, arranging 
transport, accompanying women, facilitating admission and supporting 
inpatient nursing care. During the nine-year study period, there was only 
one maternal death. The study suggests that skilled and experienced 
nurses can especially improve access to skilled maternal nursing care in 
rural areas. Nurses have the ability to prevent and manage pregnancy-
related complications with or without the need for referral. 
 
 
DISCUSSION 
 
The included studies investigated the standardization of blood 
pressure measurement technique, highlighting specific aspects for the 
early diagnosis and treatment of pre-eclampsia and eclampsia. In the 
twentieth week of pregnancy, high blood pressure is one of the most 
important diagnostic criteria for case definition, and the presence of 
protein in the urine, clarifying the diagnosis of pre-eclampsia (WHO, 
2011). The measurement of blood pressure is an important predictor of 
pre-eclampsia and eclampsia. It should be correctly assessed to avoid 
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complications. Slowly deflation of the mercury column ≤ 2 mmHg to 
obtain more reliable and more precise results in the diagnosis 
(REINDERS et al., 2006), early identification and drug treatment of 
hypertensive crisis through institutional protocols are very essential 
(STEPHENS-HENNESSY; SENN, 2014). 
Skilled and effective nursing assessments of the signs and 
symptoms are essential in the detection, monitoring, and effective 
management of Pre-eclampsia and eclampsia. In addition, patient 
education and awareness and friendly environment provided by nurses 
are also helpful for the wellbeing of mother and baby (KHANUM et al., 
2016). 
Many authors investigated the training of nurses with simulation 
to face pre-eclampsia and eclampsia (ELLIS et al., 2008; MARTIN; 
MCINTOSH, 2013; DANIELS et al., 2010; CHRISTIAN; 
KRUMWIEDE, 2013). As a strategy the realistic simulation for 
teaching and learning were used, characterized by a possibility of 
teaching that encompasses not only technical skills but the emergency 
management, leadership, teamwork and clinical reasoning. The results 
indicated improvement in the performance of professionals in simulated 
environments (DANIELS et al., 2010) and positive impacts on care 
(ELLIS et al., 2008) as the early identification of signs and symptoms of 
pregnant women with pre-eclampsia (CHRISTIAN; KRUMWIEDE, 
2013), adoption of actions based on current protocols, more agility and 
performance of the multi-professional team in front of emergency 
situations (MARTIN; MCINTOSH, 2013). The training of professionals 
involved in health care at different levels of attention brought gains to 
users and health professionals (CHRISTIAN; KRUMWIEDE, 2013). 
Similarly, instruments, which helps in follow-ups and continuous 
monitoring of pregnant women with pre-eclampsia and eclampsia, 
should be used by nurses, in order to improve the quality of nursing care 
(BLACK; MORIN, 2014; AMEH; EKECHI; TUKUR, 2012). Low 
quality of nursing care including lack of blood pressure check-ups, late 
urine test, and delayed referrals, for the women with pre-eclampsia and 
eclampsia, was also reported in (SCHUTTE et al., 2008). 
Knowledge enhancement for in-service nurses and midwives, 
including short periods of didactic and case demonstrations, to increase 
their efficiency in dealing with pregnancy and its complications is very 
important (TEN HOOPE-BENDER et al., 2011). Knowledge of the 
direct and indirect causes of maternal mortality is fundamental to all 
practicing midwives. Nurse’s knowledge regarding pre-eclampsia 
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definition, signs and symptoms, edema checking, time of urine 
collection, can be improved and updated with continuing education 
programs (MOUSA; ALI; ADAWY, 2013; FULLERTON et al, 2011). 
Skilled and experienced nursing care can improve the quality of 
obstetric care particularly in rural areas (IYENGAR, K.; IYENGAR, S. 
D., 2009). 
 
 
CONCLUSION 
 
Nursing care practices have an important role in the prevention of 
pre-eclampsia and eclampsia. This integrative review point out specific 
key nursing care practices which play an important role in the 
prevention of pre-eclampsia and eclampsia and in the reduction of 
maternal mortality. These includes a physical examination of pregnant 
women, early detection of signs and symptoms of pre-eclampsia and 
eclampsia, monitoring laboratory tests, fetal assessment, correct blood 
pressure measurement techniques, early identification and treatment of 
hypertension through institutional protocols, standardization of care and 
instruments and decision-making abilities. 
Midwives and nurses are the main professionals who provide care 
to pregnant women. Professional training and continuing education as 
well as review of cases and work processes are necessary for nurses in 
order to enhance their knowledge and improve their practice and play a 
better role in providing quality nursing care to pregnant women. 
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4.4 MANUSCRIPT 4 - PREGNANCY NURSING CARE VIRTUAL 
NETWORK: A THEORETICAL DESIGN 
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Abstract: All pregnant women need timely access to the healthcare 
services and skilled nursing care. This including awareness about 
pregnancy-related complications, customized information, timely help 
and care from health care providers. Information and communication 
technologies can play an important role in facilitating some of these 
services to pregnant women. Also with efficient way and can thus 
prevent pre-eclampsia and eclampsia, and other pregnancy-related 
complications and reduce maternal mortality. Objective: To design a 
pregnancy nursing care virtual network for prevention the pre-eclampsia 
and eclampsia. Methodology: The development life-cycle was used The 
basic idea behind this method is to develop a system through repeated 
cycles (iterative) and in smaller portions at a time (incremental). In this 
study was developed two phases: the requirements and design process of 
the network. Result: The system will enable effective and real-time two-
way communication between pregnant women and nurses, and all units 
the health system (ambulance, health facility staff, and other level) 
through smartphones. The primary expected result of the system is an 
improved access to antenatal, postnatal care, institutional delivery, and 
emergency obstetric care. Conclusion: Pregnant women need 
customized information and education according to their demands, 
needs and respective situation. Information and communication 
technologies can play an important role in facilitating these services in a 
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fast and efficient way and can contribute to prevent pre-eclampsia and 
eclampsia and other pregnancy-related complications 
 
Keywords: Pre-eclampsia. Eclampsia. Maternal Mortality. Nursing 
Care. Nursing Practice. 
 
 
INTRODUCTION 
 
Pre-eclampsia is a pregnancy-related complication and one of the 
leading cause of death in pregnant women in the developing countries 
(KHAN et al., 2006). In 2015 every day, approximately 800 women died 
from preventable causes related to pregnancy and childbirth 
complications (WHO, 2015). Maternal mortality is higher in women 
living in rural areas and among poorer communities. The major causes 
that account for nearly 75% of all maternal deaths are severe bleeding 
(27%), pre-eclampsia and eclampsia (14%), and infections (11%) 
(WHO, 2015). Since 1990 maternal deaths have dropped by 45% 
worldwide. However, between 1990 and 2013, the global maternal 
mortality ratio (the number of maternal deaths per 100,000 live birth) 
declined by only 2.6% per year. This was far from the annual decline of 
5.5% required to achieve MDGs5 (WHO, 2015; SAY et al., 2014). 
Most maternal deaths are preventable, as the health-care solutions 
to prevent complications of pregnancy are well-known (WHO, 2014). 
All women need access to antenatal care in pregnancy, skilled and 
timely nursing care during pregnancy, childbirth, and support in the 
weeks after childbirth. However, factors that prevent women from 
receiving care during pregnancy and childbirth are poverty, delays (in 
the home, in the way, and in care center), lack of information and 
awareness, lack of adequate health care services and skilled health 
professionals, home deliveries, and cultural practices (WHO, 2014). The 
delays also include; (i) identifying a life-threatening event and making 
the decision to go to the health facility, (ii) reaching the health care 
facility, and (iii) intervening effectively. Technologies including 
smartphones, computers, equipment, supplies, products, procedures, and 
techniques can play an important role in the prevention of pre-eclampsia 
and eclampsia and other pregnancy-related complications and can 
contribute to a significant reduction in maternal mortality around the 
world (TSU; FREE, 2001). 
Since the boom in communication and information technologies 
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(ICT), the field of eHealth has emerged into many forms and its 
potential has been discussed globally. eHealth has increasingly become 
part of people’s everyday lives and has the ability to change how health 
care is delivered, the quality of the patient experience, and the cost of 
health care (WANG; LIU, 2009). It enables, among other things, the 
exchange of healthcare and administrative data and the transfer of 
medical images and laboratory results. The use of ICT in the health 
sector has the potential to change the face of global health systems and 
can deliver life-saving information even in the most remote and 
resource-poor settings (WHO, 2011). Improvement in ICT, development 
of smaller components with higher levels of security, decreasing costs 
and increasingly user-friendly features are the main reasons for adopting 
eHealth solutions in our daily lives (PIETTE et al., 2012). 
The number of mobile phones in the world was 97 per 100 people 
at the end of 2014 (THE WORLD BANK, 2016) and has exceeded the 
world population in 2016 and among those more than 50% are 
smartphones (STATISTA INC., 2016). Similarly, the number of internet 
user worldwide was 3 billion in 2015 (CIA, 2016; THE WORLD 
BANK, 2016). Mobile and wireless technologies offer exciting 
opportunities for a low cost, high reach health care services such as 
helping with chronic disease management, empowering the elderly and 
expectant mothers, reminding people to take medication at the proper 
time, extending service to underserved areas, and improving health 
outcomes and medical systems efficiency (WEST, 2012). In addition, it 
also offers significant opportunities for improving the data analysis and 
office operations of health care system. It can replace the paper-based 
work in low-resource settings where most of the clinical data is being 
kept by patients themselves. In the case of the paper-based work, it is 
very difficult and costly to develop a national overview of patient 
statistics and is extremely hard for individual institutions within the 
healthcare sector to share information between each other. 
Improvement and increase in data transfer rates over networks of 
interconnected computers has removed all barriers to the exchange of 
medical data, physiological signals and medical imagery between 
computers. The standardization of exchange protocols between 
computers, such as the Internet Protocol for example, in addition to the 
improved structuring of medical data and data security rules, is 
increasingly making it possible for health professionals in different 
locations to understand one another and work together, despite 
differences in location and languages. It is now clear that the value of 
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these applications lies not in the technology itself, or even in the 
exchange of data, but in the ability to develop efficient networks and 
expertise in the field of health. 
Networks, such as family network, social networks, and 
professional networks, are playing an important role in our daily lives. 
Social networks include our friends, those we meet in classroom 
settings, people we like to spend time with and those we engage in 
social media. Our family network includes all of our family members 
and extended family. Lastly, our professional network includes 
colleagues, coworkers, and customers. Especially in healthcare, the 
professional network between patients and nursing professionals can be 
vital to both sides. Mobile devices and other communication 
technologies can be used to make a network between nurse and pregnant 
women as a fast and easy way to pushing information to every possible 
pregnant woman. It helps in information sharing between pregnant 
women and maternity homes and improve decision making and reduce 
delays. 
The most important contacts in health care will always be the 
face-to-face meetings. However, with the help of interactive tools on the 
Internet, patients can strengthen their influence on health care by getting 
both general and specific information. Health care accessibility increases 
when patients can contact health care professionals at any hour or are 
able to retrieve information and leave messages by the same media. 
Mobile phones are in the hands of increasingly more women and 
nurses, including those in some of the poorest and most difficult to reach 
areas of the world (SPECIALE; FREYTSIS, 2013). Mobile phone and 
internet connectivity are creating unprecedented opportunities for 
improving maternal and child health outcomes by facilitating 
interactions and information sharing between nurses and patients 
(BOULOS; MARAMBA; WHEELER, 2006). This interactivity and 
connectivity are greatly improving health care accessibility by 
increasing contacts of patients with nursing professionals at any time 
anywhere and can retrieve specific information in less time. 
Generally, less than 10% of mothers know about the development 
of the fetus they were carrying (SALAMEH et al., 2011). Not only that, 
the pregnant mothers do not know what is good and bad things they 
should do and avoid during pregnancy. There should be a way to help 
expectant mothers to be aware of their pregnancy development. They 
should be able to access pregnancy related customized information and 
useful tips regarding each stage of their pregnancy at their fingertips and 
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should be connected to health care providers whenever and where ever 
they want. 
Nurses need a wide range of theoretical and practical knowledge 
to provide the appropriate level of care to patients. Their knowledge 
should be dynamic and continuously evolve. Partnership by the 
networking tools facilitates interaction and communication between 
nurses and patients resulting in comprehensive and more accessible 
nursing care. On one hand, a collaboration between nurses let them get 
involved and grow their skills and knowledge, while, on the other hand, 
the interaction between nurses and patients results in quality nursing 
care to patients, promote the family health and health of the societies. 
As technology grows, nurses need to understand and adapt the 
complex ways in which society now communicates. Nurses need to 
further develop ways to interact, monitor and collaborate with peers and 
patients. They need to learn how to effectively manage these tools and 
leverage their benefits. However, several factors need to be taking care 
of, in order to make IT applications more effective in health care. These 
include better training and increased awareness of staff regarding the 
tools and applications used. In addition, the applications also need to be 
flexible enough to adjust to the changes in routine clinical practices. 
Last but not least, the privacy, security, and reliability of data are 
extremely important in improving the quality of nursing care practices. 
Breakthroughs in integrated and intelligent computer and 
communication systems are highly desired in future nursing care 
practices. We are continuously evolving and so is our knowledge and 
understanding. Today, we are living in an information age where we 
have unprecedented opportunities for communication, interaction, 
collaboration, and sharing. It is essential that nursing and healthcare 
providers effectively harness the power of these new technologies for 
global outreach (KHANUM et al., 2015). Based on the discussions in 
previous paragraphs, this study aims at proposing the designing a 
network model, Pregnancy Nursing Care Virtual Network (PNCN), 
which will strengthen communication links between health care 
providers and pregnant women and increase education, awareness, and 
quality of nursing care during pregnancy. The goal is to educate 
mothers, monitor pregnancy, prevent pre-eclampsia and eclampsia and 
other pregnancy complications and improve maternal health. The 
PNCN, a computer, and smartphone base application will help pregnant 
women know about their maternal health and pregnancy related 
complications and connect them to maternity homes. It will enable 
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health care providers to collect real-time data about pregnant women 
and their status in a region for effective care and follow-up and policy 
making. 
In addition, PNCN will help establish a communication and alert 
system, support documentation of pregnancies in the community, 
increase antenatal care visits and the number of facility deliveries 
through automated reminders, develop an overview of women statistics 
and sharing pregnant women data between institutions for an effective 
referral. Moreover, PNCN can contribute to the reduction of delay 
associated with transport to the referral facility and delay associated 
with timely intervention when the mother reaches the referral facility. 
The remainder of this paper is organized as follows. 
 
 
RELATED WORK 
 
Before the arrival of smartphones, personal digital assistants 
(PDAs) were experimented with the electronic eHealth tools. These 
tools were designed to improve health surveillance, health-system 
management, health education and clinical decision-making, disease 
management and offered a significant advantage over paper data 
collection (AL-SHORBAJI, 2006).  
Blaya et al., (2009) demonstrated that PDAs were more efficient 
than paper and preferred for collecting tuberculosis bacteriology data in 
Peru. Data were collected over a large geographical area, much of which 
did not have Internet access. 
Similarly, systems facilitating clinical practice include electronic 
medical record systems, archiving and communication systems for 
managing digital medical data, and laboratory information systems that 
automate laboratory workflow and reporting, early disease warning and 
disaster management were introduced. These systems collect data from 
health facilities and patients to create community-wide views of disease 
trends and clinical activity (MOURA et al., 1998). In addition, systems 
facilitating care at remote areas were implemented to use a short 
message service (SMS) for reminders, monitoring, health education and 
asynchronous communication. 
A mobile phone based system (NGABO et al., 2012) was 
implemented in Rwanda to monitor pregnancy and newborn 
information. The SMS-based project was developed to track the 
pregnancy lifecycle; enabling instant reporting of the pregnancy-related 
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event and timely notification for emergencies, alerting health facilities, 
hospital, and ambulances. The project helped to reduce the delay in 
seeking health care through a short SMS sent by a community health 
worker alerting the health system for timely and appropriate medical 
assistance. The system also served as the most remote data entry point 
for pregnant women and children health status, and as a unique interface 
to provide real-time data to health care providers. 
Similarly, a cluster-randomized, controlled trial (LUND et al., 
2013) was conducted in Zanzibar to evaluate the association between a 
mobile phone intervention and perinatal mortality in a resource-limited 
setting. At their first antenatal care visit, 2550 pregnant women (1311 
interventions and 1239 controls) who attended antenatal care at selected 
primary health care facilities were included in this study and followed 
until 42 days after delivery. Twenty-four primary health care facilities in 
six districts were randomized to either mobile phone intervention or 
standard care. The intervention was based on a mobile phone text 
message. Secondary outcome measures included stillbirth, perinatal 
mortality, and death of a child within 42 days after birth as a proxy of 
neonatal mortality. Mobile phone applications were shown to improve 
the health of the newborn and should be considered by policy makers in 
resource-limited settings. 
PotM, a mobile health application (LIM et al., 2015; 
DUNSMUIR et al., 2014) has been developed to help health workers in 
the management of women with pre-eclampsia. PotM is based on a 
decision model that combines accurate risk prediction of maternal 
adverse outcomes associated with pre-eclampsia with World Health 
Organization (WHO) recommendations for the management of pre-
eclampsia. PotM combines two previously successful innovations into 
an mHealth app: the miniPIERS risk assessment model and the Phone 
Oximeter. The application guides health worker through a standardized 
process of antenatal assessment, including measurement of blood 
pressure, dipstick proteinuria, and symptoms. 
There are a plenty of pregnancy-related applications on the world 
wide web, and Windows, Google Play and Apple App stores. However, 
none of them utilize mobile and wireless technologies to provide 
pregnant women the opportunity to enhance their pregnancy-related 
knowledge, prevent and control complications of pregnancy as well as 
connect them to nurses and other healthcare providers by establishing 
reliable communication and alert system. Our aim in this study is to 
educate mothers, monitor pregnancy and connect mothers with nurses 
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and other health professionals for prevention and control of pre-
eclampsia and other pregnancy-related complication. Our primary focus 
is to design a mother care network to prevent and control pre-eclampsia 
and eclampsia but such system can also be used for the prevention of 
other pregnancy related complications. 
 
 
METHODOLOGY 
 
PNCN Overview 
This section discusses the main features of the PNCN and 
presents the theoretical design of PNCN in details. The prevalent 
functionality of the PNCN is to equip nurses, health care providers, and 
expectant mothers with a mobile and computer-based application which 
will help them manage their pregnancy-related knowledge and needs. 
PNCN will store, query and retrieve pregnancy related information and 
women health records including their clinical data. Health records and 
clinical data of women will reside on a remote server, uploaded/stored 
by health care providers and pregnant women themselves through web 
user interface and PNCN application. Pregnancy-related information 
will be stored locally on the smartphones or computers where the 
application is installed in order to be used without an internet 
connection.PNCN will allow users to retrieve medical content (such as 
symptoms, preventions, guidance in case of danger signs and unknown 
conditions) as well as upload and modify clinical data and laboratory 
results. In addition, it will enable fast and reliable communication 
between nurses, health care providers, and pregnant women. 
The network is designed keeping in mind both low and high 
resource settings, making it equally applicable in all scenarios. In low-
resourced settings where there is limited availability of electricity and 
reliable internet connectivity, PNCN will use SMS for emergency 
communication and locally stored data in PNCN app. In the presence of 
a reliable internet connectivity, PNCN will have access to the latest data 
from the central server and will facilitate audio and video 
communication between women and health care providers. 
Synchronization of the data with the central server will occur when 
cellular or wireless internet connectivity is available. 
The primary users of PNCN are pregnant women, nurses and 
other health professionals who provide care to pregnant women in the 
community in rural health care facilities or in a hospital setting. The 
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level of education of these users can vary significantly so the system and 
its use are intended to be kept as simple as possible while still being 
comprehensive to ensure usability at all levels of intended use. 
PNCN offers a tool to health care providers for registration of 
new pregnancies in their respective community or hospital. Registered 
pregnancies will be effectively monitored up to the time of delivery and 
post-partum. Each area or community has selected staff in charge of 
Maternal and Child health. They are responsible for motivating 
community members to attend antenatal care and provide support and 
referral to the health centers for antenatal care, particularly in the case of 
a life-threatening event. After the registration of new pregnancies in the 
system, women download and install the app on their smartphone or PC, 
start getting customized information about their pregnancy and report all 
danger signs to the respective authorities through the facility provided in 
PNCN. 
For a normal pregnancy, the PNCN system will send automated 
notification and reminders at a specific date for clinical appointments 
(medical check-ups and follow-up visits), development of the fetus, 
delivery date etc. through the app and by SMS. In the case of danger 
signs, an emergency alert system can be triggered, which provides 
immediate feedback to the respective health care provider, advising on 
immediate action. Ambulance requests are forwarded to the nearest 
ambulance vehicle point to ensure that mother/infant is timely 
transferred for emergency obstetric and neonatal care. 
 
System Architecture 
In the Figure 1 illustrates the theoretical design and proposed 
system architecture for PNCN. The main components of the PNCN are 
the online server, web user interface, and the client app. Two interfaces, 
a web client and a standalone application will allow the user to 
communicates and interact directly with the online server and will allow 
the management and storage of Women health records. Web client (web 
user interface) will be used by health staff, health supervisors and 
emergency team while the standalone application (client app) will be 
used by pregnant women and general interested readers. The online 
server manages the physical infrastructure, such as storage file and 
women health records and is also responsible for performing 
maintaining operations, such as backing up data. 
Women health records at the online server is a system dedicated 
to collecting, storing, manipulating, and making available clinical 
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information important to the delivery of quality nursing care. The central 
focus of such systems is clinical data which consist of longitudinal 
record of a patient’s care carried out across different institutions and 
time. Women health records include demographic data, health history, 
laboratory results, immunization history, radiology reports, and drug 
allergies. 
 
 
Figure 1 – System Architecture of Pregnancy Nursing Care Virtual Network. 
 
 
Source: Made by the author (2016). 
 
Similarly, in client App, pregnancy-related information will be 
organized by time (month), by signs and symptoms and by disease name 
with the search facility as well, as shown in Figure 6. The locally 
maintained medical content will include information about female 
anatomy and reproductive system, health issues related to pregnancy, 
danger signs and precautionary measure in the form of videos, pictures 
and text and internet links. 
In addition to getting customized information, client App will 
also be used by pregnant women (if needed) to communicate with nurses 
and other health professionals. This communication can be real time 
(with video, audio, and text chat facility) or can be asynchronous where 
the sender and receiver reply whenever they are available. In the case of 
non-availability of internet coverage, pregnant women can send an 
important message via SMS. All she has to do is to press a button and 
the app will compose necessary content for the SMS and will send it to 
the web user interface and the pre-defined mobile number of the 
respective health professionals. There will also be a one click emergency 
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call option where the emergency team can be contacted via client app. 
Similarly, the web user interface will allow nurses and other 
health professionals to register pregnancy, manage and maintain women 
health records, interact and communicate with women, send messages 
and reminders and schedule appointments. 
The PNCN full system will consist of a client app running on the 
user’s smartphone, a central database containing all demographic and 
clinical data of women on an online server, and a web-interface that 
allows health professionals and supervisors to enter, retrieve and analyze 
health data of expectant mothers as shown in Figure 2. 
 
 
Figure 2 – Components and function of Pregnancy Nursing Care Virtual 
Network. 
 
 
Source: Made by the author (2016). 
 
System Development 
The application development life-cycle is a term used in systems 
engineering, information systems, and software engineering to describe 
a process for planning, creating, testing, and deploying an information 
system. It is a splitting of software development work into distinct 
phases (or stages) containing activities with the intent of better planning 
and management. We use the iterative and incremental development 
(LARMAN; BASILI, 2003) methodology for PNCN. The basic idea 
behind this method is to develop a system through repeated cycles 
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(iterative) and in smaller portions at a time (incremental), allowing 
software developers to take advantage of what was learned during the 
development of earlier parts or versions of the system. Learning comes 
from both the development and use of the system. The development is 
started with a simple implementation of the system and then iteratively it 
is improved until its full functionality is achieved. At each iteration, 
design modifications are made and new functional capabilities are 
added, as needed. 
It must be noted that during this thesis, I have focused and 
completed only the first two phases (Requirements and Design) of the 
development process of this network model. The others phases are 
intended to be completed in partnership with my advisor in a future 
research project. 
The development of PNCN will involve a process consisted of 
the following steps (LARMAN; BASILI, 2003): 
- Requirements: This phase consist of gathering information 
about the target population, determining the needs or 
conditions to meet, deciding the contents and knowledge to be 
delivered, the tasks and function to be completed, and analysis 
of available technologies feasible for development and 
implementation. 
- Design: The design phase consists of planning, creating 
specifications, conceptualizing and framing material and 
production of content, preparing the storyboard and layout 
design and user interface (color, fonts, images and buttons). 
- Develop: The third phase, development, involves the creation 
of the activities that will be implemented. It consists of 
developing and programming the navigation structure, user 
interface, settings, images, content, and animations. 
- Test: Testing ensures that the materials achieved the desired 
goals and basic functionality. It is used to verify whether the 
component meets the requirements decided earlier, responds 
correctly to all kinds of inputs, performs its functions in an 
acceptable manner, is sufficiently usable, can be installed and 
used in its intended environments, and achieves the general 
result its end users require. 
- Debug: Debugging is the process of identifying and removing 
errors that prevent correct operation of computer software or a 
system. 
- Deployment: This stage consists of the installation of PNCN 
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files to a central server and making available the client app 
through different mobile platforms. 
- Evaluate and Maintain: This phase involves review, 
evaluation and modification in a component after deployment 
to correct faults, add features, improve the performance or 
other attributes. 
 
Technology and Tools 
During design and development of PNCN, free software will be 
we preferred whenever possible. 
We will use Visual Studio Community 2015 Edition which is a 
free and rich integrated development environment for creating desktop, 
web and mobile applications and cloud services. It contains workspace 
and an extensible plug-in system for customizing the environment. 
Visual Studio Community 2015 Edition comes with Xamarin, which is a 
tool used to write native Android, iOS, and Windows apps with native 
user interfaces and share code across multiple platforms. For the 
development of client app, we used Visual Studio together with C# 
programming language and Xamarin. C# is a general-purpose 
programming language used for building desktop, web and mobile 
applications. 
For server side app and web user interface, we will use ASP.net 
and C# programming language. SQL Server database will be used for 
storing and managing demographic and health records of expectant 
mothers. For the production of two-dimensional graphics and 
manipulating and retouching photos we will MS Paint and Adobe 
PhotoShop CS6. For animation Adobe Flash CS6 (vector graphics 
program used to create interactive animations) will be used. in addition, 
tools like JavaScript, XML, AJAX, Web 2.0, Web-services and JSON 
will also be incorporated during the development of PNCN. 
Programming files of PNCN will be installed on a central server 
and client app will be made available for free download on different 
mobile platforms (Windows, Android, and iOS), where anyone will be 
able to download it and use it. 
 
User Interface 
The web user interface and client app will be equally used from 
any computing device (mobile, tablets and desktops) with internet 
connectivity. The interfaces will be responsive (adjusted automatically 
according to the device screen size) and will look good on all devices 
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including small mobile devices, tablets, and desktops. The content will 
reside remotely on an online server but access will be presented to the 
user as the resources are located locally in the device. Women clinical 
data management, information regarding women status, related 
biosignals can be displayed and managed through the system’s interface 
(web user interface and client app). Pregnancy-related information is 
stored locally in the client app so that it can be used without any active 
connection to the Internet. Connectivity to health professionals will 
require an active Internet connection or a mobile operator connection. 
 
 
Figure 3 – User interface login. 
 
 
Note: (a) show welcome screen of the client app. (b) show login screen for registered women. 
Source: Made by the author (2016). 
 
Client App 
PNCN will support the ability to input, view, and edit the women 
history, clinical information, and current symptoms. The app will also 
allow viewing of past evaluations and prescribed medications. All 
entries will be logged with timestamps to ensure data consistency. The 
expected date of delivery is calculated from ultrasound measurements, 
last menstrual period or fundal height, in order of reliability when 
available. 
PREGNANCY NURSING CARE PREGNANCY NURSING CARE 
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The first screen of the client app is shown on Figure 3 (a), where 
the user has an option to use the app as a guest user or as a registered 
pregnant woman. As a guest user, only pregnancy related information 
are available for display. Figure 3 (b) shows the login screen for 
registered pregnant women. Similarly, Figure 4 (a) shows the front 
screen for the guest user when they enter the client app and Figure 4 (b) 
shows the front screen for registered users where pregnancy-related 
information, as well as clinical data, are available. 
The app will display pregnancy related information divided into 
different sections. The app will educate women about female anatomy 
and pregnancy-related diseases and provide help and guidance regarding 
prevention, control, signs and symptoms of each stage and complication 
of pregnancy and delivery. It will provide interactive information based 
on text, images, videos and internet links and will keep women informed 
and connected anytime, anywhere. 
 
Figure 4 – User interface start screen. 
 
Note: (a) Main screen for guest users (b) main screen for registered pregnant women with 
explanation of icon bar. 
Source: Made by the author (2016). 
 
In the Figure 5 are self-explanatory and show options for 
communication with health staff and emergency team. The system will 
allow a two-way flow of information. A registered health professional 
PREGNANCY NURSING CARE PREGNANCY NURSING CARE 
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can create and send a customized message to particular women. In the 
same way, registered women can create and send customized messages 
to health professionals. Each party will be notified if they receive a 
message and the sender will be notified when his/her message is read. If 
a high priority message is not signaled read in a particular amount of 
time, it is assumed that the receiver is offline and an SMS will be tried 
to send as an alternative method. For each registered pregnancy, the 
system will send notification and reminders, one from the health 
professionals and one from the system itself (it will be automatic, based 
on the time and characteristics of women). In the case of danger signs 
(hemorrhage, in labor and at home, and unknown serious condition) 
during pregnancy the system can be used to send emergency requests to 
nearest ambulance service manager for immediate intervention. This 
message will include the danger sign reported, the name, address and 
contact details of women. A message will be sent back to the women 
indicating the immediate action to manage the danger sign and prepare 
pending ambulance arrival. 
It must be noted that users can access information in a nonlinear 
way, without any specific order to navigate the PNCN leaving user free 
to establish the construction of knowledge. 
 
Figure 5 – User interface main. 
 
Note: (a) Main screen for triggering Pregnancy Emergency Response System. (b) Main screen 
for communication with health staff. 
PREGNANCY NURSING CARE PREGNANCY NURSING CARE 
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Source: Made by the author (2016). 
Web User Interface 
A password-protected Web user interface will be developed for 
use by nurses and other health professionals. Web user interface will 
give access to women demographic and clinical data and enables 
tracking history of individual woman as well as the output of reports. 
The password protected web user interface presents an overview of the 
system’s outputs including individual and aggregated reports, statistics, 
and system administration, a log of reminders. 
 
 
Figure 6 – Proposed Contents for PNCN. 
 
Source: Made by the author (2016). 
 
Data can be filtered by the community, age, complication and 
other characteristics. A user working in a health facility at the district 
level will be assigned an account, granting him/her permission to view 
and possibly modify data only from his health facility’s catchment area. 
The web user interface will also enable dynamic data collection and 
sharing regarding pregnant women and maternity care centers. 
 
Functionalities 
Women will be registered in the system at her first pregnancy. 
Primary health care centers, maternity homes, and hospitals, which have 
154 
 
administrative access to the system can register pregnancy of women 
when it is confirmed. All details of women are inserted into the system 
including, name, date of birth, contact details, any medical conditions 
etc. Each time a woman gets pregnant, her pregnancy has to be 
registered into the MNCN system. If a woman is already in the system 
and this is the second or third time she becomes pregnant then only her 
pregnancy is registered and other registration details are updated (if 
required). At first registration, each woman will be allocated a unique 
username (or registration number) and a temporary password which she 
can change later. Figure 7 presents the system’s workflow in the MNCN 
system. 
 
Figure 7 – Information Flow in Pregnancy Nursing Care Virtual Network. 
 
Source: Made by the author (2016). 
 
Each time pregnant women have some complication and visit 
maternity home, her profile will be updated with the latest medical tests 
and treatment. After registration, women will start using the client app 
(using smartphone, tablet or PC). At each stage of pregnancy, women 
will get useful information and guidance about respective complications 
in pregnancy. Pregnant women and Nurses can use PNCN to 
communicate with each other. Real-time communication can be done in 
case if both parties are online at the same time, otherwise, a message 
will be left which can be accessed when the user become online. Details 
functions of the system are presented in Fig. 8. 
Primary health care centers and health authorities can get 
statistics of pregnant women in a certain region or area which will help 
them in important decisions regarding women health and maternal 
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mortality. PNCN will automatically remind pregnant woman about each 
visit, follow-up visit, expected and delivery date, possible complication, 
nearest emergency and referral centers. 
A feedback option is available for possible suggestion, 
improvement, and complaints about the system from potential users. 
MNCN will support the following task through its client app and web 
interface. 
 
 
Figure 8 - System Features of Pregnancy Nursing Care Virtual Network. 
 
Source: Made by the author (2016). 
 
 
Using Client App 
- Educate women; 
- Immediate access to women data (only available to registered 
user); 
- Longitudinal collection of health information of women (only 
available to registered user); 
- Connect with Health staff and emergency service (only 
available to registered user); 
- Feedback to the system. 
 
Using Web User Interface (Authorized Users) 
- Register pregnancies; 
- Add and update clinical data; 
- Provide guidance, make appointments and referrals; 
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- Set reminders; 
- Analyze data and monitor pregnancies; 
- Feedback to the system. 
 
Security, Privacy, and Confidentiality of Women Information 
In the client app, the privacy of each registered pregnant women 
will be taken into account by using passwords for login. Access to an 
online database and clinical data is granted only to authorized users to 
protect and maintain women’s health information. On the web user, 
interface access can be granted by policies and job titles. Different 
policies can be generated for a different type of staffs according to their 
role in the health system. Each policy will define who can access and 
what type of activities are permitted. For instance, health staff is granted 
complete access in order to perform their care provision role. Similarly, 
the emergency team has no access to clinical data, they can only 
communicate and respond to emergency calls from authorized pregnant 
women. Despite particular access level, it is the health care 
professional’s responsibility to protect and maintain the privacy of 
women’s information and clinical data. Moreover, the online server will 
be configured to back up necessary data daily or weekly. 
 
Ethical Considerations 
This study was developed in the context of project TO 
13075/2012 - FAPESC, Opinion No. 120.343 and No. 169.110 of the 
year 2012 (Annexes A and B) and for that reason, it respects what is set 
out the resolution no. 466/2012, of the Ministry of Health Brazil 
(BRASIL, 2013). However, the completion of this research work did not 
involve any human subjects. 
 
 
EXPECTED RESULT 
 
The PNCN system will enhance the quality, safety, and efficiency 
of pregnancy care during pregnancy and childbirth. It will enable 
effective and real-time two-way communication between pregnant 
women and CHW / nurses at the community level, and the rest of the 
health system (ambulance, health facility staff, District Hospital, and 
Central level) through smartphones. The primary expected result of the 
system is an improved access to antenatal, postnatal care, institutional 
delivery, and emergency obstetric care. In addition, PNCN will provide 
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a database for keeping clinical records of pregnant women and maternal 
care delivery. 
PNCN will make possible, easy and useful communication 
between pregnant women and health care providers and will improve 
women knowledge and awareness regarding pre-eclampsia and 
eclampsia and other pregnancy-related complications and maternal 
health. It will reduce the different type of delays associated with 
pregnancy care such as in-home (due to lack of information and 
awareness). 
It will improve antenatal, postnatal care and record keeping and 
maternal health indicators for policy makers. This network will enable 
monitoring, follow-up, referrals and interactive information for pregnant 
women along with continuity of care from the start of the pregnancy all 
the way through her post-partum period. 
PNCN will replace paper-based medical records which can be 
incomplete, fragmented, hard to read and sometimes hard to find. It will 
provide a single, shareable, up to date, accurate, the rapidly retrievable 
source of information, potentially available anywhere and anytime. 
PNCN will require less space and administrative resources and has the 
potential for automating, structuring and streamlining clinical workflow. 
It will provide integrated support for a wide range of discrete care 
activities including, monitoring, electronic appointments and reminders, 
electronic referrals, real-time communications and health profile display 
and continuing pregnancy education and awareness. It will increase 
antenatal care visits through application reminders and enable access / 
call to emergency obstetric care when complications arise and will 
improve referral communication and will increase access to quality care. 
It will provide easy access to women clinical data and reduce medical 
errors. 
 
 
LIMITATIONS 
 
It must be noted that different mobile network operators and 
internet access are available in many parts of the world and its 
availability is increasing day by day. The proposed technology of PNCN 
and its prominent functions can be equally used in those areas where 
either a mobile network operator or internet access is available. 
However, there might be some parts of the globe where neither a mobile 
network operator nor internet access is available. In that case, only half 
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of the functionality of PNCN can be used. It’s locally stored pregnancy 
related information can be used by pregnant women but the main feature 
and innovation of MNCN which is its ability to communicate remotely 
with nurses and health professionals, will not be available. 
Similarly, in the initial phase, PNCN will be implemented in 
English language only and in the future it will be gradually realized in 
other major languages as well. Moreover, during the development and 
implementations phase of PNCN, some of the features and components 
can be modified or new ones may be added to our current design 
proposal. The big advantage is that women will have free access which, 
of course, will also encourage authors to perform adjustments to the 
proposed design to meet new demands. 
 
 
CONCLUSION 
 
All pregnant women need timely access to high-quality health 
care services. Moreover, pregnant women need customized information 
and education according to their demands, needs and respective 
situation. Information and communication technologies can play an 
important role in automating and facilitating these services to pregnant 
women in a fast and efficient way and can thus prevent pre-eclampsia 
and eclampsia and other pregnancy-related complications to reduce 
maternal mortality. In this research we have proposed a design of a 
PNCN, a network model which can be used to educate mothers, monitor 
pregnancy and improve maternal health. The network model is designed 
to strengthen communication links between health care providers and 
pregnant women and to increase education, awareness, and quality of 
nursing care during pregnancy, childbirth till the period of post-partum. 
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5 FINAL CONSIDERATION 
 
 
Maternal mortality indicates the quality of women’s health and 
the life quality of a population providing a measure of human and social 
development. Information on maternal mortality is essential for setting 
priorities for policy making and research strategies. 
Every day women die due to pregnancy and childbirth 
complications. The risk of a woman in a developing country dying from 
a maternal-related cause during her lifetime is higher when compared to 
a woman living in a developed country. 
Pregnant women die as a result of complications which either 
develop during pregnancy or may exist previously but are aggravated 
during pregnancy. The primary causes of death are hemorrhage, 
hypertension, and infections.  
Pre-natal nursing care support is very important for the 
prevention of pre-eclampsia, eclampsia and other causes of the maternal 
mortality. Therefore, due to the rapid improvement in information and 
communication technologies and the growing acceptability of mobile 
devices, we proposed a study theme that meets both the demands of 
nursing care and women health, opting to develop a Pregnancy Nursing 
Care Virtual Network in order to strengthen links between nurses and 
pregnant women and prevent pre-eclampsia and eclampsia. 
A process was involved in the development of Pregnancy 
Nursing Care Virtual Network, but in this thesis, only two steps were 
applied: requirements and design. The first consists of gathering 
information about the target population, determining the needs or 
conditions to meet, deciding the contents and knowledge to be 
delivered, the tasks and function to be completed, and analysis of 
available technologies feasible for development and implementation. In 
the second was planning, creating specifications, conceptualizing and 
framing material and production of content, preparing the storyboard, 
layout design and user interface (color, fonts, images and buttons). For 
that reason we conducted a review to analyze and evaluate the available 
technologies, techniques and the nursing care practices used for the 
prevention and control of pre-eclampsia and eclampsia. When this 
information was acquired we defined the design of the network. 
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Why Nursing Care Virtual Network? 
 
Nurses provide health care and are the frontline health care 
providers. So they are expected to offer skilled and effective nursing 
care to the pregnant women. They should have the ability to detect any 
pregnancy complications and conduct initial management and referral of 
maternal and newborn complications to higher health facilities. The 
nurse can promote communication between health care providers and 
pregnant women, increase education and quality of nursing care during 
pregnancy. 
The most important contacts in health care will always be the 
face-to-face meetings. However, with the help of interactive tools on the 
Internet, patients can strengthen their influence on health care by getting 
both general and specific information. Health care accessibility 
increases when patients can contact health care professionals at any hour 
or are able to retrieve information and leave messages by the same 
media. This interactivity and connectivity are greatly improving health 
care accessibility by increasing contacts of patients with nursing 
professionals at any time anywhere and can retrieve specific information 
in less time. 
The PNCN full system consist of a client app running on the 
user’s smartphone or PC, a central database containing all demographic 
and clinical data of women on an online server, and a web-interface that 
allows health professionals and supervisors to enter, retrieve and analyze 
health data of expectant mothers. Client app will provide pregnant 
women, customized information and education according to their 
demands, needs and respective situation. 
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